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Abstract 
 
Enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), and Citrobacter 
rodentium are diarrhoeal pathogens grouped together on the basis of their ability to intimately 
adhere to host intestinal epithelia and efface brush border microvilli to form the broader 
category of attaching effacing (A/E) pathogens. While EPEC and EHEC are human 
pathogens of global health concern, C. rodentium is a natural murine pathogen which serves 
as an excellent animal model for in vivo studies.  
 
A/E pathogens encode a filamentous type 3 secretion system (T3SS) which is used to deliver 
virulence factors called effectors directly into the host cell. Both in vivo and in vitro studies 
have demonstrated that the T3SS is integral to the A/E pathogen virulence strategy. Once 
translocated to the host cell, effector proteins modulate and disrupt a wide range of host cell 
signalling pathways and processes including the immune response, cytoskeletal dynamics, 
GTPase signalling pathways, phagocytosis and apoptosis. As a defence strategy, the host 
responds by activating an immune response and apoptosis. However, several studies have 
reported that epithelial cells infected with EPEC do not undergo apoptosis despite the 
presence of early markers of apoptosis.  
 
Recently the NleH effectors were identified in a secretomic and genomic analysis, however 
their function remains unknown.  NleH effectors are present in all sequenced A/E pathogen 
strains and can be found in duplicate copies (nleH1 and nleH2). We verified that EPEC 
NleH1 and NleH2 are secreted and translocated in a T3SS dependent manner. 
 
In this study we demonstrate that NleH effectors have anti-apoptotic function. During 
infection of cultured cell lines, we found increased nuclear condensation, membrane 
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blebbing, caspase-3 cleavage and cell death and detachment in an nleH1 and nleH2 double 
mutant in comparison to wild type EPEC. Furthermore, treatment with a global caspase 
inhibitor abolished cell loss due to cell death or detachment. Using ectopic expression, we 
showed that NleH1 alone is sufficient to inhibit caspase-3 cleavage in the presence of the 
general apoptosis inducers staurosporine and the ER stress apoptosis inducers tunicamycin 
and brefeldin A. Interestingly we found that NleH effectors are kinases, however their kinase 
activity is not involved in the inhibition of apoptosis. However, an intact C terminus is 
essential for NleH’s anti-apoptotic activity.  
 
To determine the pathway by which NleH effectors inhibit apoptosis a HeLa human cDNA 
library was used to screen for potential binding partners using a Y2H assay. The ER anti-
apoptotic protein Bax inhibitor 1 (BI-1) was identified as a putative binding partner and 
verified using a direct 2 hybrid assay. Knockdown of BI-1 resulted in loss of NleH’s 
cytoprotective function. As BI-1 plays a role in calcium homeostasis, the effect of NleH 
effectors on cytosolic Ca2+ levels was assessed. We found that NleH effectors reduced 
cytosolic Ca2+ levels in a BI-1 dependent manner.  
 
Using the C. rodentium animal model we verified the ability of NleH to inhibit apoptosis in 
vivo by demonstrating that NleH inhibits caspase-3 activation and nuclear condensation at the 
site of bacterial attachment. Furthermore, we found a reduction in cell exfoliation in the 
presence of NleH. Additionally we showed that the NleH effectors play a role in 
competitiveness and also induce a mild but significant increase in NF-KB activation and 
TNF-expression.  
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Together our results demonstrate that NleH effectors are multi-functional proteins that inhibit 
apoptosis both in vitro and in vivo, and are kinases with an unknown function. Furthermore, 
NleH effectors induce a local NF-KB and TNF- upregulation which could be linked to its 
anti-apoptotic activity. NleH effectors may provide a competitive advantage by preventing 
shedding of infected cells to prolong infection.  
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1.1 Pathogenic E. coli  
 
 
Escherichia coli is a member of the commensal intestinal microflora of humans and other 
mammals. The host and commensal E. coli coexist in auspicious symbiosis rarely causing 
infection except in immunocompromised hosts or when the gastrointestinal barriers are 
breached. However, several E. coli clones have acquired specific virulence attributes via 
horizontal transfer of mobile genetic elements resulting in the generation of more virulent 
“pathotypes” of E. coli (Kaper et al., 2004). Their capacity to infect and disseminate can be 
attributed to the presence or absence of virulence factors including toxins, adhesins and 
secreted effectors.  
 
Pathogenic E. coli most commonly infects the gastrointestinal and urinary tract causing 
enteric/diarrhoeal disease or urinary tract infections (UTIs) respectively. Some pathotypes of 
E. coli also have the capacity to induce more severe systemic complications, which can 
include sepsis, meningitis and renal failure. The tremendous plasticity, highly dynamic 
genome (Donnenberg and Whittam, 2001) and divergent niches of pathogenic E. coli has 
resulted in the recent grouping of pathogenic E. coli into three major categories: (i) 
extraintestinal pathogenic E. coli (ExPEC), (ii) intestinal pathogenic E. coli (InPEC) and (iii) 
commensal E. coli (Kaper et al., 2004; Russo and Johnson, 2000).  
 
1.2 The Intestinal Pathogenic E. coli (InPEC)  
 
There are six InPEC pathotypes which include: enteropathogenic E. coli (EPEC), 
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enterohaemorrhagic E. coli 
(EHEC), enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC), each 
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having distinct histopathological and clinical characteristics (Figure 1) (Chen and Frankel, 
2005; Kaper, 2005; Kaper et al., 2004; Nataro and Kaper, 1998). Traditionally, clonal groups 
were classified on the basis of which O (Somatic lipopolysaccharide, LPS), H (flagellar) and 
K (capsular) antigens they express. Serogroups are defined on the basis of O antigen 
presentation and serotypes are based on the combination of O and H antigens (Nataro and 
Kaper, 1998). Some serogroups can be found in multiple pathotypes, so one pathotype can 
comprise several serogroups and one serogroup can belong to multiple pathotypes including 
non-pathogenic E. coli (Campos et al., 2004; Nataro and Kaper, 1998).  
 
Among the pathotypes, EPEC was the first E. coli to be associated with human disease and is 
a major cause of infantile diarrhoea in developing countries (Nataro and Kaper, 1998). EPEC 
is characterised on the basis of its ability to form attaching effacing (A/E) lesions (Figure 2A) 
(Chen and Frankel, 2005). The most prevalent serogroups within the EPEC pathotype are: 
O26, O55, O86, O111, O114, O119, O125, O126, O127, O128, O142 and O158 (Nataro and 
Kaper, 1998). EPEC has recently been divided in to two distinct evolutionary lineages: 
EPEC1 and EPEC2. EPEC1 is characterised on the basis of its expression of the flagellar 
antigens H6 or H34 (Whittmen et al 1993) and the Intimin subtype α (Adu-Bobie 1998). 
EPEC2 expresses the flagellar antigen H2 or can be H-, and encodes the Intimin subtype  
and the effector protein TccP2 (see below). EPEC strains can also be differentiated as typical 
or atypical depending on the presence or absence of the EAF (EPEC Adherence Factor) 
plasmid respectively.  
 
Like EPEC, EHEC also has the capacity to form A/E lesions, but is most prevalent in 
industrialized countries. EHEC causes a plethora of illnesses ranging from mild diarrhoea to 
severe diseases such as haemorrhagic colitis and haemolytic uremic syndrome (HUS), which 
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are mediated by of the potent Shiga toxins (Stx) (Nataro and Kaper, 1998). The most 
prevalent EHEC serogroups are: O26, O111ab, O113, O145, O157 and O15. Interestingly, 
many of the EHEC serogroups are also found in EPEC (Stenutz et al., 2006).  
 
ETEC also causes diarrhoea in children especially in tropical climates, where uncontaminated 
water is not readily available, and is the most common cause of traveller’s diarrhoea. ETEC 
strains are classified on the basis of their ability to produce a number of fimbrial colonisation 
factors and two types of enterotoxins: Heat-stable toxin (ST) and Heat-labile toxin (LT) 
(Nataro and Kaper, 1998). The prevalent ETEC serogroups are: O6, O8, O11, O15, O20, 
O25, O27, O78, O128, O148, O149, O159 and O173 (Stenutz et al., 2006).  
 
While most pathogenic E. coli remain extracellular, EIEC is a truly intracellular pathogen 
that is very closely related to Shigella, causing diarrhoea and dysentery that begins with the 
invasion of epithelial cells or macrophages and spreads into adjacent cells (Kaper et al., 2004; 
Lan et al., 2004). The most common EIEC serogroups are: O28ac, O29, O112ac, O124, 
O136, O143, O144, O152, O159, O164 and O167 (Stenutz et al., 2006). Interestingly the 
serogroups O112ac, O124, and O152 are identical to Shigella boydii and Shigella dysenteriae 
(Parsot, 2005).  Both EIEC and Shigella harbour a 220 kilobase (kb) plasmid referred to 
generally as pINV which is the primary locus required to bring about bacterial invasion of 
non-phagocytic cells. 
 
The EAEC and DAEC pathotypes are defined based on patterns of adherence to cultured cell 
lines. EAEC is defined as E. coli that do not secrete heat-labile or heat-stable enterotoxins, 
and adhere to HEp-2 cells in an aggregative adherence pattern (Nataro and Kaper, 1998). 
EAEC is an emerging pathogen of concern in both developing and industrialised countries 
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that causes acute and persistent diarrhoea in children, adults, travellers and 
immunocompromised hosts (Nataro and Kaper, 1998). Since the initial characterisation of its 
pathotype, EAEC strains have been found to produce several enterotoxins and cytotoxins 
(Harrington et al., 2006; Kaper, 2005). Serogroups identified within the EAEC group include 
O3, O7, O15, O44, O77, O86, O111, O126 and O127 (Stenutz et al., 2006). DAEC, on the 
other hand, has been grouped on the basis of its diffuse pattern of adherence on HEp-2 cells 
(Nataro and Kaper, 1998). The DAEC pathotype is a heterogeneous group and can be divided 
into two classes. The first class of DAEC strains harbour Afa/Dr adhesins (Afa/DrDAEC) 
and are associated with urinary tract infections and less frequently with enteric infections. In 
general Afa/Dr DAEC strains appear to express characteristics of extraintestinal E. coli 
strains (Servin, 2005). The second class of DAEC includes E. coli strains that express 
adhesins involved in diffuse adherence (AIDA) and have homologues of several virulence 
factors associated with EPEC and EHEC. This class of DAEC is a potential cause of infantile 
diarrhoea (Servin, 2005). 
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Figure 1: Schematic diagram of the 6 major diarrhoeagenic E. coli categories. Each category has unique 
features in respect to their interaction with eukaryotic cells as found from in vitro studies. A) EPEC 
adheres (1) to enterocytes disrupting microvillar architecture and utilizing its type 3 secretion system (2) 
to inject effectors to form attaching and effacing lesion (A/E) (3) and inducing diarrhoea. B) EHEC also 
induces A/E lesions but also utilise its potent Shiga toxin (Stx). C) ETEC colonises the brush border via 
CFA and uses its LT and ST enterotoxins to induce watery diarrhoea. D) EAEC adheres to the epithelia 
in a thick biofilm and secretes enterotoxins and cytotoxins. E) EIEC invades the epithelial cells, lyses the 
phagosome and nucleates actin microfilaments for lateral spread into an adjacent cell or out of the cell to 
enter the baso-lateral cells. F) DAEC initiates growth of longer finger like cellular projections that wrap 
the bacteria. (AAF, aggregative adherence fimbriae; BFP, bundle-forming pilus; CFA, colonization factor 
antigen; DAF, decay-accelerating factor; EAST1, enteroaggregative E. coli ST1; LT, heat-labile 
enterotoxin; ShET1, Shigella enterotoxin 1; ST, heat-stable enterotoxin.) Reproduced from Kaper et al. 
(2004) (Kaper et al., 2004). 
 
 
1.3 Secretion Systems: T1SS-T6SS 
 
A key feature of bacterial pathogens is their ability to secrete proteins from the bacterial 
cytoplasm to the bacterial cell surface, the extracellular milieu or even to inject virulence 
factors in the cytosol of the eukaryotic cell (Figure 3). Several secretion systems including 
type 1, 2 and 5 (T1SS, T2SS and T5SS) secrete proteins from the bacterial cell cytoplasm to 
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the extracellular space. Other secretion systems including type 3, 4 and 6 (T3SS, T4SS and 
T6SS) deliver proteins across the bacterial cell and directly into the host cell cytosol. Proteins 
secreted by these secretion systems are termed effectors and play major roles in defining the 
pathogens’ virulence properties (Kenny and Valdivia, 2009). Secretion systems such as the 
chaperone/usher pathway can also be employed for the formation of bacterial surface 
adhesive organelles. 
 
Among the secretion systems, T1SS is relatively simple and is composed of a translocator 
ABC-transporter, which energises the system through ATP hydrolysis, a multimeric 
Membrane Fusion Protein (MFP), which begins at the periplasm and forms a continuous 
channel to the cell surface, and an outer membrane trimeric protein secretin. The secretion 
signals for the T1SS are uncleaved and poorly conserved (Holland et al., 2005). The 
prototypical protein secreted by the T1SS is -haemolysin (Holland et al., 2005).  
 
The majority of protein transport across bacterial plasma membranes is carried out by the 
general secretion pathway (Sec) (Driessen and Nouwen, 2008). The Sec system is composed 
of several key elements including a membrane spanning translocase channel composed of 
three integral membrane proteins SecY, SecE and SecG (Brundage et al., 1990) and the 
multifunctional protein SecA (Economou, 1998). SecA binds to the unfolded cytoplasmic 
precursor substrates of the Sec system, which are defined by the presence of an amino 
terminal signal sequence, and guides them to the SecYEG translocase. SecA then acts as an 
ATPase undergoing several sequential rounds of ATP loading and hydrolysis associated with 
conformational shifts in order to drive the secretion of substrate proteins (Economou and 
Wickner, 1994).  
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In addition to the Sec dependent transport of unfolded proteins, folded proteins can be 
transported across the bacterial cytoplasmic membrane via the Twin arginine transport 
system (Tat). The Tat system is so called based on the presence of two adjacent arginine 
residues within the signal sequence. Tat secretion is dependent on two or three integral 
membrane proteins and energy for protein conduction is provided via proton motive force 
(Natale et al., 2008). Following translocation of proteins to the periplasm the Sec or Tat 
signal peptide is cleaved and the secreted proteins either remain in the periplasm (Tat) or are 
translocated across the outer membrane (Sec). Translocation across the outer membrane is 
mediated by a number of mechanisms known as the terminal branches of the general 
secretory pathway (T2SS, T5SS and chaperone/usher pathway).  
 
The T2SS consists of 12 core components which include the outer membrane secretin, a 
cytoplasmic ATPase, an inner transmembrane protein, the major and minor pseudopilins, the 
pre-pseudopilin peptidase/methyltransferase, and a protein that might be involved in substrate 
recognition and/or secretin interactions (Cianciotto, 2005). Apart from translocation of 
proteins to the extracellular space, a T2SS-like system is also fundamental to the extension of 
cell surface attached appendages such as type IV pili (Pugsley, 1993). 
 
The T5SS consists of two sub-systems, the autotransporter protein system and two-partner 
system. Proteins in the T5SS consist of four functional domains, the signal sequence, 
passenger domain, linker region and -domain. Autotransporter proteins are synthesised and 
exported via the Sec machinery through the cytoplasmic membrane. The signal sequence is 
cleaved upon secretion and the -domain inserts into the outer membrane to form a -barrel 
structure that forms a pore in the outer membrane. The passenger domain inserts into the pore 
and is translocated to the bacterial cell surface for further processing. The two-partner 
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secretion system is similar to the autotransporter system involving export to the periplasm 
and insertion of the outer membrane pore formed by a -barrel however instead of the protein 
being produced by a single polypeptide, the passenger domain and pore-forming -domain 
are translated as two separate proteins (Henderson et al., 2004).  
 
The chaperone/usher pathway is also a terminal branch of the Sec pathway and is dedicated 
to the assembly and secretion of a broad range of adhesive virulence structures on the surface 
of Gram-negative bacteria. This pathway requires only two components which includes a 
periplasmic chaperone and an outer membrane protein called usher. The prototypical 
organelles that are assembled using the chaperone/usher pathway are P and type 1 pili. Once 
in the periplasm the pilus subunits interacts with the chaperone via donor strand exchange 
(Thanassi and Hultgren, 2000). The chaperone-subunit complexes are targeted to the outer 
membrane usher, which results in chaperone dissociation, exposing subunit assembly 
surfaces and allowing the pilus fibre formation via donor strand complementation (Thanassi 
and Hultgren, 2000). The usher also provides a translocation channel through the outer 
membrane for secretion of the pilus (Thanassi and Hultgren, 2000). 
 
Unlike the T2SS, T5SS and chaperone/usher pathways, secretion via the T3SS is a one-step 
process. The T3SS is a major virulence determinant expressed by many Gram-negative 
human, animal and plant pathogens, including Salmonella, Shigella, Pseudomonas and E. 
coli. The T3SS consists of conserved proteins similar to the bacterial flagellar basal body. 
The key component of the T3SS is the injectisome complex, which is composed of about 25 
proteins, of which about half are conserved in all T3SSs. The T3SS apparatus has a basal 
body consisting of inner and outer membrane rings, a membrane-associated ATPase, and a 
helical extracellular stiff needle-like structure. The outer membrane ring is composed of one 
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main protein component, secretin, which is secreted via the Sec system (Yip and Strynadka, 
2006)). The signals recognised by the injectisome are encoded on the N-terminal region of 
the secreted effector proteins (Mota and Cornelis, 2005; Mota et al., 2005). However, the 
secretion signal is not cleaved upon secretion and does not seem to have a conserved feature 
shared among all substrates of the same T3SS (Galan and Wolf-Watz, 2006). The T3SS 
apparatus is also involved in the secretion of structural components responsible for 
constructing extracellular structures during the assembly process including the needle, needle 
extension and translocation pore subunits. Once assembled the T3SS translocates proteins 
directly into the cytoplasm of the eukaryotic host cell (Yip and Strynadka, 2006). The 
assembly and operation of T3SS secretion system is dependent upon cytosolic chaperones. 
Class I chaperones bind effector proteins, maintain them in a secretion competent 
conformation and may also play a role in secretion hierarchy (Creasey et al., 2003a). Class II 
chaperones bind to the translocator proteins in order to inhibit their toxicity to the bacterial 
cell (Creasey et al., 2003b). Class III chaperones are involved in mediating the correct 
assembly of the T3SS injectisome and preventing premature assembly of the complex by 
masking the oligomerisation domains (Yip et al., 2005).  
 
Like the T3SS, the T4SS can also inject its substrates directly into the host cell, or into the 
extracellular space, however the T4SS substrates can be proteins or DNA-protein complexes 
and the recipient can be bacteria from the same or different specie or can be a mammalian, 
fungal or plant cell (Backert and Meyer, 2006). The typical T4SS apparatus spans the 
periplasm and both bacterial membranes, and in some T4SS is associated with an 
extracellular pilus. Three ATPases are involved in substrate secretion and system assembly, 
along with an inner membrane channel, and possibly a periplasmic protein in complex with a 
short lipoprotein (Fronzes et al., 2009).  
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Recently a novel secretion system, the T6SS was identified. The T6SS is encoded on 
approximately 15 genes and is composed of an ATPase, a channel that extends through and 
outside the cell envelope, a puncture device, a putative outer membrane lipoprotein and inner 
membrane proteins (Filloux et al., 2008). A recent model of T6SS suggests that the structural 
proteins of the T6SS are exported into the periplasm though a multi-protein complex at the 
inner membrane. In the periplasm they form a hexameric ring that docks beneath the phage 
tail-like tip. This creates an elongated tube that pushes through the outer membrane. Upon 
contact with a host membrane, this phage tail-like structure punctures the lipid bilayer and the 
tip exposes a previously concealed effector-domain to the host cytosol allowing it to interact 
with host cell target proteins to affect host cell function. The tip then detaches from the T6SS 
apparatus leaving a uncapped conduit for effector protein delivery into the host cell (Pukatzki 
et al., 2009). Pathogens utilise these secretion systems to secrete and/or translocate effector 
proteins to the surface of or directly into eukaryotic cells to modulate host cellular pathways. 
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Figure 2: Type 1-5 secretion systems in Gram-negative bacteria showing one-step secretion systems 
(T1SS, T3SS and T4SS). T3SS and T4SS proteins are transported from the bacterial cytoplasm to the 
target cell cytosol. T2SS and T5SS are two-step processes. Proteins are first transported to the periplasm 
via the Sec or Tat system before they reach the cell surface. In the T5SS autotransporter system the C-
terminus of the protein forms the outer membrane channel (cylinder) while the N-terminus (pink line) is 
exposed to the surface or released by proteolytic cleavage (scissors). C, bacterial cytoplasm; IM, bacterial 
inner membrane; P, bacterial periplasm; OM, bacterial outer membrane; ECM, extracellular milieu. PM 
(beige region), host cell plasma membrane. When appropriate, coupling of ATP hydrolysis to transport is 
highlighted. Arrows indicate the route followed by transported proteins. Reproduced from Filloux et al., 
2008 (Filloux et al., 2008). 
 
 
1.4 Attaching Effacing Pathogens 
 
The EPEC and EHEC pathotypes share many commonalities, the most pronounced being the 
ability to produce the attaching effacing (A/E) histopathology (Figure 2A), which is 
characterised by intimate adhesion of the pathogen to the host intestinal epithelia and 
localised effacement of brush border microvilli (Knutton et al., 1987). Based on these 
characteristics, EPEC and EHEC are members of the broader category of the A/E pathogens, 
which also include rabbit EPEC (REPEC, RDEC-1), porcine EPEC (PEPEC), dog EPEC 
(DEPEC) and the mouse pathogen C. rodentium (Goosney et al., 2000).  
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The ability to form A/E lesions is attributed to the presence the locus of enterocyte 
effacement (LEE) pathogenicity island (PAI) (McDaniel et al., 1995). The LEE PAI encodes 
gene regulators, the outer membrane adhesin Intimin (Jerse et al., 1990), the structural 
components of a T3SS (Jarvis et al., 1995), chaperones, translocators and several effector 
proteins (Garmendia et al., 2005).  
 
Figure 3: A) Attaching effacing lesion shown using electron micrograph of cultured human intestinal 
mucosa infected with EPEC. Bacteria are intimately attached to a cup-like projection of the enterocyte on 
the apical membrane causing localised destruction of microvilli and cytoskeleton magnification X 45, 000 
Reproduced from Knutton et al. (1987) (Knutton et al., 1987) B) Epithelial cells form pedestal-like 
structures resulting from localised actin polymerisation. Reproduced from Kaper et al. (2004) (Kaper et 
al., 2004). 
 
1.5 The A/E Pathogen T3SS  
 
The T3SS of A/E pathogens consists of a membrane embedded needle apparatus with a 
continuous channel linking the bacteria to the host cell allowing delivery of the effectors 
proteins directly into the host cell cytosol (Garmendia et al., 2005). The fundamental 
components of the T3SS resemble those in other bacteria with EscC, EscR, EscS, EscT, EscU 
A B 
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and EscV forming the basal body, EscJ linking the inner and outer membrane complex while 
EscF forms the needle providing a projection channel and, EspD and EspB form the 
translocation pore (Figure 3). The unique feature of the A/E pathogen T3SS is the presence of 
the filamentous extension to the needle complex, formed by the polymerisation of EspA 
filaments, forming a hollow conduit between the bacterial cell and the host membrane. Due to 
this feature, the A/E pathogen T3SS forms a unique class of filamentous T3SS (FT3SS) 
(Daniell et al., 2001).  
 
Figure 4: Schematic diagram of the EPEC/EHEC type III secretion apparatus. The basal body of the 
T3SS is composed of secretin EscC, innermembrane proteins EscR, EscS, EscT, EscU and EscV, and the 
lipoprotein EscJ connecting the inner membrane with the outer membrane. EscF makes up the needle 
structure, while EspA subunits polymerise to form the EspA filament. The translocation pore in the host 
plasma membrane is formed by EspB and EspD, connecting the bacteria and host through the EspA 
filaments. EscN, the cytoplasmic ATPase hydrolyzes ATP molecules into ADP, providing energy for 
secretion. Reproduced from Garmendia et al., 2005 (Garmendia et al., 2005). 
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1.6 The A/E pathogen T3SS Effectors  
 
The effectors secreted via this T3SS are responsible for subversion of multiple cellular signal 
transduction pathways (Garmendia et al., 2005; Mundy et al., 2005). Six effector proteins Tir 
(Kenny et al., 1997), Map, EspG, EspF EspZ and EspH (Garmendia et al., 2005) are encoded 
on the LEE PAI. In addition, a large number of effectors are encoded by genes that are 
scattered around the bacterial genome, mainly carried on prophages, insertion elements and 
genomic islands (Deng et al., 2004) which includes Cif (Marches et al., 2003), EspI/NleA 
(Gruenheid et al., 2004; Mundy et al., 2004), TccP (EspFU) (Campellone et al., 2004; 
Garmendia et al., 2004), TccP2 (Whale et al., 2006), EspG2 (Matsuzawa et al., 2004; Shaw et 
al., 2005b), EspJ (Dahan et al., 2005), EspM (Arbeloa et al., 2008), EspT (Bulgin et al., 
2009), NleB, NleC, NleD, NleE, NleF, NleG,and NleH1/NleH2 (Deng et al., 2004; Iguchi et 
al., 2009; Tobe et al., 2006). Importantly, 21 effectors are conserved between all pathogenic 
A/E strains (referred to as the core effectors) (Iguchi et al., 2009), while other effectors are 
strain-specific and might be involved in increased virulence, competitiveness or host range. 
Using these effectors A/E pathogens subvert host cell processes and signalling pathways 
resulting in eukaryotic cytoskeleton reorganisation, interference with Rho GTPase signal 
transduction, inhibition of phagocytosis and exocytosis, disruption of tight junctions integrity 
and modulation of apoptosis.  
 
1.6.1 Actin Pedestal Formation  
 
One of the central effectors required for A/E lesion formation is Tir. Tir is inserted into the 
host plasma membrane and acts as the receptor for the bacterial outer membrane adhesin 
Intimin (Frankel et al., 2001). During EPEC infection in vitro, actin accumulation under 
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attached bacteria results in formation of a raised protrusion above the plasma membrane in a 
pedestal-shaped structure (Figure 2B). EPEC Tir differs from EHEC Tir in the mechanism by 
which they trigger actin polymerisation. During EPEC infection Tir is tyrosine 
phosphorylated on Y474, which leads to the direct recruitment of the eukaryotic adaptor Nck 
(Campellone et al., 2002; Gruenheid et al., 2001), which in turn binds and activates Wiskott-
Aldrich syndrome protein (N-WASP) leading to actin related protein 2/3 (Arp2/3) complex-
mediated actin polymerisation (Lommel et al., 2001). In contrast, Tir EHEC does not contain 
the Y474 Nck binding site and utilises the effector TccP/EspFu (Tir cytoskeleton coupling 
protein) instead to bind and activate N-WASP (Campellone et al., 2004; Garmendia et al., 
2004). Recently, several EPEC strains have been shown to utilize both the TccP/TccP2 and 
Nck pathways simultaneously (Whale et al., 2006). The ability to form pedestals is the basis 
for diagnosis of infections caused by A/E pathogens using the Fluorescence Actin Staining 
(FAS) test. The FAS test detects actin aggregation underneath adherent bacteria (Knutton et 
al., 1991). However, recent studies in vivo and ex vivo have found that mucosal infections 
exhibit efficient A/E lesion formation which is independent of both Nck and TccP, suggesting 
that in EPEC and EHEC A/E lesion formation but not actin accumulation or pedestal 
formation is the key feature of infection (Frankel and Phillips, 2008).  
 
1.6.2 Modulation of the Cell Cytoskeleton and Rho GTPases  
 
Other effectors such as Map (Berger et al., 2009), and EspG/EspG2 (Matsuzawa et al., 2004) 
have also been shown to trigger cytoskeletal rearrangements in vitro (Caron et al., 2006). 
EspG and EspG2 interact with tubulin triggering microtubule dissociation underneath 
adherent bacteria (Matsuzawa et al., 2004; Shaw et al., 2005b), while Map induces transient 
filopodia early in infection (Kenny and Jepson, 2000) via the activation of Cdc42 and RhoA 
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(Berger et al., 2009). Map is a member of a recently identified family of proteins termed as 
WxxxE effectors which were group together based on a conserved motif consisting of an 
invariant tryptophan and gluatamic acid residue separated by three variable amino acids and 
their shared ability to subvert host cell small GTPase signalling (Alto et al., 2006; Arbeloa et 
al., 2008; Berger et al., 2009). The WxxxE family also includes the A/E pathogen effectors 
EspM, and EspT which also modulate the host cell cytoskeleton and Rho GTPases. EspM 
proteins direct the formation of actin rich stress fibres via the activation of RhoA (Arbeloa et 
al., 2008), while EspT which is encoded by C. rodentium and a subset of EPEC strains 
(Bulgin et al., 2009) induces the formation of lamellipodia and membrane ruffles via the 
activation of Rac1 and Cdc42 (Bulgin et al., 2009).  
 
1.6.3 Modulation of Other Cell Processes and Pathways  
 
EspF causes disruption of the mitochondrial membrane potential, release of cytochrome c 
into the cytoplasm, cleavage of caspase -9 and -3 and apoptosis (Nagai et al., 2005; 
Nougayrede and Donnenberg, 2004). Induction of apoptosis is dependent of interaction with 
Abcf2, a protein of unknown function with a putative cytoprotective role (Nougayrede et al., 
2007). EspF also disrupts epithelial tight junctions (Dean and Kenny, 2004; McNamara et al., 
2001), and interferes with phagocytosis (Celli et al., 2001; Marches et al., 2006; Marches et 
al., 2008; Quitard et al., 2006). Another effector EspI/NleA ((Kim et al., 2007) has been 
shown to interfere with exocytosis. EspJ have been shown to inhibit receptor-mediated 
phagocytosis (Marches et al., 2008). Cif induces host cell cycle arrest and reorganisation of 
actin cytoskeleton (Marches et al., 2003). While many effectors and their function have been 
identified, many effectors remain uncharacterised including the core non-LEE encoded 
effector proteins NleH1 and NleH2.  
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The study of effector function during infection of cultured cell lines provides an insight into 
the possible roles of bacterial effectors in disease. However, it is essential that conclusions 
drawn from such in vitro studies are confirmed in vivo. As EPEC and EHEC have narrow 
host specificity and mice are resistant to infection, C. rodentium, a natural murine pathogen 
(Mundy et al., 2005), provides an excellent animal model for EPEC and EHEC infection and 
is a powerful tool for elucidating the role of effector proteins during disease. 
 
1.7 The C. rodentium Animal Model 
 
 
C. rodentium, which shares many virulence factors and T3SS effectors with EPEC and 
EHEC, has become over the last few years a popular model to study the in vivo role of 
effector proteins during a natural host pathogen interaction.  
 
Following inoculation via the oral route, bacteria colonise the colon typically peaking at day 
9 before clearance at around day 17 (Mundy et al., 2006). Mutant strains in genes encoding 
the effectors Tir (Deng et al., 2003), EspI/NleA (Gruenheid et al., 2004; Lee et al., 2008; 
Mundy et al., 2004), NleB (Kelly et al., 2006; Wickham et al., 2006) and EspL (Wickham et 
al., 2006) as well as intimin, are greatly attenuated. Mutants in genes encoding the effectors 
EspG/EspG2 (Gill et al., 2007; Mundy et al., 2004), Map (Ma et al., 2006; Mundy et al., 
2004), and EspF (Mundy et al., 2004; Nagai et al., 2005; Ritchie and Waldor, 2005; Shaw et 
al., 2005a) shows reduced competitiveness during mixed infection in comparison to wild type 
C. rodentium. However, mutation in genes encoding the effectors EspH (Mundy et al., 2004; 
Ritchie and Waldor, 2005; Shaw et al., 2005a), NleD/NleD2 (Kelly et al., 2006; Marches et 
al., 2005), and NleC (Kelly et al., 2006; Marches et al., 2005) have no in vivo phenotype.  
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Recently the C. rodentium mouse model was refined by developing a non-invasive 
bioluminescence imaging (BLI) technique to monitor infection dynamics and tissue tropism 
in real time in vivo (Wiles et al., 2006). Using this method, it was shown that C. rodentium 
first targets the murine caecal patch and rectum before the infection spreads to the large 
intestine. Additionally, Wiles et al. (2005) demonstrated the appearance of a “hyperinfectious 
state” after passage of C. rodentium through the murine gastrointestinal tract. Seed mice were 
first infected via oral gavage and at the peak of infection housed together with uninfected 
mice, which picked up the pathogen from the contaminated cage environment. The 
‘hyperinfectious state’ dramatically reduced the dose required to infect secondary individuals 
and removed the requirement for the primary colonisation of the caecal patch. This method of 
inoculation is more representative of the natural course of infection and was therefore 
referred to as natural transmission (Wiles et al., 2005). The use of both oral gavage and 
natural transmission to study infection in murine models has led to the recognition of 
significant novel phenotypes for EPEC, EHEC, and C. rodentium virulence factors which 
were not revealed using in vitro infections. 
 
Both in vivo and in vitro studies demonstrate that the T3SS effectors are essential for the 
virulence of A/E pathogens, and through these effectors the pathogen modulates, subverts, 
and hijacks many key cellular pathways. As a result the host initiate a plethora of defensive 
measures to limit the infection including induction of inflammatory responses and cell death 
pathways.  
1.8 Cell Death 
 
Cell death is a fundamental cellular response that plays an essential role during development 
and regulating tissue homeostasis by eliminating unwanted cells (Degterev and Yuan, 2008). 
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Cell death can occur though a variety of biochemically distinct pathways including apoptosis, 
autophagy, necrosis, cornification, mitotic catastrophe, anoikis, excitotoxicity, paraptosis, 
pyroptosis, pyronecrosis, and entosis (Kroemer et al., 2009). The most common pathways are 
apoptosis, autophagy and necrosis. 
 
Apoptosis, a term coined from the ancient Greek word to describe the “falling off” of leaves 
from trees or petals from flowers, is a regulated and pre-existing death programme encoded 
in the genome (Saikumar et al., 1999)). Apoptosis refers to the characteristic morphological 
features which include cell shrinkage (pyknosis), cell rounding, nuclear condensation and 
fragmentation (karyorrhexis), chromatin condensation, plasma membrane blebbing, 
fragmentation and formation of membrane bound apoptotic bodies and eventual engulfment 
by phagocytes (in vivo) with classically little or no ultrastructural changes of cytoplasmic 
organelles (Kroemer et al., 2009; Saikumar et al., 1999). Apoptosis is mostly a non-
immunogenic process, however some stimuli can lead to secretion/exposure of proteins that 
elicit engulfment of apoptotic material by dentrictic cells followed by antigen presentation 
and stimulation of a specific immune response (Kroemer et al., 2009).  
 
Selective degradation of intracellular substrates also occur during apoptosis, and is mainly 
due to the activity of highly conserved cysteine proteases called caspases (cysteinyl aspartate 
specific proteinases) (Alnemri et al., 1996; Nicholson and Thornberry, 1997). Caspases are 
cysteine proteases synthesised as inactive proenzymes that act in a hierarchy, cleaving and 
activating other caspases, ultimately activating executioner caspases that cleave substrates 
involved in ensuing the apoptotic morphology. The executioner caspase-3 is involved in the 
cleave of a large number of substrates including PARP, DNA-dependent protein kinase 
(DNA-PK), U1-70 kDa, heteronuclear ribonucleoproteins C1 and C2, sterol regulatory 
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binding proteins, D4-GDP dissociation inhibitor, huntingtin and retinoblastoma protein (Rb) 
(Cohen, 1997).  
 
While apoptosis is a rapid process, autophagy (autophagic cell death) occurs in a slow 
manner and is characterised by cytoplasmic material being sequestered into autophagosomes, 
two-membrane-containing vesicles containing cytoplasmic organelles or cytosol, for 
degradation by lysosomes. Morphology associated with autophagic cell death includes the 
absence of chromatin condensation, and little or no association with phagocytes. Unlike 
autophagy, and apoptosis, necrosis was considered an accidental form of cell death, however, 
it is now understood that necrosis could be programmed (regulated) or fortuitous (accidental). 
Necrosis is morphologically characterised by a gain in cell volume (oncosis), swelling of 
organelles, rupture of the plasma membrane and unorganised dismantling and loss of 
intracellular contents (Galluzzi et al., 2007; Kroemer et al., 2009).  
 
Among the other forms of cell death, some can be very distinct from apoptosis, such as, 
cornification, which is specific to the epidermis and forms corneocytes. Corneocytes are dead 
keratinocytes containing specific proteins and lipids necessary for the mechanical resistance, 
elasticity, water repellence and structural stability of the cornified skin layer. While others 
can share properties of apoptosis or necrosis and can look morphologically similar, such as 
mitotic catastrophe, cell death which occurs shortly after failed mitosis (Galluzzi et al., 2007; 
Kroemer et al., 2009), anoikis, apoptosis in response to cell detachment (Chiarugi and 
Giannoni, 2008) and excitotoxicity, cell death in response to excitation of neurons resulting 
in Ca2+ overload. Yet other forms of cell death differ significantly but share few distinct 
properties with apoptosis and necrosis such as paraptosis, pyroptosis, and pyronecrosis. 
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Paraptosis is cell death associated with extensive cytoplasmic vacuolization and 
mitochondrial swelling, without any other hallmark of apoptosis, while pyroptosis is cell 
death involving activation of caspase-1, which is a interleukin IB converting enzyme 
(Galluzzi et al., 2007; Kroemer et al., 2009) and is not involved in apoptosis (Bergsbaken et 
al., 2009). Pyronecrosis is similar to pyroptosis but does not require caspase-1. Finally, 
Entosis is a form of cellular cannibalism in which independently of apoptosis and autophagy. 
Internalized cells disappear possibly via lysosomal degradation. 
 
Among these cell death pathways, apoptosis can easily be distinguished from other forms of 
cell death, except anoikis, using its key morphological features. Within the apoptotic pathway 
there are several distinct subtypes that are morphologically similar but are triggered through 
distinct biochemical pathways. 
 
1.9 Apoptosis Pathways 
 
Apoptosis can occur via two major pathways the intrinsic and extrinsic pathways (Figure 4). 
Both pathways can involve the B cell lymphoma-2 (Bcl-2) family of proteins, which function 
in a balancing act in the homeostasis between induction and inhibition of apoptosis. Bcl-2 
family proteins contain at least one of the four conserved motifs known as the Bcl-2 
homology (BH1-4) domains (Oltvai et al., 1993). The Bcl-2 family is classified into pro- and 
anti-apoptotic members. The anti-apoptotic members include Bcl-2, Bcl-XL, Bcl-w, Mcl-1 
and A1, all of which have all four BH domains. Bcl-2 and Bcl-XL are localised to the 
mitochondria, ER and nucleus. Pro-apoptotic members are sub-classified into two groups; the 
multidomain proteins including Bax, Bak and Bok which localised to the mitochondria and 
ER and contain BH domains 1-3, and the BH3 only proteins which are primarily cytosolic but 
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have also been found at the ER and includes Bad, Bid, Bik/Nbk, Bim, Bmf, Nix/BNIP3, Hrk, 
Noxa and Puma. Pro-apoptotic multi-domain members like Bax and Bak have been proposed 
to homo-oligomerise forming a pore on the mitochondrial outer membrane releasing 
cytochrome c. While anti-apoptotic members function as antagonists for multi-domain pro-
apoptotic proteins, and apoptotic BH3 only proteins can function as agonists that enhance the 
activity of multidomain pro-apoptotic proteins or antagonists for anti-apoptotic proteins 
(Szegezdi et al., 2009).  
 
The extrinsic pathway, also known as the receptor mediated pathway, involves the binding of 
ligands such as Tumour Necrosis Factor- (TNF-) or FasL to the receptors on the host cell 
membrane. This is followed by the formation of the death inducible signalling complex 
(DISC), which activates pro-caspase-8 (Boldin et al., 1996; Muzio et al., 1996; Orrenius et 
al., 2003). Caspase-8 activates pro-caspase-3, which results in activation of apoptosis. 
Alternatively, caspase-8 cleaves Bid resulting in the translocation, oligomerisation and 
insertion of the pro-apoptotic Bcl-2 family members Bax and/or Bak into the mitochondrial 
membrane releasing proteins including cytochrome c from the mitochondrial outer 
membrane. Cytochrome c complexes with apoptosis activating factor-1 (APAF-1) and pro-
caspase-3 in the presence of dATP to form the cytosolic apoptosome, activating pro-caspase-
9, which then cleaves and activates pro-caspase-3, -6 and -7 (Li et al., 1997; Orrenius et al., 
2003).  
 
The intrinsic or mitochondrial-endoplasmic reticulum mediated pathway requires death 
signals that act directly or indirectly on the mitochondria, resulting in the formation of the 
apoptosome complex. Bcl-2 family proteins that regulate cytochrome c release play a major 
role in control of this pathway (Cory and Adams, 2002). During the induction of apoptosis 
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the pro-apoptotic BH3 only proteins are activated and multi-domain pro-apoptotic proteins 
such as Bax and Bak oligomerise at the mitochondrial membrane (Cory and Adams, 2002) 
resulting in the permeabilisation of the mitochondrial outer member and release of 
cytochorme c (Elmore, 2007). Cytochrome c complexes with APAF-1 and pro-caspase-9 to 
form the cytosolic apoptosome, activating pro-caspase-9 which then cleaves and activates the 
executioner caspases pro-caspase-3, -6, -7 (Li et al., 1997; Orrenius et al., 2003) resulting in 
irreversible apoptosis.  
 
Inhibitor of apoptosis proteins (IAPs) (Srinivasula et al., 2001), which inhibit caspases, and 
the second mitochondrial activator caspase (Smac) (Du et al., 2000) and Omi (Hegde et al., 
2002), which negatively regulates IAPs, also function in the control of the intrinsic pathway. 
These proteins striking a balance which can sway towards or against apoptosis (Orrenius et 
al., 2003). The intrinsic pathway can occur in a caspase-independent mechanism which 
requires the release of at least two proteins; apoptosis inducing factor (AIF) and endonuclease 
G (EndoG) from the mitochondria and translocation of these proteins to the nuclease (Li et 
al., 2001; Orrenius et al., 2003).  
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Figure 5: The major apoptosis pathways. Apoptosis can occur via the intrinsic or extrinsic pathway. The 
extrinsic pathway involves the activation of death receptors on the cell outer plasmamembrane via stimuli 
such as the binding of TNF- or Fas ligand (FasL). This results in cleavage of caspase-8 which then 
cleaves caspase-3 directly or indirectly via the activation of pro-apoptotic Bid which releases cytochrome 
c resulting in apoptosome formation when in complex with APAF-1 and pro-caspase-9. The intrinsic 
pathway occurs through signals within the cell which directly or indirectly trigger mitochondrial 
membrane permeabilisation and cytochome c release. This is controlled by the fine balance of Bcl-2 
family members, and other factors including inhibitor of apoptosis proteins (IAPs) including the most 
potent XIAP (X-linked IAP). Cytochrome c release results in apoptosome formation, and activation of 
caspase-9 and caspase-3. Bcl-2 and Bcl-XL also localise to the ER where they bind and inactivate Bax and 
Bak. BI-1 is an ER protein known to bind Bcl-2 and Bcl-XL, and inhibit Bax induced apoptosis, as well as 
ER stress induced apoptosis. Recently BI-1 has been shown to play a role in Ca2+ homeostasis. Increased 
Ca2+ release into the cytoplasm and mitochondria can result in sensitization to or induction of apoptosis. 
Modified and reproduced from Faherty et al., 2008 (Faherty and Maurelli, 2008).  
 
1.9.1 The ER in Apoptosis 
 
In addition to the mitochondria and nucleus, the ER also plays an essential role in apoptosis. 
The Bcl-2 family proteins play an important role in the control of apoptosis at the ER (Figure 
4) (Szegezdi et al., 2006). Apart from the Bcl-2 family members, the ER multi-
transmembrane anti-apoptotic protein Bax inhibitor-1 (BI-1), which also contains a BH3 
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domain and binds both Bcl-2 and Bcl-XL but not Bax, also plays an important role in 
apoptosis (Chae et al., 2003; Xu and Reed, 1998). Interestingly, BI-1 can inhibit apoptosis 
induced by a wide range of stimuli including Bax, etoposide, staurosporine (STS; a kinase 
inhibitor and inducer of apoptosis), growth factor deprivation (Xu and Reed, 1998) and ER 
stress such as that induced by the chemical inducers tunicamycin (TUN), brefeldinA (BFA) 
and thapsigargin (TG) (Chae et al., 2004). BI-1 inhibits apoptosis by reducing Bax activation, 
inhibiting the activation of caspases, and preventing mitochondrial membrane depolarisation 
and ultrastructural changes (Xu and Reed, 1998).  
 
Recent studies suggest that the ER may have a more important role in the regulation and 
onset of apoptosis than previously thought. Mitochondrial, endoplasmic reticular, and 
cytoplasmic Ca2+ homeostasis plays an important role in the onset of both early and late 
stages of apoptosis (Pinton et al., 2008). The release of high concentrations Ca2+ ions, for 
example via the ER Ca2+ channel Inositol 1,4,5-Triphosphate Receptor (IP3R), can lead to 
mitochondrial Ca2+ overload and loss of mitochondrial membrane potential leading to the 
release of cytochrome c and pro-apoptotic proteins involved in triggering apoptosis (Pinton et 
al., 2008). Although it is unclear exactly how BI-1 inhibits apoptosis, it is likely that this may 
be through the regulation of Ca2+ levels. Many studies have found that BI-1 modulates Ca2+ 
levels (Kim et al., 2008; Westphalen et al., 2005; Xu et al., 2008). BI-1 may modulate Ca2+ 
directly or via interaction with Bcl-2 and Bcl-XL, which bind and modulate IP3Rs. 
Interestingly, the ability of Bcl-XL to reduce resting ER Ca2+ concentrations is dependent on 
the presence of BI-1 (Szegezdi et al., 2009; Westphalen et al., 2005).  
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1.10 Modulation of Apoptotic Pathways during Bacterial Infection 
 
 
Many bacterial pathogens have developed mechanisms involved in inducing cell survival or 
apoptosis in order to manipulate the host cell environment to promote the most successful 
infection conditions (Figure 6). For example, the Salmonella enterica serovar Typhimurium 
effector SopB has been found to inhibit apoptosis by sustained Akt (a pro-survival protein) 
activation allowing intracellular bacterial replication (Edelblum et al., 2006). Additionally, 
the S. Typhimurium effector AvrA utilises its acetyltransferase activity towards specific 
mitogen-activated protein kinase kinases (MAPKKs) and inhibits JNK and Nuclear Factor-
Kappa B (NF-KB) signalling to inhibit the pro-apoptotic immune response during Salmonella 
infection (Faherty and Maurelli, 2008). Shigella flexneri can also inhibit apoptosis during 
infection and can block apoptosis induced by STS (Clark and Maurelli, 2007). Its T3SS 
effector IpgD has been shown to activate Akt (Pendaries et al., 2006), although it is not 
essential for inhibition of cell death, suggesting the existence of functional redundancy (Clark 
and Maurelli, 2007). Mycobacterium tuberculosis, also inhibits apoptosis via NuoG, a subunit 
of the multicomponent complex type I NADH-dehydrogenase, SodA, a secreted superoxide 
dismutase which catalysis conversion of superoxide anions to hydrogen peroxide, and PknE, 
a serine threonine kinase that protects against apoptosis induced by nitric oxide (NO) stress 
(Briken and Miller, 2008). Additionally Mycobacterial lipoglycans such as 
Lipoarabinomannan can promote survival via the PI3K/Akt pathway (Maiti et al., 2001). 
Neisseria gonorrhoea on the other hand injects PorB (Binnicker et al., 2004), which blocks 
caspase activation by preventing mitochondrial depolarization and release of cytochrome c, 
(Massari et al., 2003). Legionella pneumophila inhibits apoptosis by translocating the type IV 
secretion system effector SdhA (sidH paralogue A) (Laguna et al., 2006) and SidF. SidF 
inhibits the intrinsic death pathway by binding pro-apoptotic Bcl-2 family members Bcl-
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rambo and BNIP3 (Isberg et al., 2009; Shin and Roy, 2008). Interestingly, almost all 
pathogens identified so far to utilise inhibition of apoptosis in their infection strategy are 
intracellular pathogens. However, Helicobacter pylori, which is considered largely 
extracellular, has been found to inhibit intrinsic apoptosis via CagA by increasing levels of 
phospho-ERK, a pro-survival factor (Mimuro et al., 2007).  
 
 
 
 
Figure 6: Mechanism by which bacterial pathogens inhibit apoptosis. Chlamydia utilizes the chlamydial 
proteasome-like activity factor (CPAF) to inhibit pro-apoptotic proteins with one BH3 domain which 
inhibit pro-survival proteins upon activation. Nisseria meningitides utilizes PorB porin to prevent 
cytochrome c release. Salmonella uses SopB to activate phosphatidylinositol 3-kinase/Akt (PI3K/Akt) 
pathway to prevent cytochrome c release. Anaplasma also activates the PI3K/Akt pathway and activates 
NF-KB to prevent cytochrome c release and activate inhibitor of apoptosis proteins (IAPs). Bartonella, 
Ehrlichia, and Rickettsia also activates NF-KB while, Shigella inhibits caspase-3 activation. Legionella 
directly activates caspase-3 to enhance infection, but inhibits apoptosis through NF-KB. Bacterial 
proteins involved are shown where known. Red lines indicate inhibition in the pathway while green 
arrows indicate activation. Reproduced from Faherty et al., 2008 (Faherty and Maurelli, 2008). 
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1.11 Apoptosis during Infection with A/E Pathogens  
 
 
It has previously been reported that EPEC infected cells show key early features of 
apoptosis including expression of phosphatidylserine on the host cell surface, 
internucleosomal cleavage of host cell DNA, and cytokeratin 18 cleavage (Crane et 
al., 1999; Crane et al., 2001). Recently, it was reported that EPEC-induced apoptosis 
in T84 intestinal cells involves the activation of caspase-3, -6, -8, and -9 during 
prolonged infections (Flynn and Buret, 2008). Further evidence of apoptotic 
signalling during EPEC infection is the Ca2+ influx which has been reported and 
disputed for many years (10, 13, 14). However, EPEC infected cell do not undergo 
cell shrinkage, membrane blebbing or nuclear condensation and fragmentation (Crane 
et al., 1999; Crane et al., 2001), all key features of the latter stages of apoptosis (Allen 
et al., 1997). Apoptosis relies on the fine balance between pro and anti-apoptotic 
factors, as there are many cell death signals during EPEC infection (membrane 
changes, cytoskeletal rearrangements, and cytotoxic effectors), we hypothesize that 
there must be an inhibitor of apoptosis to counter these effects.  
 
1.12 NleH Family of Effectors from A/E Pathogens 
 
 
Recently, a novel family of core, non-LEE-encoded effectors, NleH, was identified in 
A/E pathogens. The genome sequences of EHEC O157:H7 strain EDL933 and Sakai, 
EPEC strain E2348/69 and C. rodentium (strain ICC168) revealed that EHEC and 
EPEC contain two nleH alleles (nleH1 and nleH2) (Iguchi et al., 2009; Tobe et al., 
2006), while C. rodentium harbours only one nleH gene. In EHEC O157:H7 Sakai, 
nleH1 is carried on the Sp3 PAI and nleH2 is carried on the Sp9 PAI. Interestingly, 
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NleH1 and NleH2 effectors are homologues of OspG, a kinase that downregulates 
NFKB signalling (Kim et al., 2005). 
 
NleH effectors utilize the multivalent chaperone CesT which interacts with many 
T3SS effectors including Tir, EspZ, Map, EspF, EspG, NleG, NleH1, NleH2 and 
NleA from EPEC (Creasey et al., 2003a; Thomas et al., 2007; Thomas et al., 2005). 
CesT binds the N-terminal region of EPEC NleH1, and the first 100 amino acids of 
NleH1 are required for CesT dependent secretion in EPEC (Thomas et al., 2007).  
 
The nleH1 gene in EHEC is part of a 58.6 kb chromosomal locus encoding prophage 
genes and the non-LEE effectors nleA and nleF and an nleG-like protein, which 
interrupt yciD, between E. coli backbone genes yciE and ynfA. In EPEC, the 55.5 kb 
locus containing nleH1 is inserted between the E. coli backbone genes yciD and trpA 
and also contains nleA and nleF but not nleG. nleH2 gene in EPEC and EHEC are 
also found in a cryptic prophage containing the E. coli K-12 backbone genes ybhC 
and ybhB. The locus containing nleH2 is 52.3 kb in size, while in EHEC it is 38.1 kb. 
The EPEC nelH2 locus contains a cif homologue, while EHEC nleH2 locus contains 
nleD, nleC and nleB2 (Figure 7).  
 
The nleH locus in C. rodentium is similar to that of nleH1 of EHEC and EPEC. The 
nleH locus of C. rodentium is inserted between the backbone genes yllG and prfC and 
carry the effectors nleF, nleG and espJ (Figure 7) (Garcia-Angulo et al., 2008).  
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Figure 7: Schematic representation of the loci containing nleH in C. rodentium DBS100, and 
nleH1 and nleH in EPEC E2348/69 and EHEC EDL933. Flanking genes correspond to the E. coli 
K12 conserved genes which border the insertion site of these putative horizontally acquired 
genes. This image has been modified from Garcia-Angulo et al., 2008 (Garcia-Angulo et al., 
2008).  
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1.13 Aims 
 
The function of the NleH effectors is not currently known. Our preliminary studies 
revealed that a double nleH1nleH2 EPEC mutant induces cell detachment and cell 
shrinkage, suggesting it could modulate the apoptotic pathway. Through this study we 
aim to characterise the functional role of NleH in vitro and in vivo. To do this we aim 
to: 
 
1. Confirm that NleH proteins are T3SS effector. 
2. Determine if like OspG, NleH effectors are kinases. 
3. Study if NleH effectors modulate apoptosis in cultured cells.  
4. Identify binding partners of NleH. 
5. Study the role NleH effectors in vivo.  
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CHAPTER 2 - Materials and Methods 
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2.1 Bacterial Strains 
Bacterial strains and primers used in this study are described in Tables 1 and 3, 
respectively. C. rodentium ICC169 ΔnleH, luminescent C. rodentium ICC180 ΔnleH,  
E2348/69 ΔnleH1nleH2, E2348/69 ΔsepD (hypersecretion mutant), and E2348/69 
ΔescN (type III secretion null mutant) mutant strains were generated using the one-
step PCR λ-red-mediated mutation protocol (Datsenko and Wanner, 2000). Mutants 
used in this study were made previously by Dr. Olivier Marches, with the exception of 
C. rodentium ICC180 nleH which was made personally.  
 
The PCR product of the resistance cassette, flanked by approximately 50 base pairs of 
nleH, was digested with DpnI and the cassette electroporated into the recipient strains 
carrying pKD46 encoding the λ-Red recombinase. Mutants were selected on selective 
LB plates with kanamycin or chloramphenicol. Recombinant clones were cured of 
pKD46 and the mutation confirmed by PCR using primers flanking the target gene 
and primers within the antibiotic resistance gene. Growth curves have confirmed that 
the mutant and wild type stains have an identical growth rates in LB and minimal 
media.  nleH1 and nleH2 were deleted from wild type EPEC strain E2348/69 (Levine 
et al., 1978), generating strain ICC303. The nleH1-specific primer pair 1 and 2 were 
used to amplify the kanamycin cassette from pSB315 (Dahan et al., 2005) (primer 
sequences Table 3). The nleH2-specific primer pair 3 and 4 was used to amplify the 
chloramphenicol cassette from pKD3 (Datsenko and Wanner, 2000). Deletion of 
nleH1 and nleH2 was confirmed using primer pairs 19 and 20 (nleH1 external); 21 
and 22 (kanamycin cassette-specific), 23 and 24 (nleH2 external) and 25 and 26 
(chloramphenicol cassette-specific). The EPEC E2348/69 ΔsepD (hypersecretion 
mutant) was made using primer pairs 47 and 48 and mutation was confirmed using the 
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primers 25 and 26 (chloramphenicol cassette-specific), and external primers flanking 
the sepD gene. While EPEC ΔescN was constructed as described in (Garmendia et al., 
2004).  C. rodentium ICC180 ΔnleH and ICC169 nleH mutant strains were made 
generating the strain ICC285 and ICC229 respectively. The primers 33 and 34 were 
used to amplify the kanamycin cassette in pKD4 for deletion of nleH in ICC169. The 
primer pair 35 and 36 was used to amplify the chloramphenicol cassette in pKD3 for 
deletion of nleH in ICC180.  Mutation was confirmed using primers 37 and 38 (nleH 
external) and the respective internal cassette-specific primers; 39 and 40 (kanamycin 
cassette) and 25 and 26 (chloramphenicol cassette). All PCRs were amplified using 1 
ul Deep Vent and 0.25 ul Taq (NEB). A standard PCR amplification cycle (95°C for 1 
min, 56°C for 1 min and 72°C for 1 min) was used. 
 
Bacteria were grown at 37°C in Luria–Bertani (LB) broth or agar supplemented with 
ampicillin (100 μg mL−1); chloramphenicol (25 μg mL−1), kanamycin (50 μg mL−1), 
and nalidixic acid (nal, 15-25 ug ml-1) as appropriate. For infection Bacteria were 
cultured in LB broth at 37°C for 18 h with appropriate antibiotics. Overnight LB 
cultures were primed for infection by 1:100 dilution in DMEM (Dubelcco’s minimal 
Eagle medium) containing 1000 mg/L glucose (low glucose) without phenol red and a 
further incubation for 3 h at 37°C without agitation; 1 mM isopropyl--D-
thiogalactopyranoside was added for the final 30 min when needed.  
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Table 1: List of strains 
Strains Characteristics Source/Reference 
C. rodentium ICC169   Spontaneous naladixic acid-resistant mutant of wild-type C. rodentium (Wiles et al., 2004) 
ICC229 ICC169 ΔnleH (Kanr) This study 
C. rodentium ICC180    Bioluminescent C. rodentium harboring the Photorhabdus luxCDABE operon  (Kanr) (Wiles et al., 2004) 
ICC285 ICC180 ΔnleH (Cmr) This study 
ICC299 A commensal E. coli strain isolated from the cecum of a C57/Bl mouse This study 
EPEC E2348/69 Wild-type EPEC O127:H6 (Levine et al., 1978) 
ICC303 
 
EPEC E2348/69 ΔnleH1nleH2, nleH1::Kan, nleH2::Cm (Kanr 
Cmr) This study 
EPEC ΔnleH1 E2348/69 nleH1::Kan (Kanr) This study 
EPEC ΔnleH2 E2348/69 nleH2::Cm (Cmr) This study 
ICC192 E2348/69 escN::Kan (Garmendia et al., 2004) 
EPEC ΔsepD E2348/69 sepD::Cm (Cmr) This study 
AH109 
 S. cerevisiae MATa mating type with HIS3, ADE2, lacZ, and 
MEL1 reporters for interaction, and TRP1 and  LEU2 
transformation markers 
(James et al., 1996);  
Holtz, Unpublished 
Y187 S. cerevisiae MATα mating type with lacZ, and MEL1reporters for interaction, and TRP1 and  LEU2 transformation markers (Harper et al., 1993) 
*Kanr (Kanamycin), Cmr  (Chloramphenicol), Nalr (Nalidixic acid) 
 
Table 2: List of plasmids  
Plasmids Characteristics Source/Reference 
pKD3 oriRg, blaM, Cmr cassette flanked by FRT sites (Datsenko and Wanner, 2000) 
pKD4 oriRg, blaM, Kanr cassette flanked by FRT sites  (Datsenko and Wanner, 2000) 
pKD46 ori101, repA 101 (ts), araBp-gam-bet-exo, blaM (Datsenko and Wanner, 2000) 
pCP20 FLP synthesis under thermal control (Cherepanov and Wackernagel, 1995) 
pSA10 
 pKK177-3 expression vector containing lacI gene  
(Schlosser-Silverman et al., 
2000) 
pICC443 pSA10(nleH1), Derivative of pSA10, expressing NleH1 This study 
pICC444 pSA10(nleH2), Derivative of pSA10, expressing NleH2 This study 
pICC445 pSA10(nleH1VLSKI), Derivative of pSA10, expressing NleH1VLSKI This study 
pICC446 pSA10(nleH2VLSKI), Derivative of pSA10, expressing NleH2VLSKI This study 
pGBT9 Y2H bait expression vector with GAL4 DNA binding domain (GAL4-BD) (Bartel et al., 1993) 
pGAD-T7 Rec Y2H vector containg library inserts fused to GAL4 DNA activation domain Clontech 
pICC447 pGBT9(nleH1), Derivative of pGBT9, expressing NleH1 fused to GAL4-BD  This study 
pICC448 pGBT9(nleH2), Derivative of pGBT9, expressing NleH2 fused to GAL4-BD  This study 
pHM6 Mammalian expression vector, N-term HA tag and C-term His tag Roche 
pICC449 pHM6(nleH1), Derivative of pHM6, expressing HA-NleH1, stop codon before His tag This study 
pICC450 pHM6(nleH1K159A), Derivative of pHM6, expressing HA-NleH1K159A, stop codon before His tag This study 
pET28-a Vector for expression of His-tagged proteins Novagen 
pICC451 pET28-a expressing NleH1 His tagged This study 
pICC452 pET28-a expressing NleH1K159A His tagged This study 
pSB315 Source of aphT cassette (Datsenko and Wanner, 2000) 
pCX340 Cloning vector used to construct TEM-1 β-lactamase fusions, Tetr (Charpentier and Oswald, 2004) 
pCX(:nleH1) Derivative of pCX340 encoding a NleH1-TEM-1 fusion This study 
pCX(:nleH2) Derivative of pCX340 encoding a NleH2-TEM-1 fusion This study 
pRK5myc Mammalian expression vector, Myc tag Clontech 
pRK5(bi-1) pRK5myc transfection vector expressing BI-1 This study 
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Table 3: List of primers  
 Sequence 5’-3’ 
1 ATGCTATCACCATCTTCTGTAAATTTGGGGTGTTCATGGAATTCTTTAACCACGTTGTGTCTCAAAATCTC 
2 AATTTTACTTAATACCACACTAATAAGATCTTGCTTTCCTCCATGATAAGGAATTCCCCGGATCCGTCGAC 
3 ATGTTATCGCCCTCTTCTATAAATTTGGGATGTTCATGGAATTCTTTAACGTGTAGGCTGGAGCTGCTTC 
4 TATCTTACTTAATACTACACTAATAAGATCCAGCTTTCCTCCGTGATAAGCATAGAATATCCTCCTTA 
5 CCGCGGGTCGACATGCTATCACCATCTTCTG 
6 AAAACTGCAGTCATCAAATTTTACTTAATACCACACTAAT 
7 CCGCGGGTCGACATGTTATCGCCCTCTTCTA 
8 AAAACTGCAGTCATCATATCTTACTTAATACTACACTAAT 
9 CGGGATCCTGCTATCACCATCTTCTG 
10 CCAATGCATTGGTTCTGCAGCTAAATTTTACTTAATACC 
11 CGGGATCCTGTTATCGCCCTCTTCTA 
12 CCAATGCATTGGTTCTGCAGTTATATCTTACTTAATACT 
13 CCCGGAAGCTTGATGCTATCACCATCTTCT 
14 ATAGTTAGCGGCCGAATTTTACTTAATACCACACTAAT 
15 AAGGTCGGAGTCAACGGATTTGGT 
16 AGTGATGGCATGGACTGTGGTCAT 
17 CTATTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAG 
18 TTAGCATCTATGACTTTTTGGGGCGTTCAAGTG  
19 GTCATGGTGATGTTTGTTAAG 
20 TACCAACTCCATCCATGCAAC 
21 CAGGATCTTGCCATCCTATGGA 
22 GCTTGATGGTCGGAAGAGCATA 
23 GCAAATCCTGCGTGCTGACGG 
24 CGGATCCTCATCCACATTGTAAAGATCC 
25 TTATACGCAAGGCGACAAGG 
26 GATCTTCCGTCACAGGTAGG 
27 AAAACTGCAGTCATCATACCACACTAATAAGATCTTGCTT 
28 AAAACTGCAGTCATCATACTACACTAATAAGATCCAGCTT 
29 GGAATTCCATATGCTATCACCATCTTCTG 
30 GGATCCAGAACCCTAAATTTTACTTAATACC 
31 GAT GCA ACA AAA GTC CTG GCG ATG TTT ACT ACA TCT CAA AGC 
32 GCT TTG AGA TGT AGT AAA CAT CGC CAG GAC TTT TGT TGC ATC 
33 ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTTTAACTGTGTAGGCTGGAGCTGCTTCG 
34 AATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCATGATAAGCATATGAATATCCTCCTTAG 
35 ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTTTAACGTATACTTATAGGAGGAATC 
36 TTAAATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCATGATACACATCCGACCTCGACGAAGC 
37 ATG ATT AAG TTC ACT TAC TGA TTC 
38 AGT GGC ATA ACT GAG TCC GAG 
39 CAGTCATAGCCGAATAGCCT 
40 ACGGTATCGCCGCTCCCGATT 
41 ATGAGCACAGAAAGCATGATC 
42 TACAGGCTTGTCACTCGAATT 
43 AGAGGGAAATCGTGCGTGAC 
44 CAATAGTGATGACCTGGCCGT 
45 TGAACGCTACACACTGCATCTTGG 
46 CGACTCCTTTTCCGCCTTCCTGAG 
47 ATGAACAATAATAATGGCATAGCAAAGAATGATTGTGACTGGCTAACGGCCCATATGAATATCCTCCTTAGTTCC 
48 TTACAACAATTCGTCCTATATCAGAAAACAAGTGTGTTGGCGGCATCATTGTTGTGTAGGCTGGAGCTGCTTCG 
49 CCGGAATTCCAACATATTTGATCGAAA 
50 CCCAAGCTTTCATTTCTTCTCTTTCTTCTTA 
51 AAAACTGCAGTCATTTATCATCATCATCTTTATAATCAATTTTACTTAATACCACACTAAT 
52 AAAACTGCAGTCAAGCGTAGTCTGGGACGTCGTATGGGTAAATTTTACTTAATACCACACTAAT 
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2.2 Plasmids and Constructs 
The plasmids used in this study are listed in Table 2. neH1 and nleH2 were amplified 
using E2348/69 DNA as template and primer pairs 5 and 6 and 7 and 8, respectively, 
and cloned into the expression vector pSA10 (Schlosser-Silverman et al., 2000) 
(generating pICC443 and pICC444 respectively). nleH1-FLAG tag, and nleH1-HA 
tag was constructed using primer pairs 5 and 51 and 5 and 52 respectively to add a C-
terminal FLAG epitope tag (DYKDDDDK) or C-terminal Hemagglutinin (HA) 
epitope tag (YPYDVPDYA). Deletion of the 5 C-terminal amino acids was achieved 
using the reverse primers 27 and 28 generating p(nleH1VLSKI) and 
p(nleH2VLSKI) respectively (pICC445 and pICC44). All PCRs were gel purified 
using the QIAquick® Gel Extraction Kit (QIAGEN) and digested with SalI and PstI 
restriction enzymes (NEB) overnight at 37°C. The vector pSA10 was purified using 
the QIAprep® Spin Miniprep Kit (QIAGEN) and digested with the same restriction 
enzymes. The digested products were gel purified or purified using the QIAquick® 
PCR Purification Kit and ligated overnight using T4 ligase (NEB) at 16°C. The 
constructs were verified via restriction digests and sequencing.  
 
For purification of His-tagged NleH1, nleH1 was amplified using primers 29 and 30, 
and cloned into pET28-a (generating pICC451) using the restriction enzymes BamHI 
and NdeI (NEB). pICC451 was used as a template for site directed mutagenesis using 
QuikChange® Site-Directed Mutagenesis Kit (Stratagene) and the primer pair 31 and 
32 to make pET28-a(nleH1K159A) His tagged kinase mutant (generating pICC452). 
 
For transfection experiments, nleH1 and nleH1K159A were cloned into the 
transfection vector pHM6 (Roche) using the restriction enzymes HindIII and NotI 
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(NEB) to make N-terminal HA tagged fusion proteins using primers 13 and 14 and 
E2348/69 DNA or pICC452 as templates respectively, generating pHM6(nleH1) 
(pICC449) and pHM6(nleH1K159A) (pICC450). A stop codon was added to the end 
of the primer to eliminate the pHM6 C terminal His tag. The pEGFP-N1 (Clonetech) 
vector was used as a control in all transfection experiments. For translocation assays, 
EPEC nleH1 and nleH2 were amplified, double-digested by Nde1 and Kpn1 and 
cloned in pCX340 generating the plasmids pCX-NleH1 and pCX-NleH2 encoding 
TEM-1 β-lactamase fusion proteins. TEM-1 fusions were made previously by Dr. 
Olivier Marches. For yeast two hybrid screen, neH1 and nleH2 were cloned into 
pGBT9 (Clontech) (to generate pICC447 and pICC448 respectively) with PstI and 
BamHI restriction enzymes (NEB) using primer pairs 9 and 10 and 11 and 12 
respectively. pGBT9(nleH1) and pGBT9(nleH2) were transformed into reporter host 
strain Saccharomyces  cerevisiae AH109 (MATa strain) using the LiAc Yeast 
Transformation Protocol described in the Yeast Protocols Handbook(YPH) (Clontech 
BD Matchmaker TM)  and selected for using the appropriate minimal synthetic dropout 
(SD) media for yeast (YPH, Appendix C). bax inhibitor variant 1(bi-1) was amplified 
from Y2H HeLa cDNA library (BD Matchmaker, Clontech) derived positive 
interacting clone pGADT7-Rec(bi-1) and cloned into the transfection vector pRK5-
myc (Clontech) using primer pairs 49 and 50 and restriction enzymes EcoRI and 
HindIII (NEB).  
 
All PCR reactions were amiplified using 1ul Deep Vent (NEB) and a standard PCR 
amplification cycle was used.  
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2.3 Western Blotting 
For Western blotting, all samples collected and boiled at 100°C for 5-10 min and run 
on SDS–PAGE gels (12% acrylamide). Gels were transferred to nitrocellulose 
membrane or polyvinylidene fluoride (PVDF) membrane using a standard wet transfer 
procedure. Membranes were then blocked in 5% semi-skimmed powdered milk in 1X 
Tris buffered saline (50 mM tris-HCL, 150 mM NaCl, pH 7.4) with 0.1% Tween 20 
(0.1%TBST) except when antibodies specific for phosphorylated proteins were used, 
for which 5% BSA 0.1% TBST was used for blocking.  Membranes were incubated 
with primary antibody for 1 h at room temperature or overnight at 4°C where 
appropriate, and then washed 3 times for 15 min in 0.1% TBST. Secondary antibodies 
were used at a 1/3000 dilution for anti-rabbit HRP conjugate (Dako) and 1/1000 for 
anti-mouse HRP conjugate (Dako) where appropriate. Membranes were developed 
using ECL reagents (GE healthcare) detection in LAS 3000 Fuji imager.  
 
2.4 Tissue Culture, Transfection and Pharmacology 
HeLa cells were maintained in a 75 cm2 flask in a static 37°C incubator with 5 % CO2 
atmosphere with DMEM low glucose with phenol red, 10% (v/v) heat inactivated 
foetal calf serum (FCS, Sigma), 1% (v/v) glutamax (Invitrogen), and 0.1 mM non 
essential amino acids (Sigma). For infections and transfections, HeLa cells were 
seeded into 24 well plates for a final confluence of 70-80% with approximately 2.5 x 
105 cells per well. For infections of cells for use in Western blotting, HeLa cells were 
seeded into 6 well plates for a final confluence of 70-80% with approximately 1 x 106 
cells per well.  
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Prior to infection wells were washed 3 times with PBS or HBSS and the media was 
replaced with serum free low glucose DMEM without phenol red. Cells were infected 
with primed bacteria. For prolonged infections, cells were washed vigorously 5 times 
1 h after infection and the media was replaced with with low glucose DMEM with 
phenol red and 250ug/ml gentamycin to prevent overgrowth of bacteria. For 
transfections, wells were washed 3 times with PBS and the media was replaced with 
serum free high glucose DMEM with phenol red. Cells were transfected with the 
different expression vectors using lipofectamine 2000 (Invitrogen) or siRNA using 
hyperfect (Qiagen) according to the manufacturers’ recommendations. 20 μM BI-1 or 
control siRNA using hyperfect (Qiagen) according to the manufacturers’ 
recommendations. After 72 h, knockdown of BI-1 expression was tested by RNA 
isolation using the QIAGEN RNAeasy kit according to the manufacturer’s 
recommendation and semi-quantitative RT-PCR using BI-1 (h)-PR (Santa cruz, sc-
37298-PR) or GADPH (primers 15 and 16) primers. 
 
Prior to treatment with pharmacological agents the cells were washed 5 times with 
HBSS and the media was replace with low glucose DMEM with phenol red and 250 
μg/ml gentamycin. Apoptosis was induced using 1 μM of staurosporine (STS, 
Calbiochem) for 4 - 6 h. ER stress was induced by the addition of 10 μg/ml of 
brefeldin A (BFA, Sigma) or 5 μg/ml of tunicamycin (TUN, Sigma) followed by 18 h 
incubation. The global caspases inhibitor z-VAD-fmk (Calbiochem) was used at a 
final concentration 66 μM (added together with bacteria or with STS). 
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2.5 Immunofluorescence Staining  
 
For immunfluoresence staining cultured cells were fixed in pre-chilled methanol for 
10 min at -20°C or fixed in 4% PFA or 3.7% formaldehyde (formalin) for 10 min at 
room temperature, permeabilised for 5 min in PBS 0.5% Triton X-100, quenched for 
30 min with 50 mM NH4Cl, blocked for 45 min with PBS 0.5% BSA and stained. 
Between each step coverslips were washed 3 times in PBS. The rabbit anti-NleH1 
antibody we developed was used at a dilution of 1/250 and applied overnight at 4°C to 
test for specific labelling of NleH1 during infection. Caspase-3 activation was 
visualized by overnight incubation at 4°C with rabbit anti-caspase-3 (Cell Signalling 
Technology) and cells transfected with pHM6(nleH1) (expressing N-terminal HA 
tagged NleH1) were visualized with mouse anti-HA (Cell Signalling Technology) 
diluted at 1/1000 and 1/500 respectively in 5% BSA. Donkey anti-rabbit IgG 
conjugated to Cy3 and donkey anti-mouse IgG conjugated to Cy2 (Molecular Probes) 
were used at concentrations recommended by the manufacturer for 45 min. Nuclear 
condensation was visualized by labelling the DNA with Hoescht 33342 (Molecular 
Probes). After 3 additional washes, the coverslips were mounted on slides using 
ProLong Gold antifade reagent (Invitrogen) and visualized by Zeiss Axioimager 
immunofluorescence microscope. All images were analysed using Axiovision Rel 4.5 
software.  
 
2.6 Protein Secretion via the T3SS 
Secreted proteins were prepared for Western blotting by inoculating LB overnight 
cultures of wild type EPEC and mutant strains. Cultures were then diluted 1:50 into 
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DMEM 4500 mg/L glucose (high glucose) supplemented with 25mM Hepes in the 
presence of appropriate antibiotics at 37°C in a 5% CO2 static incubator. Expression 
of NleH1-FLAG was induced by the addition of 1mM IPTG and incubation for 2 h. 
Secreted proteins were harvested by centrifuging cultures at 14 000 rpm for 30 min, 
separating the supernatants from the pellets.  The pellets were resuspended in 2X 
Laemmli buffer (0.1 M Tris pH6.8, 10% glycerol, 0.026% bromophenol blue, 2% 
SDS, and 0.04% 2-mercaptoethanol) in normalising volumes dependent on culture 
optical density OD600. Proteins in the supernatant were prepared for electrophoresis by 
precipitation overnight with a final volume of 10% TCA on ice followed by 
centrifugation at 14 000 rpm at 4°C for 30 min. Precipitated proteins were rinsed in 
cold 100% acetone twice, allowed to air dry to remove residual acetone, and 
resuspended in 25 ul of 2X Laemmli. All samples were boiled and used for Western 
blotting using a 1/2000 dilution of monoclonal mouse anti-FLAG antibody (Sigma) as 
primary antibody and anti-mouse HRP conjugate as secondary antibody.  
 
2.7 Protein T3SS Dependent Translocation (TEM Assays)  
EPEC E2348/69 wild type and an isogenic T3S-negative mutant (ΔescN) harboring 
the TEM-1 fusion plasmids were grown for 2.5 h in DMEM low glucose with 25mM 
Hepes , 10% FCS, 2mM L-glutamine and incubated at 37°C in a 5% CO2 static 
incubator for 2.5 h before being used to infect HeLa cells (1 h in DMEM with IPTG). 
After infection, cells were washed with HBSS and loaded with the fluorescent 
substrate CCF2-AM (Invitrogen), and incubated at room temperature in the dark for 
1.5 h. Before visualisation, cells were washed again in HBSS 3 times. Cleavage of 
CCF2-AM by the TEM-1 β-lactamase was detected by blue fluorescence of 
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eukaryotic cells after illumination at 409 nm, indicating translocation of the effector 
fusion protein. Conversely, green fluorescence due to the presence of uncleaved 
CCF2-AM was taken to indicate absence of translocated fusion protein within the 
eukaryotic cells.  
2.8 Protein Purification and Antibody Production 
His tagged constructs for protein purification were transformed into E. coli BL21 
strain. BL21 pet28-a(nleH1), and BL21 pet28-a(nleH1K159A) overnight cultures 
were subcultured at a dilution of 1/100 into 50 ml fresh LB broth supplemented with 
50μg/ml kanamycin. The culture was incubated in a shaking 37°C incubater until an 
OD600 of 0.4-0.5 was reached. At this point protein expression was induced by the 
addition of 1mM IPTG and incubation for 4 h. Bacterial pellets were lysed using 
PopCulture (Novagen) supplemented with 12.5 mg of Lysozyme (Sigma) and 1.5 
ul/50ml culture of DNAse I (Ambion), and centrifuged for 15 min at 10 000 rpm prior 
to column application. 
 
NleH1-His and NleH1K159A-His were purified using a Ni2+ agarose His-Bind Resin 
Column (Novagen). Protein purification was tested by using a 10 μl samples of 
purified protein, mixed with 2X Laemeli buffer and denatured by heating at 100°C for 
10 min followed by centrifugation at 14 000g for 30 sec before running on a 12 % 
SDS PAGE gel. Gels were stained with commercially available BioRAD Biosafe 
Coomassie overnight or were used in wet transfer to nitrocellulose membrane for 
Western blotting with rabbit anti-His antibody (Sigma). Purified NleH1-His was sent 
to CovalAB in order to raise polyclonal antibodies in sera of rabbits.  
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2.9 Antibody Testing 
 
 
Anti-NleH1 antibody was tested by Western blotting and immunofluorescence 
microscopy. EPEC E2348/69 ΔnleH1nleH2 strains with or without pSA10(nleH1) or 
pSA10(nleH2) were used. For Western blotting, bacterial cell supernatants were 
collected after growth in low glucose DMEM and labelled using 1/1000 anti-NleH1 
antibody. For immunofluorescence, HeLa cells were infected using a multiplicity of 
infection (MOI) of 1:100, washed in PBS and fixed with formalin (3.7% 
formaldehyde). Immunofluorescence staining was conducted with rabbit anti-NleH1 
antibody.  
 
2.10 Kinase assays  
Prior to conducting kinase assays purified NleH1-His and NleH1K159A-His were 
dialysed against EB50 buffer (50 mM Tris pH 8, 2mM DTT, 2mM EDTA, 10% 
glycerol, 50 mM NaCl). Dialysed proteins were then concentrated using 10 KDa 
Millpore’s Amicon Centricons and frozen in 50 μl aliquots at -80°C. NaCl 
concentration was adjusted to 125 mM and 0.1% Triton X-100 was added equally to 
all samples to prevent precipitation during storage. 
 
NleH1-His and NleH1K159A-His were added to the kinase assay reagent mix (50 mM 
Tris-HCl pH 7.5, 10 mM MgCl2, 100 mM NaCl, 1 mM Dithiothreitol, 50 μM ATP) with 
5 μCi [γ-33P]ATP (MP Radiochemicals, 370 MBq/ml, 3000 Ci/mmol) with or without 
10 μg of the general substrate myelin basic protein (MBP; Sigma). The mixture was 
incubated for 30 min at 37°C and subjected to SDS-PAGE followed by Coomassie blue 
staining and autoradiography. For autoradiography the gel was dried onto 3MM filter 
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paper using a vaccum drier and placed in a light tight Exposure cassette with a Kodak 
BioMax MS film in a dark room and incubated at -70°C for 48 h. The cassette was 
allowed to warm to room temperature before the film was processed in an automatic 
film developer system.  
 
To determine if NleH1 is autophosphorylated on a tyrosine, threonine or serine 
residue, kinase assays were conducted with non-radioactive ATP. Western blotting 
was conducted using PVDF membrane. The membrane was blocked in 5% BSA 0.1% 
TBST and labelled with either 1/1000 mouse monoclonal anti-phospho-Tyrosine 
(clone PY20) (Sigma), 1/880 mouse monoclonal anti-phospho-Serine (Sigma), and 
1/2000 mouse monoclonal anti-phospho-Threonine (Sigma). A control Western blot 
was labelled with rabbit anti-His antibody (sigma). Phosphorylation was then 
confirmed using 400U of λ-phosphatase (NEB) for dephosphorylation of NleH1. 
 
2.11 Nuclear Condensation and Membrane Blebbing  
 
HeLa cells grown on glass coverslips were washed before the growth media was 
replaced by colourless DMEM. The inoculum of primed bacteria was normalized by 
OD (OD600 = 0.4), and infections were carried out for 1 h. Following 5 washes with 
HBSS, 200 g/ml gentamicin (Invitrogen) was added for a further 2 h. Cells were 
fixed in pre-chilled methanol for 10 min at -20°C and processed for 
immunofluorescence. 
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Membrane blebbing was observed by phase contrast and confirmed by scanning 
electron microscopy (SEM). Cells were washed with PBS, fixed in formalin (3.7% 
formaldehyde in PBS), washed 3 times in 0.1 M phosphate buffer (pH 7.3), fixed 
overnight in 3% glutaraldehyde in 0.1 M phosphate buffer and post-fixed in 1% 
osmium tetroxide in phosphate buffer for 30 min. Samples were processed using 
standard dehydration and critical point drying methods, sputter coated using a gold 
sputter (gold-palladium target). Samples were examined using a Jeol JSM-6390 SEM.  
 
2.12 Cell Viability Assay 
 
HeLa cells grown in a 24 well plates were infected for 1 h and then treated with 
gentamicin for 4 h. Cells were washed 3 times with PBS, trypsinated and 700 μl of 
culture media was added. 0.05% Trypan blue in PBS was mixed with HeLa cells at a 
1:1 ratio just prior to counting on a Nebauer haemocytometer. Each condition was 
tested in triplicate and each experiment was repeated a minimum of three times. All 
counts were compared to the level of uninfected untreated cells and plotted as 
percentage of cells survival. 
 
2.13 Detection of pro-caspase-3 by Western blotting 
HeLa cells, grown in 6 well plates, were infected during 1 h with primed bacteria. 
Then, gentamicin and STS were added and the cells were incubated at 37°C for 3 h, 
washed, and lysed in 1% Triton X-100 containing a protease inhibitor cocktail 
(Sigma). Cells were scraped on ice and the lysates were sonicated. Whole cell lysates 
were concentrated using biomax protein concentrating columns (Millipore), run on 
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12% SDS-PAGE gels and transferred to PVDF membrane. Membranes, processed by 
conventional methods, were incubated with anti-rabbit pro-caspase-3 at a 1/500 
dilution, followed by incubation with the anti-rabbit HRP conjugate secondary 
antibody. The same membrane was then washed and incubated with the primary 
mouse anti-tubulin antibody (DSHB) and secondary anti-mouse HRP conjugate as a 
control. 
 
2.14 Measurement of cytosolic Ca2+ levels 
 
Cytosolic Ca2+ levels were measured using the commercially available fluorescent 
indicator Fluo-4 Direct (Invitrogen) according to the manufacturer’s instructions. 
HeLa cells were grown in a 96 well microplate, incubated with Fluo-4 Direct for 1 h 
at 37°C and then infected. Fluorescent intensities were determined using a flurometer 
set for excitation at 494 nm and emission at 516 nm.  
 
2.15 Yeast-two hybrid system 
 
A pre-transformed MATCHMAKER HeLa cell cDNA library (Clontech) was 
screened against the NleH1 bait according to the manufacturer’s protocol. Following 
mating of Saccharomyces cerevisiae AH109 carrying the bait pGBT9(nleH1) with S. 
cerevisiae Y187 (MATa) carrying the prey plasmid pGADT7-Rec encoding fragments 
of the human HeLa cDNA library, diploids were selected on triple drop-out plates (-
Trp/-Leu/-His (TDO)) and tested for interaction on quadruple drop-out selective 
plates (-Trp,-Leu,-His-Ade (QDO)). Expression of the lacZ reporter gene to verify 
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interaction was assessed by testing for β-galactosidase activity in cell extracts as 
described by (Miller, 1972). In each case, expression of lacZ was tested in triplicates. 
Plasmid from positive colonies were purified using the yeast plasmid purification 
protocol described in Clonetech Yeast Protocols Handbook (PT3024-1). Purified 
plasmids were transformed into HB101, selected on M9 minimal media supplemented 
with proline, thiamine, streptomycin (100 μg/ml) and ampicillin (100μg/ml). The 
potential interacting partners of NleH1 were identified by amplification by PCR using 
primers 17 and 18 and sequencing of the amplified fragment. Protein interactions 
were confirmed by co-transforming with pGBT9(nleH1) or pGBT9(nleH2) and BI-1 
the yeast AH109, and plating on QDO and yeast minimal media with glucose or 
galactose as a sole carbon source. AH109 cannot grow on media with galactose as the 
sole carbon source due to deletion of the regulator GAL4 (Johnston, 1987). p53 and T 
antigen were used as a positive control, and NleH1 and T antigen as a negative 
control. 
 
2.16 Animal Models 
All animal experiments were performed in accordance with the Animals Act 1986 and 
were approved by the local Ethical Review Committee. C. rodentium ICC180 ΔnleH 
infections of the murine host, measurement of pathogen burden and bioluminescence 
imaging were carried out under the personal licence no. PIL70/19765  
 
2.17 Murine models 
Specific-pathogen-free female 6- to 8-week-old mice were used in this study. Wild-
type inbred C57BL/6 and DBA-1 mice were purchased from Harlan UK Ltd. 
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(Bicester, United Kingdom), while the transgenic light-producing animal model DBA-
1 NF- B-luc (Oslo) (P/N 119335) was purchased from Xenogen-Caliper Corp. 
(Alameda, CA). The transgenic light-producing animal model NF- B-RE-luc (Oslo)-
Xen, commonly called NF- B-RE-luc (Oslo), carries a transgene containing three NF-
B responsive-element (RE) sites from the immunoglobulin light-chain promoter and 
modified firefly luciferase cDNA. All animals were housed in individually HEPA-
filtered cages with sterile bedding and free access to sterilized food and water. 
Independent experiments were performed at least twice using at least four mice per 
group.  
2.18 Oral infection of mice, harvesting and collection of 
tissues, and bacterial stool counts 
Mice were orally inoculated using a gavage needle with 200 µl of overnight LB grown 
bacterial suspension in PBS ( 5 x 109 CFU). The number of viable bacteria used as 
the inoculum was determined by retrospective plating onto LB agar containing 
antibiotics. Stool samples were recovered aseptically at various time points after 
inoculation and the number of viable bacteria per gram of stool determined after 
homogenization at 0.1g ml–1 in PBS and plating onto LB agar containing the 
appropriate antibiotics. At selected time intervals post-infection, blood was collected 
by cardiac puncture and mice were sacrificed by cervical dislocation. Sections of 
distal colon were collected and snap frozen in liquid nitrogen before storage at –70°C 
prior to analysis. For co-infection studies, the CI was calculated as described 
previously by Mundy et al. (Mundy et al., 2003). For this experiment, the input ratio 
of wild-type strain to mutant strain was approximately 1:2. The null hypothesis that CI 
= 1 was tested by a nonparametric Wilcoxon two-tailed test using the GraphPad InStat 
software (GraphPad Software Inc., San Diego, CA).  
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For natural transmission experiments seed mice were split into pairs and each pair 
was housed with 6 uninfected mice for co-mingling. The tail of each mouse was 
marked with coloured pen to allow infection dynamics to be followed for all mice in 
all 4 co-mingling cages. The natural transmission of C. rodentium ICC180 ΔnleH was 
followed by aseptic recovery of faecal samples from each animal at various time 
points after seeder introduction. Infection by natural transmission was conducted as 
described previously by (Wiles et al., 2005; Wiles et al., 2006).  
2.19 In Vivo Bioluminescence Imaging 
Prior to imaging, the abdominal region of each mouse was depilated to minimize any 
potential signal impedance by melanin within pigmented skin and fur. 
Bioluminescence (photons s–1 cm–2 sr–1) from living infected animals was measured 
after gaseous anaesthesia with isofluorane using the IVIS50 camera system (Xenogen-
Caliper Corp., Alameda, CA). The sample shelf was set to position D (field of view, 
15 cm). A photograph (reference image) was taken under low illumination prior to 
quantification of photons emitted from strain ICC180 at a binning of 4 over 1 to 10 
min using the software program Living Image (Xenogen-Caliper Corp.) as an overlay 
on Igor (Wavemetrics, Seattle, WA). For anatomical localization, a pseudocolor 
image representing light intensity (from blue [least intense] to red [most intense]) was 
generated using the Living Image software and superimposed over the gray-scale 
reference image. Bioluminescence within specific regions of individual mice was also 
quantified using the region-of-interest tool in the Living Image software program 
(given as photons s–1). For expression of light from the NF- B reporter mice, 180 mg 
kg–1 D-luciferin (Gold Biotechnology, St. Louis, MO) dissolved in 250 µl PBS (pH 
7.8) was administered by intraperitoneal injection 5 min prior to imaging. As a 
positive control for luciferase gene expression from the NF- B-RE-luc (Oslo) mice, 
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tumor necrosis factor alpha (TNF- ) (2 µg per mouse) was administered by 
intraperitoneal injection.  
2.20 Histopathology 
Segments of the cecum and the terminal colon of each mouse were collected at 9 and 
14 days post-inoculation, rinsed of their content, and fixed in 10% buffered formalin 
for microscopic examination. Formalin-fixed tissues were then processed, paraffin 
embedded, sectioned at 5 µm, and stained with hematoxylin and eosin (H&E) 
according to standard techniques. Sections were examined by light microscopy for the 
presence of intimately adhering bacteria on intestinal cells, as previously described 
(Girard et al., 2005). Crypt length was also evaluated, and the lengths of at least four 
well-oriented crypts were measured for each section.  
2.21 Immunohistochemistry  
Snap-frozen colonic tissues, embedded in OCT mounting medium (VWR BDH, 
Lutterworth, United Kingdom), were sectioned using a cryostat to a thickness of 5 
µm. Sections were mounted on polysine slides (VWR BDH) and air dried overnight 
before fixing in acetone at room temperature for 20 min. After air drying for 1 h, 
sections were rehydrated in Tris-buffered saline (TBS) for 5 min and then incubated 
with antibodies against CD3, CD4, and CD8 (Serotec, Oxford, United Kingdom) at a 
dilution of 1/50 to 1/100 for 1 h. Sections were gently washed with TBS three times 
before addition of biotinylated anti-rat immunoglobulin G (Serotec) at a dilution of 
1/200 with 4% (vol/vol) normal murine serum for blocking (Sera Laboratories 
International, Horsted Keynes, United Kingdom) for 30 min. After washing, a 1/200 
dilution of 0.1% avidin-peroxidase (Sigma-Aldrich, Dorset, United Kingdom) was 
added and left for 30 min before further washing and treatment with 
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diaminobenzadine substrate (Sigma-Aldrich) for 5 min. The reaction was stopped with 
excess TBS, and sections were counterstained with Mayer's hematoxylin (Sigma-
Aldrich) for 30 s, dipped in acid alcohol, and washed in tap water for 5 min. Sections 
were dehydrated through an ethanol gradient of 70%, 90%, and 100% solutions (2 min 
each), followed by clearing in Histoclear (VWR BDH) and mounting in DPX (VWR 
BDH). A control slide using no primary antibody was also made to show endogenous 
peroxidase-containing cells. Stained cell populations were counted in five randomly 
selected fields per section, and data were expressed as the number of T cells per 250 
µm2 of lamina propria.  
2.22 SEM in vivo  
Intestinal segments were fixed in 2.5% glutaraldehyde and processed for scanning 
electron microscopy (SEM) as previously described (Girard et al., 2007). SEM 
samples were examined blindly at 25 kV using a JEOL JSM-5300 SEM [JEOL (UK) 
Ltd., Herts, United Kingdom].  
2.23 IFA in vivo 
An indirect immunofluorescence assay (IFA) was used for the detection of C. 
rodentium (serotype O152) in formalin-fixed, paraffin-embedded sections as 
previously described (Girard et al., 2007). Sections were unwaxed in Histoclear by 
washing twice for 10 min and rehydrated in 100%, 95% and 80% Ethanol respectively 
before immersion in PBS 0.1% Tween 20 0.1% saponine (PBS-TS). Blocking was 
conduced in PBS-TS with 10% normal donkey serum before labelling with rabbit 
anti-O152 antibody. Tetramethyl rhodamine isothiocyanate-conjugated donkey anti-
rabbit (Jackson ImmunoResearch Europe Ltd., Soham, Cambridgeshire, United 
Kingdom) secondary antibody was used to visualize O152-positive bacteria, while 
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DNA of both bacteria and epithelial cells was counterstained with Hoechst 33342 
(Sigma-Aldrich Co., United Kingdom). Sections were examined with an Axio Imager 
M1 microscope (Carl Zeiss MicroImaging GmbH, Germany). Images were acquired 
using an AxioCam MRm monochrome camera and computer processed using 
AxioVision (Carl Zeiss MicroImaging GmbH, Germany) and Adobe Photoshop 5.0 
and Adobe Illustrator 8.0 software (Adobe Systems Incorporated, CA).  
For assessing cell detachment, IFA staining was conducted using chicken anti-Intimin 
antibody and Hoechst as described above. For caspase-3 cleavage IFA was conducted 
as described above except chicken anti-Intimin antibody and rabbit anti-cleaved 
caspase-3 (Cell Signalling) and Hoechst were used for labelling and after unwaxing, 
sections were placed in 10 mM sodium citrate and heated to 100°C for 10 minutes for 
heat induced antigen unmasking. Also, labelling with anti-cleaved caspase-3 antibody 
was conduced at overnight at 4°C. Multiple separate sections of each mouse wre 
observed and atleast 4 sites of adherent bacteria were analysed per mouse.  
2.24 RNA extraction and quantitative RT-PCR from Tissue 
Total RNA was isolated from frozen colonic tissue using the RNeasy Plus minikit 
(Qiagen). All tissues used were harvested from mice 14 days after oral gavage. Total 
RNA was measured using a Nanodrop. TNF- or gamma interferon (IFN-) and -
actin mRNAs were measured by semiquantitative reverse transcription-PCR (RT-
PCR) using primers 41 to 46 listed in Table 3 and the one-step Reverse-iT hot-start kit 
(Thermo) was used. The PCR amplification cycle was 20 s at 94°C, 30 s at 60°C, and 
60 s at 72°C for 35 cycles was used. One microgram of RNA was used for 
measurement of TNF- and IFN- transcript levels, and 100 ng of RNA was used for 
detection of β-actin mRNA. The PCR products were run on a 1% agarose gel 
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alongside the 100-bp ladder from NEB in Tris-borate-EDTA buffer. GeneTools 
(Syngene) was used to conduct densitometric analysis. All TNF- /-actin and IFN-
/-actin ratios were compared between mice infected with wild-type and nleH mutant 
bacteria.  
2.25 Statistics 
All statistical tests were performed using commercially available GraphPad InStat 
v3.06 software (GraphPad Software Inc., San Diego California USA). 
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Kinases 
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3.1 The NleH Family  
 
NleH belongs to a family of T3SS effectors found in diverse enteric pathogens and 
conserved in A/E pathogens. The prototypic EPEC O127:H6 E2348/69 and EHEC 
O157:H7 EDL933 strains contain two NleH paralogues, which share 83-84% protein 
identity. C. rodentium contains only one nleH gene, which shares 81 and 83% amino 
acid sequence identity with EHEC O157:H7 NleH1 and NleH2, respectively. NleH 
shares 49% amino acid sequence similarity with the serine/threonine kinase OspG of 
Shigella flexneri and YspK of Yersinia enterocolitica.  
 
We employed Geneious 2.5.4 software agent to search the NCBI protein database 
using EPEC E2348/69 NleH1 as a query sequence and created a phylogram of the 
NleH family and homologues (Figure 8). Two major clusters were formed in the 
phylogram, one containing all the NleH effectors from sequenced A/E pathogen 
strains, and the other containing closer homologues of OspG including an OspG-like 
effector (90.8% identity to OspG of Shigella) in several EHEC O157:H7 strains. 
Within the NleH family, NleH1 and NleH2 also formed separate subclusters. 
Interestingly, the most distinct difference between NleH1 and NleH2 is a 10 amino 
acid insertion in NleH2 near the middle of the protein (at position 130-139). C. 
rodentium NleH forms a separate branch from the NleH1 and NleH2 subclusters. 
Although, C. rodentium NleH does not contain the 10 amino acids insertion, its 
sequence is more similar to NleH2 than NleH1. Members of the NleH family share 
greater than 80% protein identity. For this reason, we believe their function may be 
conserved.  
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Figure 8: Distance tree of the NleH family. The Geneious agent software was used to identify 
homologues from NCBI, and create a phylogram of the alignment. Branch lengths are 
proportional to the amount of inferred evolutionary change. The NleH family is highlighted in a 
red box. 
 
3.2 NleH Secretion and Translocation 
  
In order to determine whether NleH1 is secreted via the T3SS, Western blotting was 
used to compare pellets and supernatants of EPEC E2348/69 ΔnleH1nleH2, ΔsepD 
and ΔescN mutants all overexpressing NleH1-FLAG. The hypersecretion mutant 
ΔsepD was included to increase the quantity of type three secreted effectors present in 
culture supernatants. The type three secretion null mutant (ΔescN) was included as a 
negative control along with EPEC E2348/69 carrying an empty pSA10 plasmid. 
Pellets and TCA concentrated supernatants were analysed by Western blotting using 
monoclonal anti-FLAG antibody. Western blotting confirmed that NleH1 is secreted 
NleH 
Family 
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in a type three secretion dependent manner. NleH1-FLAG was detected in all pellets 
excluding the empty vector control. However, NleH1-FLAG was only detected in the 
supernatants of strains encoding a functional type three secretion system (Figure 9). 
Furthermore, the NleH1-FLAG detected in the ΔsepD hypersecretion mutant 
supernatant was more abundant than in the complemented double mutant strain, 
confirming that NleH effectors are secreted in a T3SS dependent manner. 
 
 
 
Figure 9: NleH1 is secreted in a T3SS dependent manner. Secretion of a plasmid encoded NleH1-
FLAG was analyzed in a EPEC E2348/69 ΔnleH1nleH2, T3SS mutant ΔescN, and hypersecretion 
sepD mutant strains. EPEC wild type strain carrying empty vector was used as a control for the 
specificity of the anti-FLAG antibody. Proteins secreted in the supernatant or remaining in the 
bacterial pellet were analyzed by Western blotting.  
 
 
To determine if EPEC NleH1 and NleH2 are translocated in a T3SS-dependent 
manner NleH1 and NleH2 were fused to β-lactamase, transformed into wild type and 
escN strains and used to infect HeLa cells. A β-lactamase TEM assay was conducted 
by Dr. Olivier Marches, where infected cells were treated with cell permeable 
substrate CCF2/AM which is cleaved by β-lactamase and fluoresces blue when 
cleaved and green when uncleaved, indicating translocation of the fusion proteins. 
NleD effector was used as a positive control. Both NleH1 and NleH2 were 
translocated into HeLa cells (Figure 10). The type 3 secretion null escN mutant was 
unable to translocate NleH1 and NleH2 (not shown) into HeLa cells, demonstrating 
the NleH effectors are translocated in a T3SS dependent manner.  
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Figure 10:β-lactamase translocation assay. HeLa cells were infected with EPEC containing 
plasmid encoded β-lactamase fused to EPEC NleH1 or NleH2. β-lactamase cleaves the CCF2/AM 
substrate, which fluoresces in green when uncleaved and in blue when cleaved, indicating 
translocation of the fusion protein. NleD effector was used as a positive control.  
 
 
3.3 Anti-NleH1 Antibody Production  
A polyclonal anti-NleH1 antibody was raised in the sera of a rabbit to provide a tool 
for immunofluorescence imaging and to detect chromosomally encoded NleH1. For 
antibody production NleH1-His (6X) (approximately 35 KDa) was purified (Figure 
11A) and approximately 1.5 mg of protein was sent CovalAB for antibody production 
in rabbits. The protein concentration in these fractions was quantified using a standard 
Bradford assay. To test the antibody, secretomes of nleH1nleH2 mutant and 
nleH1nleH2 mutant complimented with p(nleH1) or p(nleH2) were run on a SDS-
PAGE gel and western blotting was conducted using the rabbit NleH1 antiserum. The 
anti-NleH1 antibody had some background but specifically labelled NleH1 but not 
NleH2 (Figure 11B).  
 
 
WT pCXnleD 
escN pCXnleH1
UninfectedWT pCXnleH2 
WT pCXnleH1  
Blue Translocated 
Green Not translocated 
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Figure 11: A) Purification of EPEC NleH1-His used for antibody production and B) Western blot 
of EPEC nleH1nleH2 secretome with or without plasmid encoded nleH1 or nleH2. The rabbit 
NleH1 antibody produced specifically labels NleH1 and not NleH2.  
 
 
The antiserum produced was tested for its ability to label NleH1 by 
immunofluorescence microscopy on fixed HeLa cells infected with nleH1nleH2 
mutant with or without p(nleH1). This was done to provide insight into the function of 
NleH effectors as cellular localisation of NleH1 could suggest site of action. Staining 
with anti-NleH1 antibody non-specifically labelled bacteria, however, when NleH1 
was overexpressed, this non-specific labelling was largely diminished and was 
replaced by a strong cell junction/membranar staining and distinct staining within the 
cell cytoplasm, suggesting NleH1 may localise to two different locations (Figure 12). 
However to use this antiserum further it would first need to be affinity-purified 
adsorbed.  
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Figure 12: Labeling of anti-NleH1 antibody by immunofluoresence microscopy. HeLa cells 
infected with nleH1nleH2 with or without p(nleH1). Overexpression of NleH1 resulted in 
membranar and distinct cytoplasmic staining. The anti-NleH1 antibody non-specifically labels 
bacteria and needs to be purified further.  
 
3.4 NleH1 Kinase Activity 
 
 
Another avenue of research that may provide more insight into the function of NleH1 was 
the characterisation of its physicochemical activity. As NleH1, similar to its homologue 
OspG of Shigella flexneri (Kim et al., 2005), contains the highly conserved kinases 
subdomains I, II and III (Hanks et al., 1988) it is predicted to be a kinase (Figure 13). 
These subdomains play an essential role in ATP binding, orientation and stability. In 
particular, subdomain II contains an invariant Lys residue that interacts with the α- and β- 
phosphates in order to anchor ATP in the correct orientation (Hanks and Hunter, 1995). 
Mutation of subdomain II invariably results in a loss of kinase activity (Bossemeyer, 
1993). Subdomain I contains the consensus sequence Gly-X-Gly-X-X-Gly is involved in 
nucleotide positioning (Bossemeyer, 1994), and the Glu residue of subdomain III aids in 
the stabilisation of the interactions between the Lys residue and ATP (Hanks and Hunter, 
1995). 
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Figure 13: Alignment of members of the NleH family and homologues (BioEdit). Conserved 
residues of the kinase subdomains I, II and III are indicated (*).  
 
In order to determine if the NleH effectors are protein kinases, NleH1 Lys159 of the 
kinase subdomain II was replaced with the hydrophobic aliphatic alanine residue by site 
directed mutagenesis as previously described for OspG (Kim et al., 2005) to make 
NleH1K159A-His. His-tagged wild type NleH and NleH1K159A polypeptides were 
purified and incubated separately with γ-33P-ATP in the presence or absence of the general 
kinase substrate myelin basic protein (MBP). NleH1 phosphorylated MPB and underwent 
autophosphorylation (Figure 14), a characteristic of many known kinases (Hanks and 
Hunter, 1995), while a K159A substitution resulted in total loss of kinase activity, 
demonstrating that NleH1 is a kinase that requires the conserved subdomain II for its 
ability to transfer phosphate groups. So far as we are aware, NleH1 is the only T3SS 
EPEC and EHEC effector to be identified displaying kinase activity.  
Subdomain           I                     II                    III   
   * *    *    * 
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Figure 14: Autoradiograph (A) and Coomassie staining (B) of NleH1 kinase assay using [γ-33P] 
ATP. Kinase assays were conducted using purified proteins in the presence and absence of the 
general substrate myelin basic protein (MBP). NleH1 phosphorylated MBP (Lane 1) and 
autophosphorylated itself (Lane 2). A K159A substitution resulted in loss of kinase activity 
(Lanes 3 and 4). 
 
Protein phosphorylation networks play an integral role in signal transduction 
pathways (Hunter, 1995). To determine which residue was phosphorylated during 
autophosphorylation of NleH1 a non-radioactive approach utilizing commercially 
available anti-phospho-tyrosine, -serine and -threonine antibodies was used (Figure 
15). NleH1 autophosphorylation could not be detected using anti-phospho-threonine 
antibody, while a very faint band was detected using anti-phopho-serine antibody 
(Figure 15A). As background labelling was stronger than labelling of NleH1 with 
anti-phospho-serine antibody it is possible that this faint band could be non-specific. 
A positive control is needed to confirm these results. Interestingly, NleH1 was 
strongly autophosphorylated on tyrosine residue(s) (Figure 15B). As a control, 
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λphosphatase was used to dephosphorylate NleH1. λ phosphatase treatment for 30 
min greatly diminished tyrosine phosphorylation of NleH1 (Figure 15C). The online 
prediction algorithm KinasePhos 2.0 predicted 12 putative tyrosine phosphorylation 
sites on NleH1. 
 
 
Figure 15: Purified EPEC NleH1-His was used in non-radioactive kinase assay and run on an 
SDS-PAGE gel and immunoblotted with A) anti-phospho-serine, threonine or B) tyrosine 
antibody. Anti-His tag antibody was used to label for NleH1. C) Tyrosine phosphorylation 
wasconfirmed by treating phosphorylated protein with λ phosphatase. 
  
 
Together our results demonstrate that the NleH family of effectors are secreted and 
translocated in a type three secretion dependent manner. Although they share strong 
protein identity, antibody production against EPEC NleH1 is NleH1-specific and does 
not label EPEC NleH2. Using the anti-NleH1 antibody we found that NleH localises 
to the membrane and to distinct regions within the cell. Due to the high background, 
the antibody needs to be purified further before use. Like the NleH homologue OspG, 
NleH effectors are kinases. NleH1 autophosphorylates on tyrosine residue(s). 
Although our results suggest that NleH1 does not autophosphorylate on serine and 
threonine residues, this requires further confirmation. So far as we are aware, only 
α-p-Thr
α-p-Tyr
NleH1 
λpptase - +
α-p-Serα-His
NleH1-His 
α-p-Tyr
NleH1-His 
α-His 
A 
B C
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four other T3SS effectors have been identified displaying kinase activity. These 
effectors include the Salmonella SteC, involved in the formation of F-actin meshwork 
(Poh et al., 2008), the Shigella flexneri OspG that inhibits NF-KB activation (Kim et 
al., 2005), the Yersinia YspK, the OspG homologue (Matsumoto and Young, 2006), 
and YopO/YpkA (Galyov et al., 1993) which disrupts the target cell cytoskeleton 
(Juris et al., 2000) and mimics guanidine nucleotide dissociation inhibitors (GDIs) of 
the Rho GTPases (Prehna et al., 2006). Interestingly, so far all type 3 secreted kinases 
have been found to be serine threonine kinases (Galyov et al., 1993; Juris et al., 2000; 
Kim et al., 2005; Matsumoto and Young, 2006; Poh et al., 2008; Prehna et al., 2006). 
To our knowledge, NleH effectors are the only type 3 secreted effectors identified so 
far to possess tyrosine phosphorylation activity. However, the function of NleH 
effectors and the role of its kinase activity is currently not known. 
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CHAPTER 4 - NleH Effectors Inhibit Apoptosis in a 
Bax Inhibitor-1 Dependent Manner 
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Recently, it has been shown that EPEC can trigger early signs of apoptosis (Crane et 
al., 1999; Crane et al., 2001). Interestingly, in preliminary studies we noted that in 
contrast with wild type EPEC infection with the nleH1nleH2 mutant resulted in 
increased cell detachment. This led us to hypothesise that the NleH effectors have 
cytoprotective activity. To investigate the effect of NleH effectors on apoptosis we 
studied their ability to prevent key signs of apoptosis including nuclear condensation, 
membrane blebbing, cell survival, and inhibition of caspase-3 activation. 
 
4.1 NleH Effectors Inhibit Nuclear Condensation  
 
To investigate if NleH1 and NleH2 interfere with nuclear condensation, HeLa cells 
were infected with wild type EPEC (strain E2348/69), nleH1nleH2 mutant and the 
nleH1nleH2 mutant complemented with nleH1 or nleH2. The pro-apoptotic protein 
kinase inhibitor staurosporine (STS) (Tafani et al., 2002; Tafani et al., 2001), was 
used as a control. 
 
Nuclear condensation was analyzed by Hoechst staining. Typical images are shown in 
Figure 16. Quantification under fluorescence microscopy of the number of cells with 
condensed nuclei demonstrated that HeLa cells infected with the EPECnleH1nleH2 
mutant (15%) and STS-treated cells (38%), contained significantly more condensed 
nuclei (arrow) in comparison to uninfected cells or cell infected with EPEC wild type 
or complemented EPEC mutant strains (all ≤2%) (Figure 16B).  
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Figure 16: Nuclear condensation and fragmentation during infection of HeLa cells with wild type 
EPEC, EPEC nleH1nleH2 mutant and complemented strains [p(nleH1) or p(nleH2)]. 
Uninfected and STS-treated cells were used as controls. (A) Hoechst staining and (B) nuclear 
condensation and fragmentation counts show a significant increase of nuclear condensation and 
fragmentation in cells infected with EPEC nleH1nleH2 or after treatment with STS (*) in 
comparison to uninfected cells or cells infected with EPEC wild type or the complemented 
mutant strains (* p value <0.05). 
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4.2 NleH Effectors Inhibit Membrane Blebbing 
 
Membrane blebbing was assessed using phase contrast and confirmed by scanning 
electron microscopy (SEM). Images of typical cells observed by SEM are shown in 
Figure 17A. Membrane blebbing (arrow), typical of apoptotic cells, can be observed 
on cells infected with the nleH1nleH2 EPEC mutant or cells treated with STS. The 
number of cells with membrane blebbing was quantified under phase contrast (Figure 
17B). A significantly larger number of cells with membrane blebbing was observed in 
cells infected with the nleH1nleH2 EPEC mutant (18%) or treated with STS (38%) 
compared to uninfected cells or cells infected with wild type EPEC or the 
complemented mutant strains (all ≤3%).  
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Figure 17: Membrane blebbing during infection of HeLa cells with wild type EPEC, EPEC 
nleH1nleH2 mutant and complemented strains [p(nleH1) or p(nleH2)]. Uninfected and STS-
treated cells were used as controls. (A) SEM analysis and (B) quantification of membrane 
blebbing show significantly higher levels in cells infected with EPEC nleH1nleH2 or after 
treatment with STS (*) in comparison to uninfected cells or cells infected with wild type EPEC or 
the complemented mutant strains. (p value <0.05). 
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4.3 NleH Effectors Promote Cell Survival by Inhibiting 
Apoptosis 
 
The observed increase in both nuclear condensation and membrane blebbing during 
infection in the absence of nleH1 and nleH2 prompted us to further analyze their 
effect on cell survival. To this end we quantified the number of adherent living cells 
after infection. While infection with wild type EPEC does not significantly alter cell 
survival, less than 50% of cells remained attached during infection with the EPEC 
nleH1nleH2 mutant (Figure 18A). Complementation of EPEC nelH1nleH2 by 
nleH1 or nleH2 significantly restored cell survival. In order to localise NleH effectors, 
we complemented the EPEC nleH1nleH2 mutant with C-terminally tagged NleH 
(FLAG or HA). However, we observed that tagged NleH was unable to complement 
the nleH1nleH2 mutant in the cell viability assay (data not shown). This result 
suggested that the C-terminus of NleH might be essential for the anti-apoptotic 
activity. We tested this hypothesis by deleting the last 5 amino acids from the C-
terminal of NleH1 and NleH2 proteins in the complementation vectors 
(nleH1VLSKI and nleH2VLSKI). Quantification of living cells using truncated 
NleH1 and NleH2 (nleH1VLSKI and nleH2VLSKI) was carried out in conjunction 
with Scott Robinson. The truncated NleH1 and NleH2 were unable to complement the 
nleH1nleH2 mutant in the cell viability assay (Figure 18A). Therefore we concluded 
that the C-terminal 5 amino acids are essential for NleH’s ability to prevent cell death.  
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Figure 18: Cell survival during infection of HeLa cells with wild type EPEC, EPEC nleH1nleH2 
mutant and complemented strains [p(nleH1), p(nleH2), p(nleH1VLSKI) or p(nleH2VLSKI)]. 
Uninfected and STS-treated cells were used as controls. (A) Cell viability was significantly 
reduced in cells infected with EPEC nleH1nleH2 (* p value <0.01) compared with uninfected 
cells or cells infected with wild type EPEC. Complementation with p(nleH1) or p(nleH2) resulted 
partial complementation of cell survival (# p value <0.05). Deletion of the last 5 amino acids of 
NleH1 or NleH2 abolished complementation of the ∆nleH1nleH2 mutant (*). (B) Cells were 
treated with caspases inhibitor Z-VAD-fmk during infection with EPEC strains or STS 
treatment. Z-VAD-fmk treatment abolished the cell loss observed in STS-treated and EPEC 
nleH1nleH2 infected cells (* p value < 0.05).  
 
 
Bioinformatic analysis of the protein sequence of NleH using PSORT revealed that 
NleH proteins contains a di-lysine like motif (VVLSKI) at the C-terminal end of the 
protein, a motif for ER retention. The di-lysine motif is the minimal sequence 
requirement for targeting to the ER. Sequences surrounding the lysine influence the 
retention efficiency. Serine or alanine residues function in ER targeting (Teasdale and 
Jackson, 1996). It is possible that this di-lysine like motif may be used by NleH1 in 
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targeting the ER. Furthermore, the C-terminal VLSKI region also contains a class I 
PDZ (PSD-95/Dlg/ZO-1) C terminal ligand motif (ELM). PDZ domains are modular 
protein interaction domains that play a role in protein targeting and protein complex 
assembly (Hung and Sheng, 2002).  
 
To determine if the observed cell loss in the absence of nleH1 and nleH2 is due to 
caspase-dependent apoptosis, we used the global caspase inhibitor Z-VAD-fmk. 
Addition of Z-VAD-fmk restored survival of HeLa cells infected with the 
nleH1nleH2 mutant strain as well as control cells treated with STS (Figure 18B). 
These results suggest that NleH1 and NleH2 inhibit caspase-dependent apoptosis 
during EPEC infection. 
 
4.4 NleH Prevents Cleavage of Pro-caspase-3 
 
The caspase cascade converges on cleavage of pro-caspase-3. To investigate if NleH1 
and its kinase activity are necessary and sufficient to prevent apoptosis, HeLa cells 
were transfected with nleH1 or nleH1K159A and treated with either STS, brefeldin A 
(BFA) or tunicamycin (TUN), the latter two compounds induce ER stress related 
apoptosis (Patil and Walter, 2001). The number of transfected cells with cleaved 
(active) caspase-3 was assessed by specific immunostaining and counting under 
immunofluoresence microscopy. Typical immunofluorescent images are shown in 
Figure 19A. After treatment with either STS, BFA, or TUN, the number of NleH1 or 
NleH1K159A transfected cells that were also positive for active caspase-3 was 
equivalent to that of untreated cells (Figure 19 B, C, and D), while cells transfected 
with the negative control (GFP), and mock transfected cells showed significantly 
higher levels of active caspase-3. These results indicate that NleH1 is able to block 
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pro-caspase-3 activation; and that this inhibition of apoptosis is independent of 
NleH1’s kinase activity. 
 
In order to confirm these results, HeLa cells infected with EPEC wild type or the 
nleH1nleH2 mutant were treated with STS. Cell lysates were collected and analysed 
by western blotting using anti-pro-caspase-3 (inactive) antibody. Tubulin staining was 
used as a control of protein loading. Treating uninfected cells with STS triggered 
cleavage of pro-caspase-3 (Fig. 19E lanes 1) compared to control cells (Fig. 19E lane 
4). Cells infected with wild type EPEC inhibited pro-caspase-3 cleavage induced by 
STS (Fig. 19E lane 2) compared to uninfected STS-treated cells (Fig. 19E lane 1). In 
contrast, treating cells infected with the nleH1nleH2 mutant with STS resulted in 
cleavage of pro-caspase-3 (Fig. 19E lane 3); the signal of pro-caspase-3 was similar to 
that seen in STS treated uninfected cells (Fig. 19E lane 1). These results show that 
NleH1 and NleH2 inhibit pro-caspase-3 cleavage and activation.  
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Figure 19: Caspase-3 activation in cells transfected with nleH1, nleH2 or pEGFP and treated 
with staurosporine (STS), brefeldin A (BFA) or tunicamycin (TUN). Cells were stained with anti-
HA (green) to label N-terminal HA tagged NleH1, NleH1K159A and anti-cleaved caspase-3 (red) 
and visualized by immunofluorescence (A). The proportion of transfected cells stained for 
cleaved caspase-3 was determined by counting under an epifluorescence microscope. Ectopic 
expression of NleH1 or NleH1K159A prevented the cleavage of pro-caspase-3 by treatment with 
STS (B), BFA (C) and TUN (D) compared to mock transfected cells or transfected with GFP (*p 
value <0.05). (E) Pro-caspase-3 and tubulin Western blot of uninfected cell lysates or lysates of 
cells infected with wild type EPEC or EPEC nleH1nleH2 mutant treated with STS. Untreated 
uninfected lysates were used as control. The presence of NleH1 and NleH2 reduced STS-induced 
caspase-3 activation. 
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4.5 NleH Effectors Interact with BI-1 
 
In order to identify the signalling pathway/s by which NleH effectors are able to 
inhibit pro-caspase-3 activation and apoptosis, a yeast two-hybrid screen using a 
commercial HeLa cDNA library was conducted with NleH1 as bait.  
 
The yeast two hybrid method provides an ideal system for screening a human HeLa 
cDNA library for potential interacting proteins. Bait construct (pGBT9(NleH1)) was 
transformed into a compatible mating partner (AH109) for the yeast strain (S. 
cerevisiae Y187) containing cDNA fragments representative of the protein repertoire 
of human HeLa cells fused to the activation domain of Gal4. The AH109 NleH1 bait 
strain was tested for toxicity, transcriptional activation and mating efficiency. 
Toxicity was tested using a growth curve which showed that AH109 pGBT9 (NleH1) 
showed no significant difference to AH109 carrying an empty pGBT9 vector. No 
transcriptional autoactivation was detected and no significant difference in mating 
efficiency was observed (Table 4).  
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Table 4: Mating Efficiency  
  
AH109(pGBKT7-
53)  + 
Y187(pGADT7-T) 
AH109(pGBT9 
NleH1)  + 
Y187(pGADT7-T) 
AH109(pGBT9 
NleH2)  + 
Y187(pGADT7-T)   
No CFU/ml on 
SD/-L 
58.7 38.2 33.2 
(viability Y187 partner) 
No CFU/ml on 
SD/-T 
150.8 155.3 148 
(viability AH109 partner) 
No CFU/ml on 
SD/-L/-T 
31 15.5 19.6 
(viability of diploids) 
         
Limiting 
Partner 
Y187(pGADT7-T) Y187(pGADT7-T) Y187(pGADT7-T)
 
         
Mating 
Efficiency 
(%Diploids) 
52.8109029 40.57591623 59.03614458 
 
 
After mating AH109 yeast strain transformed with the bait plasmid vector with the 
Y187 strain encoding the pretransformed cDNA library, the entire mating culture was 
spread on low stringency triple dropout media (TDO) lacking histidine, leucine and 
tryptophan (SD-HLT). The 99 TDO positive colonies were replica plated on to high 
stringency quadruple dropout media (QDO) lacking amino acids left out in TDO plus 
adenine (SD-AHLT). After two rounds of replica plating six colonies remained. The 
Gal4 activation domain-cDNA fusion from four of these diploid colonies was 
amplified by PCR and sent for sequencing and the human cDNA was identified using 
nucleotide BLAST (NCBI) against human transcripts (mRNA) to find the closest 
possible match. Among these four clones three were mitochondrial proteins (Table 5). 
Mitochondrial proteins are common false positives in yeast two hybrid assays. As the 
NleH proteins do not have any mitochondrial localization signals, these proteins are 
unlikely to be physiologically relevant binding partners. Interestingly the fourth clone 
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identified was the β5 integrin subunit, a cell signalling protein involved in numerous 
major cellular pathways. The clone was found to encode a truncation containing the 
transmembrane domain and cytoplasmic C terminal tail of β5 integrin. The two 
remaining clones could not be amplified by PCR and plasmid purification from yeast 
and amplification of this plasmid in HB101 cells was required to identify these clones. 
These were identified as spindlin family member 3 and Bax inhibitor-1 variant. All 
six of these clones were positive for B-galactosindase activity in a qualitative filter lift 
assay (Table 5).  
 
Table 5: Sequencing/Bgal Assay Results 
Colony Identity β-galactosidase 
1 Homo sapiens cytochrome oxidase assembly protein
(mitochontrial protein mRNA) 
+ 
2 Homo sapiens enoyl coenzyme A hydratase (mitochondrial
protein mRNA)/ 
Homo sapiens mRNA similar to cadherin 5 type 2 vascular
epithelium 
+ 
3 Homo sapiens integrin β-5 subunit mRNA + 
4 Homo sapiens cytochrome b5 type B (outer mitochondrial
membrane) mRNA 
+ 
5 Homo sapiens spindlin family, member 3, mRNA + 
6 Homo sapiens mRNA for Bax inhibitor-1 variant + 
Control AH109 pGBKT7 (p53)and Y187 pGADT7-T + 
Control AH109 pGBT9(nleH1) and Y187 pGADT7-T - 
 
 
Among these potential binding partners Bax Inhibitor-1 (BI-1), which is an 
evolutionarily conserved apoptosis inhibitor (Chae et al., 2003; Chae et al., 2004) was 
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the most relevant to the anti-apoptotic phenotype of NleH effectors. A direct two-
hybrid screen was conducted to confirm the interaction between NleH1 and BI-1 and 
determine if BI-1 also interacts with NleH2. Yeast co-transformed with nleH1 or 
nleH2 and bi-1, were grown on selective media (TDO, QDO, and yeast minimal 
media with glucose or galactose) to test the interaction between the bait and pray 
fusion proteins. Once tested for growth of TDO and QDO, yeast minimal media with 
Glucose or Galactose was prepared, and AH109 nleH1 + bi-1 and AH109 nleH2 + bi-
1 positive clones selected from the QDO selection media were streaked on to both 
glucose and galactose media along with the positive and negative controls. Yeast 
strain AH101 is deleted for the regulator GAL4 controlling the expression of GAL1, 
GAL2, GAL7 and GAL10, the four main enzymes involve for the metabolism of the 
Galactose. AH101 cannot grow on media with galactose as the only source of carbon 
(Johnston, 1987). Interaction between the bait and the prey can complement the strain 
and restore the ability of the yeast to growth and minimum media containing 
galactose. Both AH109 nleH1 + bi-1 and AH109 nleH2 + bi-1 and the positive 
control (p53 + T antigen) grew on minimal media containing either galactose or 
glucose, however, the negative control only grew on media containing glucose 
(Figure 20), verifying the interaction between the NleH effectors and BI-1.  
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Figure 20: Direct two-hybrid assay demonstrating the interaction of NleH1 and NleH2 with BI-1. 
The interaction between NleH1 or NleH2 and BI-1 allows yeast growth on selective media 
(galactose) similar to the positive control (p53 and T antigen). No yeast growth was seen in the 
negative control (NleH1 and T antigen). All the strains grew on non-selective media (glucose). 
 
4.6 BI-1 Interaction is Essential for NleH Function  
 
To determine if BI-1 plays a role in the ability of EPEC to modulate cell survival, 
HeLa cells were treated with BI-1 siRNA, infected with wild type EPEC and the 
number of adherent cells were quantified. Knockdown of BI-1 expression was 
confirmed by semi-quantitative RT-PCR using GADPH as a total mRNA control 
(Figure 21, insert). Infection of BI-1-depleted cells with wild type EPEC resulted in 
significant cell loss (50%) compared to control (scrambled) siRNA-treated cells, 
similarly to the phenotype observed upon infection of HeLa cells with the EPEC 
nleH1nleH2 mutant (Figure 21). Similar levels of cell survival were observed in 
non-infected monolayers treated with either BI-1 siRNA or control (scrambled) 
siRNA or following infection of cells treated with control (scrambled) siRNA with 
wild type EPEC. These results show that BI-1 and NleH effectors co-operate in 
protecting cells from the apoptotic signals triggered during EPEC infection. 
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Figure 21: The effect of BI-1 on the anti-apoptotic activity during EPEC infection was 
determined using the cell viability assay. HeLa cells transfected with BI-1 or control siRNA 
(scrambled) were infected with wild type EPEC. Survival of cells treated with BI-1 siRNA and 
infected with wild type EPEC is similar to that of EPEC nleH1nleH2 infected cells but 
significantly lower than cell infected with wild type EPEC and treated with control siRNA. (* p 
value < 0.05). (21 insert) BI-1 knockdown was controlled by purification of total cell mRNA and 
semi-quantitative RT-PCR. GADPH mRNA levels were used as a control of total mRNA 
concentration. 
 
4.7 NleH Effectors Alter Ca2+ Release in a BI-1 Dependent 
Manner during Infection 
 
Recently, it has been shown that BI-1 regulates Ca2+ homeostasis (Kim et al., 2008; 
Xu et al., 2008). Ca2+ is an important second messenger of apoptosis (Pinton et al., 
2008). Release of Ca2+ ions from the ER, the major cellular store of Ca2+, can trigger 
apoptosis. To assess the effect of NleH effectors on cytosolic Ca2+ level a fluorometric 
intracellular Ca2+ assay was conducted by Dr. Cedric Berger. HeLa cells were infected 
with wild type EPEC and the nleH1nleH2 EPEC mutant and cytosolic Ca2+ levels 
were measured using the Ca2+ sensitive fluorescent indicator Fluo-4 Direct in a 96 
well fluorometer. Although elevation of cytosolic Ca2+ concentration was observed 
during infection with wild type EPEC in comparison to uninfected cells, significantly 
higher cytosolic Ca2+ levels were observed during infection with the nleH1nleH2 
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EPEC mutant (Figure 22A). This suggests that NleH effectors play a role in reducing 
cytosolic Ca2+ levels, supporting their role as inhibitors of apoptosis.  
 
Figure 22: Cytosolic Ca2+ accumulation is dependent on both NleH effectors and BI-1. (A) Ca2+ 
release in uninfected HeLa cells or cells infected with wild type EPEC or the EPEC nleH1nleH2 
mutant. Although significant Ca2+ release was observed in wild type EPEC-infected cells in 
comparison to uninfected cells (# p value < 0.05), HeLa cells infected with the nleH1nleH2 
mutant had significantly elevated cytosolic Ca2+ levels in comparison with cells infected with wild 
type EPEC (*) or uninfected cells (**). (*,#, ** p value < 0.05). B) Ca2+ release in HeLa cells 
transfected with BI-1 or control siRNA and infected with wild type EPEC or the nleH1nleH2 
mutant. Although no significant Ca2+ release was observed in uninfected cells transfected with 
BI-1 or control siRNA, a significant increase of Ca2+ release was observed in cells infected with 
wild type EPEC transfected with BI-1 siRNA in comparison to infected cells transfected with 
control siRNA. (* p value < 0.05). 
 
To determine if this modulation of Ca2+ is dependent on BI-1, HeLa cells were treated 
with BI-1 or control (scrambled) siRNA and infected with wild type EPEC by Dr. 
Cedric Berger. Cytosolic Ca2+ levels were measured after 3.5 h infection. As shown in 
Figure 22B, the level of cytosolic Ca2+ was 20% higher in infected BI-1 knockdown 
cells compared to infected cells treated with control siRNA. No difference was 
observed between uninfected cells treated with BI-1 or control siRNA (Figure 22B). 
Untransfected cells infected with wild type EPEC showed similar level of cytosolic 
Ca2+ compared to infected cells transfected with control siRNA (Figure 22B). These 
A B
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results suggest that both NleH1 and BI-1 are required to inhibit cytosolic Ca2+ 
accumulation during EPEC infection. 
 
Several reports have found that EPEC infected cells do not undergo apoptosis, 
although effectors such as EspF have been shown to activate apoptosis pathways 
(Crane et al., 1999; Crane et al., 2001). Through these studies we have demonstrated 
that the absence of apoptosis during EPEC infection is due to the presence of the 
NleH effectors: NleH1 and NleH2. NleH1 and NleH2 inhibit nuclear condensation, 
membrane blebbing, caspase-3 activation, and cell loss due to death or detachment. 
Furthermore, NleH alone is sufficient to block caspase-3 activation in the presence of 
the general apoptosis inducer STS or the ER stress related apoptosis inducers BFA 
and TUN. However, the ability of NleH effectors to inhibit apoptosis was independent 
of its kinase activity. Using a yeast 2 hybrid screen BI-1 was identified as a binding 
partner of NleH. This was confirmed using a direct two hybrid assay. The presence of 
BI-1 was essential for NleH’s role in apoptosis and depleting cells of BI-1 using 
siRNA resulted in the loss of NleH’s anti-apoptotic activity. BI-1 is a multi-
transmembrane protein localised to the ER membrane (Xu and Reed, 1998) which 
contains a BH3 domain and interacts Bcl-2 and Bcl-XL (Chae et al., 2004; Xu and 
Reed, 1998). Over-expression of BI-1 in mammalian cells suppresses apoptosis 
induced by a variety of stimuli including Bax over-expression, staurosporine (STS) 
and growth factor deprivation, suggesting its ability to prevent more than one pathway 
of apoptosis (Xu and Reed, 1998). BI-1 deficient cells exhibit increased sensitivity to 
ER stress stimuli (Chae et al., 2004). The mechanism by which BI-1 inhibits apoptosis 
is currently not known, however it is known that BI-1 modulates cellular Ca2+ levels 
(Kim et al., 2008; Westphalen et al., 2005; Xu et al., 2008). Interestingly, we found 
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that NleH effectors prevent cytosolic Ca2+ accumulation and that this is dependent on 
the presence of BI-1. Together these results demonstrate the NleH effectors are 
multifunctional proteins that inhibit apoptosis in a manner dependent on BI-1, and 
possess kinase activity which is involved in a currently unknown function.  
 
Identifying the function of bacterial effectors using cultured cell lines provides a 
useful indicator for their role in disease. However, any conclusions drawn from in 
vitro studies must be confirmed in vivo. It is therefore important to determine the role 
of NleH effectors play in vivo. 
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CHAPTER 5 - Role of NleH Effectors in C. rodentium 
Murine Models 
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During the study of effectors it is important to investigate their role both in vitro and 
in vivo. Determining the role of the effector in vivo provides an insight into the 
relevance of the effector to virulence and disease.  
 
To study the role of NleH effectors in colonisation, competitiveness, tissue 
histopathology, cell detachment and apoptosis and immune response, we employed 
the C. rodentium murine model. All animal experiments were performed in 
accordance with the Animals Act 1986 and were approved by the local Ethical 
Review Committee.  
 
5.1 Contribution of NleH effectors in the C. rodentium murine 
model  
 
C. rodentium is a natural mouse pathogen that, while causing colonic hyperplasia, 
shares many virulence factors with EPEC and EHEC (Mundy et al., 2005). As EHEC 
and EPEC exhibit narrow host specificity and mice are resistant to infection, C. 
rodnetium provides an excellent tool for use in murine models of A/E pathogen 
infection (Mundy et al., 2006). Following inoculation via the oral route bacteria 
colonize the colon typically peaking at day 9 before clearing at around day 17 (Mundy 
et al., 2006). Recently the C. rodentium mouse model was refined by developing non-
invasive real-time bioluminescence imaging (BLI) to monitor infection dynamics and 
tissue tropism in vivo via the use of the C. rodentium strain ICC180 (CR) strain 
possessing the lux operon (luxCDABE). Using this method it has been shown that C. 
rodentium first targets the murine caecal patch (CP) and rectum before the infection 
spreads to the large intestine (Wiles et al., 2006). Studies in murine models were 
carried out under the personal licence no. PIL70/19765. Experiments were conducted 
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with mice infected via oral gavage or natural transmission with the help and 
supervision of Dr. Siouxsie Wiles. 
 
After infection of C57BL/6 mice via oral gavage we followed anatomical localization 
and pathogenic burden using BLI and viable counts in stool of mice infected with 
either C. rodentium wild type or ΔnleH. Using BLI we observed that both wild type 
and mutant strains colonized the CP and rectum by day 3-4 post-infection. After 
adaptation to the in vivo environment (day 6-7), the entire distal colon was then 
heavily infected. Clearance began by day 10, at which point light intensity decreased. 
By day 14 the gastrointestinal tract had mostly cleared the infection (Figure 23).  
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Figure 23: Anatomical localization of luminescent C. rodentium ICC180 wild type and ΔnleH 
strains during in vivo infection of mice. Images were acquired using an IVIS50 system and 
displayed as pseudocolor images of bioluminescence. The variations in color represent light 
intensity at a given location with red being the most intense light emission, and blue being the 
weakest signal. The colored scale to the right indicates relative signal intensity in photons s-1cm-
2sr-1 units. At each time point post-gavage, mice were imaged with an integration time of 1 min. 
 
Viable counts of bacteria in stool mirrored the results obtained by BLI; no significant 
differences in viable bacterial counts between the wild type and nleH mutant were 
seen (Figure 24A). Dot plots showing shedding in individual mice can be found in 
APPENDIX I Figure 1A-B. Natural transmission of infection was achieved by co-
inhabitation of mice infected via oral gavage (seeds) in the same cage as uninfected 
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mice. Results from infection via natural transmission showed no significant 
differences between infection with wild type and nleH strain (Figure 24B). Dot plots 
showing shedding in individual mice can be found in APPENDIX I Figure 2.  
 
Figure 24: A. Course of faecal excretion following oral challenge of groups of six 6-8-week-old 
C57Bl/6 mice with either wild type C. rodentium ICC180 strain (●) or ∆nleH mutant (□). B. 
Course of fecal excretion during natural transmission following co-mingling of groups of six 6-8-
week-old C57Bl/6 uninfected mice with two infected mice at the peak of infection with C. 
rodentium ICC180 strain (●) or ∆nleH mutant (□) strains. 
 
A 
B 
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Although NleH effectors did not affect colonization mixed infections, conducted with 
the help and supervision of Dr. Valerie Crepin, showed that the C. rodentium nleH 
mutant was significantly out competed by the wild type strain (Figure 25). 
 
 
 
Figure 25: Competitive index (CI) of C. rodentium ∆nleH in mice infected with an inoculum 
containing a 1:2 ratio of wild type C. rodentium and the ∆nleH mutant. The null hypothesis that 
CI = 1 was tested by a 2-tailed non-parametric Wilcoxon test and shows that the mean CI post-
challenge is significantly less than 1 for all time points where it could be calculated.  
 
5.2 NleH does not affect A/E lesion formation and T-cell 
infiltration in the C. rodentium murine model.  
 
The hallmarks of C. rodentium infection include induction of extensive colonic 
hyperplasia and influx of T cells into the colonic lamina propria. Histological 
examination and measurement of crypt length was carried out by Dr. Francis Girard 
as a measure of colonic hyperplasia did not reveal any differences between the parent 
and mutant strains (Figure 26).  
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Figure 26: Crypts hyperplasia induced by wild type C. rodentium strain ICC180 and its nleH 
derivative and colon of orally-inoculated mice nine (D9) or fourteen (D14) days post-infection. 
The nleH derivative induced comparable crypts hyperplasia to that of ICC180. ***, P001. 
 
Immunohistochemistry, performed to investigate the influx of CD3+, CD4+ and 
CD8+ T cell subsets into the colonic lamina propria at 14 days post-inoculation was 
conducted in collaboration with Alison Dennis and Thomas T. MacDonald at Barts 
and the London School of Medicine and Dentistry, London, UK. These studies 
revealed that although the nleH-infected animals showed slightly less CD3 and CD4 
positive T cells in the lamina propria, no significant differences were observed 
between animals infected with mutant or wild type C. rodentium strains. (Figure 27 
A-E). 
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Figure 27: Infiltration of CD3+, CD4+ and CD8+ cells in distal colons of mice infected with C. 
rodentium ICC180 wild type and nleH mutant strains. A. Typical images of frozen sections of 
murine colon show that immune cell infiltrates indistinguishable in wild type and nleH mutant 
infected mice (Magnification, ×20). Counts from frozen sections with staining for delayed 
immune cell infiltration: CD3+ cells (B), CD4+ cells (C), CD8+ cells (D), and endogenous 
peroxidase-containing cells (neutrophils) (E). 
A 
B C 
D E 
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Furthermore, immunofluorescent staining with anti-O152 and SEM analysis conduced 
by Dr. Francis Girard at day 9 or day 14 post-inoculation did not reveal any 
differences between the wild type and nleH C. rodentium strains in attaching 
effacing lesion formation. Typical foci of intimately-adherent bacteria (Figure 28 
arrows) were observed (H&E panel), accompanied by a highly disorganised 
epithelium and confirmed to be A/E lesion by SEM (SEM panel).  
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Figure 28: Interaction of wild type C. rodentium strain ICC180 and its nleH mutant with the 
colonic epithelium in vivo. At day 9 post challenge typical foci of intimately-adherent bacteria 
(arrows) were observed on H&E-stained section (H&E panel), accompanied by a highly 
disorganised epithelium. IFA staining revealed these bacteria to be of O152 serotype (IFA panel, 
arrowheads), corresponding to C. rodentium serotype. These foci of intimately-adherent bacteria 
were confirmed to be A/E lesions by SEM (SEM panel). Neither O152-positive bacteria, nor A/E 
lesions were observed on sections or samples derived from uninfected mice (Uninfected). For IFA 
panel: Hoechst 33342 (blue, false colour), DNA and TRITC (intense blue, false colour), O152-
positive bacteria. Micrographs of typical sections are shown. Bar = 20m (H&E, IFA). 
 
5.3 NleH influences NF-KB levels and expression of TNF- in 
vivo 
 
Although NleH did not affect T cell infiltration or hyperplasia, due to the interplay 
between the NF-B pathway and apoptosis, we wanted to determine if NleH 
influences activation of NF-KB in vivo. The activation of NF-KB was assessed by Dr. 
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Siouxsie Wiles using NF-KB-RE-luc reporter mice, which were infected with wild 
type C. rodentium strain ICC169 or ICC169nleH; mice inoculated with a commensal 
E. coli strain ICC299 or PBS were used as controls. The number of nleH mutant 
bacteria shed from this mouse strain was similar to wild type (APPENDIX I Figure 
3). No significant differences in whole body (including chest, neck, abdomen and 
rectal) luminescence counts were recorded by live imaging, at any time point, 
between PBS gavaged animals and those gavaged with C. rodentium wild type, nleH 
mutant or the commensal E. coli. On day 14 post-challenge we recorded luminescence 
counts in different organs. While no significant difference in the luminescence counts 
were seen in the mesenteric lymph nodes (MLN), spleen and cecum of the different 
mouse groups (Figure 29 A,C,D,E, and F), there was a significant (p=0.0024) 2.5 fold 
increase in the signal from the colon in mice infected with the wild type C. rodentium 
compared to those inoculated with C. rodentiumnleH, commensal E. coli ICC299 or 
PBS (Figure 29 A and B). TNF-induced increase in luminescent signal was used as 
a positive control (APPENDIX I Figure 4) and showed a similar increase in 
luminescence to that seen in to colon in the presence of nleH. 
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Figure 29: NF-KB activation in organs of mice 14 days post-challenge. Luminescence was 
measured in extracted organs. NF-KB-RE-luc reporter mice were inoculated with wild type 
(strain ICC169) or ΔnleH C. rodentium. (A) Representative bioluminescence images captured 
using IVIS50 camera system are shown (caecum [1], mesenteric lymph nodes (MLN) [2], colon 
[3], spleen [4], and intestine [4]). Luminescence was quantified using the region of interest (ROI) 
tool in the Living Image software (given as photons s-1). (B) Graph of luminescence in extracted 
colons shows significant loss of NF-KB activation in the absence of nleH. *** P<0.005. No 
significant change in NF-KB activation was observed in caecum (C), MLN (D), spleen (E) or 
intestine (F).  
 
 
As NF-KB induces the transcription of many pro-inflammatory cytokines such as 
TNF-and IFN we compared the level of their transcripts between uninfected mice 
and mice infected with either wild type or nleH mutant C. rodentium. RNA 
extracted from distal colons of C57BL/6 mice was subjected to semi-quantitative RT-
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PCR. Transcript levels were quantified as a ratio of TNF-or IFNto -actin. This 
revealed that the levels of TNF- mRNA were higher in tissues extracted from 
infected mice compared with uninfected control mice 14 days post inoculation (Figure 
30 A-B). The levels of IFN transcript were comparable in all mouse groups (Figure 
30C).  
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Figure 30: Semi-quantitative TNF-α or IFN and actin RT-PCRs were performed on RNA 
isolated from colons of uninfected mice or mice orally challenged with wild type (strain ICC180) 
or ΔnleH C. rodentium. Raw results from experiment 1 (A) and esperiment 2 (B) for TNF-/-
actin ratios and experiment 1 for IFNy/-actin ratios (C) are shown. At Day 14, a significantly 
higher TNF-level is observed in wild type infected mice in comparison to nleH infected mice 
although IFN levels are not affected by NleH.  
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Results from TNF- RT-PCRs were combined and TNF-levels in wild type 
infected mice were compared to those infected with the nleH mutant strain. Mice 
infected with the wild type C. rodentium had statistically significantly higher TNF-
transcript levels than the nleH mutant (Figure 31), although significantly higher 
TNF-transcript levels were seen in mice infected with the nleH mutant compared 
to uninfected control mice. 
  
  
Figure 31: Semi-quantitative TNF-α and actin RT-PCRs were performed on RNA isolated 
from colons of uninfected mice or mice orally challenged with wild type (strain ICC180) or 
ΔnleH C. rodentium. Median TNF-α levels (measured as a ratio of TNF-α/actin) in C. 
rodentium ICC180-infected mice were considered the basal level of activation by wild type 
bacteria in each experiment and taken as 100%. All TNF-α/actin ratios were compared to this 
and expressed as a percentage of the median TNF-α level during wild type infection. GeneTools 
(syngene) was used for densiometric analysis. Two repetitions each using 4-5 mice per group 
were conducted and graphed. One-way Analysis of Variance (ANOVA) Bonferroni multiple 
comparisons test was used to determine significance as the three groups had normal 
distribution.*** p<0.001.  
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5.4 NleH Effectors Play a Role in Cell Detachment In Vivo 
 
To assess the role of NleH in vivo in promoting cell survival, detachment of cells from 
crypts in distal colons was studied using sections collected for histology and stained 
with anti-Intimin antibody to label bacteria and DAPI for DNA. Significantly more 
cells were detached in tissue infected with the nleH mutant in comparison to wild 
type, although bacterial load and shedding was the same at Day 9 post gavage (Figure 
32). Furthermore, DAPI staining revealed that the detached cells had condensed 
nuclei.  
This suggests that NleH may protect against apoptosis during infection in vivo. 
Furthermore, these results suggest that NleH may also be able to prevent anoikis (a 
form of apoptosis induced by detachment of cells (Chiarugi and Giannoni, 2008)). 
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Figure 32: IFA staining of histological sections labeling C. rodentium bacteria using chicken anti-
Intimin antibody, and Dapi for cells at 10X magnification. Increased detachment of cells into the 
lumen can be observed in the nleH mutant in comparison to wild type. Detached cells have 
condensed nuclei indicating that they are likely to be apoptotic as shown by nleH ROI showing 
a region of interest at 40X magnification.  
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5.5 NleH Effectors Inhibit Caspase-3 Cleavage at Bacterial 
Attachment Sites 
 
 
To confirm the ability of NleH to inhibit apoptosis in vivo, caspase-3 cleavage was 
assessed at sites of bacterial attachment. More caspase-3 cleavage was observed in the 
luminal cells infected with nleH mutant in comparison to wild type (Figure 33). 
Cells with caspase-3 cleavage also had condensed nuclei confirming their apoptotic 
status. These results demonstrate that NleH can inhibit apoptosis in vivo.  
 
 
 
Figure 33: NleH inhibits caspase-3 cleavage and nuclear condensation at the site of bacterial 
attachement in C. rodentium murine models. Significantly more caspase-3 activation and nuclear 
condensation was observed in the site of bacterial attachment during infection with nleH 
mutant in comparison to wild type in immunofluoresent labelling of paraffin embedded colon 
sections of mice using rabbit anti-cleaved caspase-3 antibody and Hoechst. C. rodnetium bacteria 
were labelled using chicken anti-Intimin antibody. 
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Taken together these results show that while NleH provides a competitive advantage 
during mixed infection. No difference was observed in T-cell infiltration or 
hyperplasia in colons of mice inoculated with the wild type or the nleH mutant strain. 
Using NF-KB reporter mice carrying a transgene containing a luciferase reporter 
driven by three NF-KB response elements, we found that NleH causes an increase in 
NF-KB activity in the colonic mucosa. Consistent with this, we found that the nleH 
mutant triggers a significantly lower TNF- response than the wild type strain. 
Importantly, infection with the C. rodentium wild type strains has significantly less 
cell detachment in the gut  lumen  and caspase-3 activation at the site of bacterial 
attachment in comparison to the nleH mutant demonstrating that NleH has similar 
cytoprotective activity in vivo and in vitro. In agreement with these results, previous 
findings using the wild type REPEC model by Heczko et al., (2006), found 
significantly decreased apoptosis in the tips of ileal apsorptive villi and whole ileal 
cell lysates suggesting the possibility that REPEC might decrease apoptosis levels in 
the rabbit ileum. It is possible that this protection in REPEC could also be due to the 
presence of NleH effectors.  
 
At this point it is not clear if NleH-dependent increase in NF-KB activation observed 
in vivo is related to NleH’s anti-apoptotic activity. This needs to be studied further. 
NF-KB is essential in regulating both inflammatory and apoptotic signalling. The 
effect of NF-KB activation on apoptosis is dependent largely on cell type. However 
several studies (Edelblum et al., 2006) show that activation of NF-KB facilitates cell 
survival in intestinal epithelial cells.  
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The cytoprotective activity of NleH may provide a likely explanation why wild type 
C. rodentium outcompetes the nleH mutant in vivo. The gastrointestinal epithelium 
has a natural high turnover rate. NleH effectors may slow-down enterocyte cell loss 
during infection, which may help sustain longer-term colonisation.  
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CHAPTER 6 - Discussion 
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The NleH family consists of members from the A/E pathogens EPEC, EHEC and C. 
rodentium. In this study we have identified the members of the NleH family from 
sequenced A/E pathogens. Using bioinformatic tools and sequence alignment 
algorithms we found that the NleH family of protein are highly conserved between 
strains, sharing greater than 80% protein identity with each other. Using EPEC 
2348/69 strains we demonstrated that NleH effectors are secreted and translocated in a 
T3SS dependent manner.  
 
Investigation of the role of nleH effectors (nleH1 and nleH2) in HeLa cell culture 
using the EPEC E2348/69 strain has shown that the presence of NleH effectors 
prevents integral morphological and biochemical features of apoptosis including 
nuclear condensation and fragmentation, membrane blebbing, and cell death and 
detachment in human epithelial cell lines. Furthermore, NleH1 and NleH2 inhibits 
apoptosis directed through the caspase cascade and inhibits the cleavage of pro-
caspase-3.  
 
Cell death is a defence strategy used by the host to clear infected cells. Bacterial 
pathogens use diverse strategies to inhibit cell death pathways to promote and sustain 
infection. Chlamydia trachomatis secrets the CPAF protease, which inhibits apoptosis 
by cleaving the pro-apoptotic BH3-only proteins (Pirbhai et al., 2006). Neisseria 
gonorrhoea injects PorB (Binnicker et al., 2004), which blocks caspase activation by 
preventing mitochondrial depolarization and release of cytochrome c, (Massari et al., 
2003). Salmonella enterica translocates the type III secretion system effector SopB 
(Knodler et al., 2005) which inhibits apoptosis by activating Akt (Edelblum et al., 
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2006). Legionella pneumophila inhibits apoptosis by translocating the type 4 secretion 
system effector SdhA (Laguna et al., 2006).  
 
Several reports have demonstrated that different EPEC proteins can induce apoptosis, 
including EspF and Map, which target the mitochondria (Crane et al., 2001; 
Nougayrede and Donnenberg, 2004). EspF has also been reported to bind the anti-
apoptotic protein AbcF2 leading to its degradation, therefore facilitating cell death 
(Nougayrede et al., 2007). Moreover, several studies have demonstrated that purified 
outer membrane EPEC proteins are able to induce expression of TNF- and activate 
caspase-3, leading to apoptosis (Abul-Milh et al., 2001; Shankar et al., 2009). It is 
notable, however, that despite the presence of pro-apoptotic factors and stress signals 
induced by the EPEC effectors, the proportion of apoptotic cells in monolayers 
infected with wild type EPEC is lower than that of cells infected by Shigella or 
Salmonella (Crane et al., 1999). The first indication that EPEC has an anti-apoptotic 
activity was provided by Heczko et al., who demonstrated that rabbit EPEC (REPEC) 
O103 did not induce apoptosis and may even decrease apoptotic levels in rabbit ileum 
(Heczko et al., 2001).  
 
Our results indicate that NleH effectors inhibit apoptosis by a novel mechanism 
involving BI-1. NleH interacts with BI-1 in a yeast two hybrid screen. BI-1 is a six-
transmembrane protein localised primarily at the ER membrane from where it exerts 
its cytoprotective function (Chae et al., 2003; Xu and Reed, 1998). Interestingly, we 
have found that the C-terminus of NleH effectors, which contains a putative ER 
retention signal, is essential for its anti-apoptotic activity. Localisation of NleH to the 
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ER in a C-terminal dependent manner needs to be investigated further. The C-
terminus of NleH effectors also contains a putative PDZ binding motif. Robinson et 
al., (unpublished) and Martinez et al., (unpublished) have conducted a PDZ array 
which identified several scaffolding proteins involved in tight junction regulation 
including Na+/H+ exchanger regulatory factor 2 (NHERF2) and the membrane 
associated gunalyate kinases (MAGUK) proteins SAP97, Zonula occluding (ZO-3) 
and MAGI-3. This may explain the membranar labelling of NleH observed when 
using the anti-NleH1 antibody we produced. 
 
The NleH interacting partner BI-1 was originally identified in a cDNA library screen 
for human proteins with the ability to inhibit cell death in yeast expressing Bax, a pro-
apoptotic member of the Bcl-2 family (Chae et al., 2003; Xu and Reed, 1998). Over-
expression of BI-1 in mammalian cells suppresses apoptosis induced by a variety of 
stimuli including Bax, etoposide, STS and growth factor deprivation, suggesting its 
ability to prevent more than one form of apoptosis (Xu and Reed, 1998). Indeed, BI-1 
over-expression reduces Bax activation, pro-caspase cleavage, mitochondrial 
membrane depolarization and ultrastructural changes induced by pro-apoptotic ER 
stress agents such as TUN, BFA and TG (Chae et al., 2004). These data correlate with 
our observation that ectopic expression of NleH1 inhibits cleavage of pro-caspase-3 in 
the presence of STS, TUN and BFA. The mechanism by which BI-1 inhibits 
apoptosis is not clearly defined but the identification of a bacterial partner may help to 
decipher the mechanism by which it functions. To our knowledge, this is the first time 
that a bacterial protein is reported to target an ER protein in order to block the 
apoptosis.  
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The ER is the major cellular store of Ca2+, an important second messenger of 
apoptosis (Pinton et al., 2008). Elevated Ca2+ levels for example through the ER Ca2+ 
channel IP3R results in mitochondrial Ca2+ overload, swelling and fragmentation 
along with the release of cytochrome c and pro-apoptotic proteins involved in 
triggering apoptosis (Pinton et al., 2008). The Ca2+ homeostasis is fine tuned by anti- 
and pro-apoptotic proteins including members of the Bcl-2 family both at the 
mitochondrial and ER membrane. The Bcl-2 family proteins Bcl-2 and Bcl-XL bind 
and modulate the activity of IP3R (Szegezdi et al., 2009). Interestingly, the ability of 
Bcl-XL to reduce resting ER Ca2+ concentrations is dependent on the presence of BI-1 
(Szegezdi et al., 2009; Westphalen et al., 2005) and overexpression of BI-1 has 
similar effects on ER calcium levels as Bcl-2 and Bcl-XL (Szegezdi et al., 2009). As 
BI-1 interacts with both Bcl-2 and Bcl-XL (Xu and Reed, 1998), it is possible that the 
mechanism by which BI-1 reduces ER Ca2+ content is by upregulating IP3R activity 
or modulating the ER Ca2+ channel and ATPase SERCA via interaction with Bcl-2 
and Bcl-XL (Szegezdi et al., 2009). Interestingly studies in yeast have shown that BI-
1 requires an active electron transport chain and the presence of ATP to protect 
against Bax induced cell death (Oshima et al., 2007) suggesting that BI-1 may play a 
role in modulating SERCA, which is supported by the findings that the effects of BI-1 
overexpression on calcium levels can be restored by overexpression of SERCA (Xu et 
al., 2008). It has also been suggested that BI-1 may be a channel itself releasing Ca2+ 
through passive leakage (Dohm et al., 2006) or may have Ca2+⁄H+ antiporter-like 
activity (Ahn et al., 2009). Together these studies show that BI-1 plays an important 
role in the regulation of Ca2+ homeostasis (Berridge, 2002; Van Coppenolle et al., 
2004). 
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During  EPEC  infection,  significantly higher cytosolic Ca2+ levels were observed in 
the absence of NleH1 and NleH2 suggesting that NleH effectors inhibit cytosolic Ca2+ 
elevation. Furthermore, inhibition of Ca2+ accumulation was dependent on the 
presence of BI-1. Based on our results and previous findings we have constructed a 
model of BI-1 during resting state and apoptosis, and a model of the effects of BI-1-
NleH interaction (Figure 34).  
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Figure 34: Model of role of BI-1 during resting state and during the mitochondrial-ER intrinsic 
pathway and the modulation of this pathway by NleH. During resting conditions, BI-1 may 
interact with Bcl-2 and Bcl-XL to modulate the activity of calcium channel IP3R and ATPase 
dependent pump SERCA to reduce the ER calcium load preventing ER stress. The excess 
calcium is taken up by the mitochondria via ion channels and eventually release from the cell. 
During intrinsic apoptosis pro-apoptotic Bax and Bak dimerize at the mitochondrial outer 
membrane sensitizing the mitochondria to cytochrome c release for apoptosome formation. This 
activity is countered by antagonistic activity of anti-apoptotic Bcl-2 and Bcl-XL. Increased 
calcium release from the ER results in increased mitochondrial membrane permeability and 
increased activation of pro-apoptotic proteins and cytochrome c release sensitising the cell to 
these apoptotic signals and shifting the balance towards apoptosis. During infection with EPEC 
the presence of NleH may bind BI-1 and via BI-1 and its binding partners Bcl-2 and Bcl-XL 
inhibits the release of excess calcium, via regulation of SERCA and IP3R, preventing 
mitochondrial membrane permeability to prevent the release of cytochrome c, desensitizing the 
cell to apoptotic signals. 
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Apart from apoptosis, BI-1 also plays a role in the unfolded protein response (UPR) 
response, which is activated in cells in adaptation to ER stress (Lisbona et al., 2009). 
During ER stress, the ER stress sensor IRE1 (Inositol requiring 1), a serine 
threonine protein kinase and endoribonuclease, activates XBP-1, the UPR 
transcription factor X-box binding protein-1, via splicing of its mRNA. Activation of 
XBP-1 results in the transcription and expression of genes involved in protein quality 
control, glycosylation, ER translocation, and ER/Golgi biogenesis (Calfon et al., 
2002; Lee et al., 2002). In addition IRE1forms a complex with adaptor proteins at 
the ER membrane that control the activation of c-Jun N-terminal kinase (JNK), ERK, 
and NF-KB pathways (Hetz and Glimcher, 2008). Lisbona et al. showed that BI-1 
expression suppressed IRE1activity in fly and murine models of ER stress. 
Furthermore, BI-1 deficient cells displayed hyperactivation of the ER stress sensor 
IRE1 resulting in the upregulation of XBP-1 levels and upregulation of UPR target 
genes. This function of BI-1 was dependent on the formation of a protein complex 
with IRE1. These findings suggested that BI-1 might be a bifunctional protein, and 
that it plays a role in early ER stress. It is possible NleH effectors might also play a 
role in ER stress and unfolded protein response via interaction with BI-1.  
 
 
In this study we have also demonstrated that EPEC NleH1 is a kinase. Although NleH 
autophosphorylates itself on a tyrosine residue, we cannot at this point rule out its 
autophosphorylation on serine or threonine residues. NleH1 is the only T3SS effector to 
our knowledge so far to be identified as a kinase in EPEC and EHEC. NleH’s kinase 
activity is not required for the anti-apoptotic activity. The role which the NleH kinase 
activity plays during EPEC infection and its substrate is currently not known. 
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However this result supports the possibility that NleH, like BI-1 might be 
bifunctional.  
 
When studying the role of an effector protein it is important to also establish their role 
in vivo. To determine the contribution of NleH to infection with C. rodentium we 
mutated nleH in the wild type ICC169 and luminescent ICC180 C. rodentium strains. 
Deletion of nleH from C. rodentium had no significant effect on in vivo tissue 
tropism, bacterial burden, colonic hyperplasia or infiltration of CD3+, CD4+ and 
CD8+ cells to the lamina propria. A subtle phenotype was recently reported for C. 
rodentium nleH in single infection, as expansion of the mutant population in vivo 
lagged behind the wild type during early stages (6 days post challenge), although at 
later stages (10 days) the mutant and wild type colonised at comparable levels 
(Garcia-Angulo et al., 2008). The reasons for the different results might be due to the 
mouse status (i.e. composition of the normal gut flora), preparation of the inocula or 
bacterial strains. Importantly, we found that in a mixed infection the nleH mutant was 
significantly out competed by the wild type strain, showing that NleH is a virulence 
factor important for bacterial fitness in vivo.  
 
To verify the anti-apoptotic function of NleH in vivo we stained colonic sections for 
cleaved capase-3 and nuclear condensation. We found that NleH protects against 
apoptosis in vivo as colonic tissue sections of mice show reduced caspase-3 activation 
and reduce nuclear condensation in mice infected with wild type C. rodentium in 
comparison to nleH mutant. The gastrointestinal epithelium has a high turnover rate 
and renews every 3-5 days, in a process involving proliferation, differentiation and 
apoptosis (Edelblum et al., 2006). A high rate of apoptosis would result in detachment 
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and shedding of epithelial cells, along with any attached EPEC bacteria. Expression of 
NleH effectors may facilitate pathogenesis by slowing down enterocyte loss and 
sustaining colonisation of the attached, extra-cellular, EPEC and EHEC bacteria.  
 
Interestingly the Shigella effector OspE which is referred to as EspO in EPEC, EHEC 
and C.rodentium has recently been demonstrated to interact with Intergrin linked 
kinase (ILK) to increase the abundance of surface exposed integrins and inhibit the 
activation of Focal Adhesin Kinase (FAK) and paxilin resulting in the stabilisation of 
focal adhesins and subsequent inhibition of cell loss during Shigella infection (Kim et 
al., 2009). This potentiates the idea that EspO and NleH may play complimentary 
roles in stabilising the host enteric mucosa in order to facilitate the longevity of 
EPEC, EHEC and C. rodentium infection. 
 
Several studies (Edelblum et al., 2006) have demonstrated that activation of NF-KB 
facilitates cell survival in intestinal epithelial cells. We studied the role NleH plays in 
the activation of the NF-KB pathway in vivo. We found lower activation of NF-KB in 
the colon of mice infected with the C. rodentium nleH mutant compared to the 
parental wild type strain, although NF-KB activation was comparable in other 
organs/regions. Consistent with these results, we found lower colonic levels of TNF- 
at 14 days post-challenge in mice infected with the nleH C. rodentium mutant 
compared to the wild type strain, while no difference was recorded for IFN. These 
data suggest that NleH triggers local activation of NF-B which in turn leads to a 
differential increase in the level of proinflammatory cytokines. We did not observe 
any difference in hyperplasia and T cell infiltration between the wild type and nleH 
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mutant strains, suggesting that NleH appears to have a local, rather than systemic, role 
possibly on the host immune response. Whether this activation of NF-B and TNF- 
is linked to NleH’s anti-apoptotic activity needs to be studied further. It is tempting to 
speculate that NleH may interact with IRE1 to modulate BI-1’s ability to inhibit 
IRE1which requires dimerisation and autophosphorylation for activation (Lisbona 
et al., 2009). It is possible that NleH’s kinase activity might be involved in the 
phosphorylation of IRE1 or its adaptor proteins TRAF2 (TNFR-associated factor 2), 
protein kinase ASK1 (Apoptosis signal-regulating kinase 1) or IkB (Inhibitor of NF-
kB) kinase IKK which activates Nf-KB (Schroder et al., 2008). This might explain the 
elevation in Nf-KB levels, provide a role for NleH’s kinase activity and link all 
observed phenotypes of NleH effectors so far.  
 
Our research demonstrates that NleH effectors have anti-apoptotic activity that is 
independent of their autophosphorylation and kinase activity but dependent on the 
endoplasmic reticulum protein BI-1. This translates in vivo to a significant 
competitive advantage during infections in mice in the presence of NleH effectors and 
reduced caspase-3 activation and nuclear condensation. Furthermore, NleH effectors 
induce a mild but significant stimulation of specific immune factors (NF-B and 
TNF-). Together these results suggest that NleH effectors are sophisticated 
multifunctional proteins manipulating multiple signalling aspects of the host cell to 
facilitate infection.  
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Figure 1: Daily faecal counts in 6-8 week old C57Bl/6 mice for experiment 1 (A) and 2 (B). 
Course of faecal excretion following oral challenge groups of 6 mice with either wild-type CR 
strain (○) or ∆nleH  mutant (●). Median () colony forming units per g stool for each day is 
shown.  
144 
 
 
Figure 2: Shedding in mice infected by natural transmission. Wild-type CR strain (○) or ∆nleH 
mutant (●). Median () colony forming units per g stool for each day is shown. 
 
 
Figure 3: Viable counts from NF-κB-RE-luc reporter mice orally gavaged with CR ICC169 and 
nleH strains. Wild-type CR strain (○) or ∆nleH  mutant (●). Median () colony forming units 
per g stool for each day is shown. 
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Figure 4: Nf-B levels in GI and whole body of NF-κB-RE-luc reporter mice after 3 hours of 
administration of TNFas a control  
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The human pathogen enterohemorrhagic Escherichia coli (EHEC) O157:H7 colonizes human and animal gut
via formation of attaching and effacing lesions. EHEC strains use a type III secretion system to translocate a
battery of effector proteins into the mammalian host cell, which subvert diverse signal transduction pathways
implicated in actin dynamics, phagocytosis, and innate immunity. The genomes of sequenced EHEC O157:H7
strains contain two copies of the effector protein gene nleH, which share 49% sequence similarity with the gene
for the Shigella effector OspG, recently implicated in inhibition of migration of the transcriptional regulator
NF-B to the nucleus. In this study we investigated the role of NleH during EHEC O157:H7 infection of calves
and lambs. We found that while EHEC nleH colonized the bovine gut more efficiently than the wild-type
strain, in lambs the wild-type strain exhibited a competitive advantage over the mutant during mixed infection.
Using the mouse pathogen Citrobacter rodentium, which shares many virulence factors with EHEC O157:H7,
including NleH, we observed that the wild-type strain exhibited a competitive advantage over the mutant during
mixed infection. We found no measurable differences in T-cell infiltration or hyperplasia in colons of mice
inoculated with the wild-type or the nleH mutant strain. Using NF-B reporter mice carrying a transgene
containing a luciferase reporter driven by three NF-B response elements, we found that NleH causes an
increase in NF-B activity in the colonic mucosa. Consistent with this, we found that the nleHmutant triggered
a significantly lower tumor necrosis factor alpha response than the wild-type strain.
The human diarrheal pathogens enteropathogenic Esche-
richia coli (EPEC) and enterohemorrhagic E. coli (EHEC)
(31) and the murine pathogen Citrobacter rodentium (reviewed
in reference 28) colonize the host gastrointestinal tract via
attaching and effacing (A/E) lesions, which are characterized
by intimate adhesion to intestinal epithelia and localized ef-
facement of brush border microvilli (21). EPEC was the first
type of E. coli to be associated with human disease and is a
major cause of infantile diarrhea in developing countries (re-
viewed in reference 2), while EHEC (O157 and non-O157
strains) is prevalent in developed countries and causes a wide
spectrum of illnesses ranging from mild diarrhea to severe
diseases such as hemorrhagic colitis and hemolytic uremic syn-
drome mediated by Shiga toxins (31).
EPEC, EHEC, and C. rodentium harbor the locus of entero-
cyte effacement (LEE) pathogenicity island, which is necessary
for A/E lesion formation in vivo (26). The LEE encodes sev-
eral gene regulators, the outer membrane adhesin intimin (18),
the structural components of a type III secretion system
(T3SS) (17), chaperones, and translocator and several effector
proteins, including Tir (19), Map, EspG, EspF, and EspH
(reviewed in reference 12), that are injected into enterocytes
via the T3SS and differentially modulate cellular actin dynam-
ics in vitro.
In addition, EPEC, EHEC, and C. rodentium use the LEE-
encoded T3SS to inject a large number of effectors which are
encoded by genes that are scattered around the bacterial ge-
nome, carried mainly on prophages and genomic islands (8).
Among these effectors are Cif (which causes irreversible cell
cycle arrest at the G2/M transition) (24), EspJ (which is in-
volved in inhibition of receptor-mediated phagocytosis) (23),
TccP/EspFU and TccP2 (which can activate N-WASP) (1, 13,
39), EspI/NleA (which affects exocytosis) (16, 29), and NleH of
unknown function (34).
EHEC infection in humans frequently results from direct or
indirect contact with ruminant feces; however, the molecular
mechanisms underlying colonization of reservoir hosts are ill
defined. The LEE-carried genes required for A/E lesion for-
mation (e.g., those for Tir and intimin) play pivotal roles in
colonization of such hosts by EHEC O157:H7 (4, 7, 37), and
structural components of the T3SS were found by signature-
tagged mutagenesis to be required for colonization of calves by
EHEC O157:H7 and O26:H (9, 36). In addition to Tir, EspK
* Corresponding author. Mailing address: Flowers Building, Impe-
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has been shown to influence colonization of the bovine intes-
tine (38), while Map (9), TccP/EspFU (37), and NleD (25) had
no measurable effect. The roles of other T3SS effectors in
colonization of ruminants are not known.
C. rodentium is a natural mouse pathogen that, while causing
colonic hyperplasia, shares many virulence factors with EPEC
and EHEC (reviewed in reference 28). Following inoculation
via the oral route, bacteria colonize the colon, typically peaking
at day 9 before clearance at around day 17 (27). Recently we
refined the C. rodentium mouse model by developing noninva-
sive real-time bioluminescence imaging (BLI) to monitor in-
fection dynamics and tissue tropism in vivo (41). Using this
method, we have shown that C. rodentium first targets the
murine cecal patch and rectum before the infection spreads to
the large intestine.
The genome sequences of EHEC O157:H7 strains EDL933
and Sakai, EPEC strain E2348/69, and C. rodentium strain
ICC168 revealed that EHEC and EPEC contain two nleH
alleles (34; A. Iguchi et al., unpublished data), while C. roden-
tium harbors only one nleH gene. NleH shares 49% sequence
similarity with the Shigella flexneri T3SS serine/threonine ki-
nase effector protein OspG, which prevents ubiquitination and
subsequent degradation of phospho-IB and downstream ac-
tivation of the transcriptional factor NF-B, possibly via the
phosphorylation of the E3 ubiquitin ligase SCF-TrCP (Skp-
Cullin-F box protein) complex (20). NF-B proteins are tran-
scriptional factors that, when activated, control the transcrip-
tion of a large number of genes, many of which are involved in
the immune (inflammatory) response. The similarities between
NleH and OspG prompted us to investigate its role in coloni-
zation and activation of the NF-B pathway in vivo.
MATERIALS AND METHODS
Bacterial strains, plasmids, and primers. The bacterial strains, plasmids, and
primers used in this study are described in Tables 1, 2, and 3, respectively.
Bacteria were grown at 37°C in Luria-Bertani (LB) broth or agar supplemented
with ampicillin (100 g ml1), chloramphenicol (25 g ml1), kanamycin (50 g
ml1), and nalidixic acid (Nal) (15 to 25 g ml1) as appropriate. C. rodentium
ICC169 nleH, luminescent C. rodentium ICC180 nleH, and EHEC O157:H7
85-170 Nalr nleH1 nleH2 mutant strains (strains ICC229, ICC285, and
ICC232, respectively) were generated using the one-step PCR  Red-mediated
mutation protocol (6) (Table 1). Primers 1 and 2 (Table 3) were used to amplify
the kanamycin cassette in pKD4 for deletion of nleH in ICC169. Primers 3 and
4 were used to amplify the chloramphenicol cassette in pKD3 for deletion of
nleH in ICC180. For construction of the EHEC O157:H7 85-170 Nalr nleH1
nleH2 mutant, primers 5 and 6 for nleH1 and 7 and 8 for nleH2 were used for
amplification of the kanamycin cassette from pKD4. Prior to deletion of nleH1
from 85-170 nleH2, the kanamycin cassette was deleted as described previously
(6) using the pCP20 vector (3).
The PCR product of the resistance cassette, flanked by approximately 50 bp of
nleH, was digested with DpnI and the cassette electroporated into the recipient
strains carrying pKD46, encoding the  Red recombinase. Mutants were selected
on selective LB plates with kanamycin or chloramphenicol. Recombinant clones
were cured of pKD46 and the mutation confirmed by PCR using primers flanking
nleH and primers within the antibiotic resistance gene. Growth curves have
confirmed that the mutant and wild-type stains have identical growth rates in LB
and minimal media. Mutations of the nleH1 and nleH2 genes created using the
same method in EPEC strains were successfully complemented in trans during in
vitro studies.
Oral inoculation of calves. All animal experiments were performed in accor-
dance with the Animals (Scientific Procedures) Act 1986 and were approved by
the local Ethical Review Committee. Groups of four 12-day-old Friesian bull
calves were separately inoculated with approximately 1010 CFU of wild-type
85-170 Nalr or 85-170 Nalr nleH1 nleH2 as described previously by Stevens
et al. (33). The magnitude and duration of fecal excretion of the bacteria were
followed daily for 14 days. Wild-type and mutant bacteria were enumerated by
plating of triplicate serial dilutions of fresh feces collected by rectal palpation
onto sorbitol-MacConkey agar supplemented with potassium tellurite (2.5 mg
ml1) (T-SMAC) containing 25 g ml1 Nal (T-SMAC-Nal) and onto T-SMAC-
Nal containing 50 g ml1 kanamycin, respectively. Recovery of wild-type and
mutant bacteria was confirmed by PCR from selected colonies using nleH-
flanking primers. The sensitivity of detection was 102 CFU/g. Fecal excretion
data were statistically analyzed for the effect of mutation by means of an F test,
with the data taken as repeated measurements and the animal as a covariant
(Proc Mixed, Statistical Analysis System 1995; SAS Institute, Cary, NC). P values
of 	0.05 were considered significant.
Oral inoculation of lambs. Fifteen 6-week-old crossbred lambs were randomly
divided into three equal groups, supplied with food and water ad libitum, and
confirmed to be free of E. coli O157:H7 by enrichment and O157 immunomag-
netic separation. All lambs were housed in biosecure containment level 2 ac-
commodations. Each group was housed in a separate room with its own air
handling. The animals were visited by experienced staff, who changed protective
clothing between groups. Five lambs were each dosed orally with 109 CFU of
either wild-type 85-170 Nalr or the isogenic nleH1 nleH2 mutant separately, or
with wild-type 85-170 Nalr and the nleH1 nleH2 mutant together, suspended
in 10 ml of 0.1 M phosphate-buffered saline (PBS) (pH 7.4). Approximately 24 h
after oral inoculation and as required thereafter for up to 28 days, rectal fecal
samples from each lamb were collected for direct plating onto SMAC supple-
mented with either 15 g of Nal/ml or 25 g of kanamycin/ml. Samples that were
O157 negative on direct plating were enriched in buffered peptone water for 6 h
at 37°C and then plated onto SMAC plates supplemented with the appropriate
TABLE 1. Strains
Species and
strain Characteristics
a Source or
reference
C. rodentium
ICC169 Spontaneous Nalr mutant of wild-type
C. rodentium
40
ICC229 ICC169 NleH1 (Kanr) This study
ICC180 Bioluminescent strain harboring the
Photorhabdus luxCDABE operon
(Kanr)
40
ICC285 ICC180 NleH1 (Cmr) This study
E. coli
85-170 Spontaneous Stx1 and Stx2 EHEC
O157:H7 strain
35
85-170 Nalr Spontaneous Nalr derivative of 85-170 33
ICC232 85-170 Nalr NleH1NleH2 (Nalr
Kanr Cmr)
This study
ICC299 Commensal strain isolated from the
cecum of a C57BL/6 mouse
This study
a Kanr, Cmr, and Nalr, kanamycin, chloramphenicol, and nalidixic acid resis-
tant, respectively.
TABLE 2. Plasmids
Plasmid Characteristics Source orreference
pKD3 oriRg blaM; Cmr cassette flanked
by FRT sites
6
pKD4 oriRg blaM; Kanr cassette flanked
by FRT sites
6
pKD46 ori101 repA101(ts) araBp-gam-
bet-exo blaM
6
pCP20 FLP synthesis under thermal
control
3
pET28-a His6 tag expression vector Novagen
pET:nleH1 Derivative of pET28-a expressing
NleH1-His6
This study
pET:nleH1K159A Derivative of pET28-a expressing
NleH1K159A-His6
This study
VOL. 76, 2008 ROLE OF NleH IN EHEC AND C. RODENTIUM INFECTION 4805
 at Im
perial College London on July 1, 2009 
iai.asm
.org
D
ow
nloaded from
 
antibiotic. Representative colonies were confirmed to be E. coli O157 by latex
agglutination (Oxoid). For coinfection studies, the competitive index (CI) was
calculated; it is defined as the ratio between the mutant and wild-type strains
within the output (bacteria recovered from the host after infection) divided by
their ratio within the input (initial inoculum). For this experiment, the input ratio
was 1:1. The null hypothesis that CI 
 1 was tested by a two-sided t test.
Murine models. Specific-pathogen-free female 6- to 8-week-old mice were
used in this study. Wild-type inbred C57BL/6 and DBA-1 mice were purchased
from Harlan UK Ltd. (Bicester, United Kingdom), while the transgenic light-
producing animal model DBA-1 NF-B-luc (Oslo) (P/N 119335) was purchased
from Xenogen-Caliper Corp. (Alameda, CA). The transgenic light-producing
animal model NF-B-RE-luc (Oslo)-Xen, commonly called NF-B-RE-luc
(Oslo), carries a transgene containing three NF-B responsive-element (RE)
sites from the immunoglobulin  light-chain promoter and modified firefly lu-
ciferase cDNA. All animals were housed in individually HEPA-filtered cages
with sterile bedding and free access to sterilized food and water. Independent
experiments were performed at least twice (but only once for histology) using at
least four mice per group.
Oral infection of mice, harvesting and collection of tissues, and bacterial stool
counts. Mice were orally inoculated using a gavage needle with 200 l of over-
night LB-grown bacterial suspension in PBS (5  109 CFU). The number of
viable bacteria used as the inoculum was determined by retrospective plating
onto LB agar containing antibiotics. Stool samples were recovered aseptically at
various time points after inoculation and the number of viable bacteria per gram
of stool determined after homogenization at 0.1g ml1 in PBS and plating onto
LB agar containing the appropriate antibiotics. At selected time intervals postin-
fection, blood was collected by cardiac puncture and mice were sacrificed by
cervical dislocation. Sections of distal colon were collected and snap frozen in
liquid nitrogen before storage at 70°C prior to analysis. For coinfection studies,
the CI was calculated as described previously by Mundy et al. (30). For this
experiment, the input ratio of wild-type strain to mutant strain was approximately
1:2. The null hypothesis that CI 
 1 was tested by a nonparametric Wilcoxon
two-tailed test using the GraphPad InStat software (GraphPad Software Inc.,
San Diego, CA).
In vivo BLI. Prior to imaging, the abdominal region of each mouse was
depilated to minimize any potential signal impedance by melanin within pig-
mented skin and fur. Bioluminescence (photons s1 cm2 sr1) from living
infected animals was measured after gaseous anesthesia with isofluorane using
the IVIS50 camera system (Xenogen-Caliper Corp., Alameda, CA). The sample
shelf was set to position D (field of view, 15 cm). A photograph (reference image)
was taken under low illumination prior to quantification of photons emitted from
strain ICC180 at a binning of 4 over 1 to 10 min using the software program
Living Image (Xenogen-Caliper Corp.) as an overlay on Igor (Wavemetrics,
Seattle, WA). For anatomical localization, a pseudocolor image representing
light intensity (from blue [least intense] to red [most intense]) was generated
using the Living Image software and superimposed over the gray-scale reference
image. Bioluminescence within specific regions of individual mice was also quan-
tified using the region-of-interest tool in the Living Image software program
(given as photons s1). For expression of light from the NF-B reporter mice,
180 mg kg1 D-luciferin (Gold Biotechnology, St. Louis, MO) dissolved in 250 l
PBS (pH 7.8) was administered by intraperitoneal injection 5 min prior to
imaging. As a positive control for luciferase gene expression from the NF-B-
RE-luc (Oslo) mice, tumor necrosis factor alpha (TNF-) (2 g per mouse) was
administered by intraperitoneal injection.
Histopathology. Segments of the cecum and the terminal colon of each mouse
were collected at 9 and 14 days postinoculation, rinsed of their content, and fixed
in 10% buffered formalin for microscopic examination. Formalin-fixed tissues
were then processed, paraffin embedded, sectioned at 5 m, and stained with
hematoxylin and eosin (H&E) according to standard techniques. Sections were
examined by light microscopy for the presence of intimately adhering bacteria on
intestinal cells, as previously described (15). Crypt length was also evaluated, and
the lengths of at least four well-oriented crypts were measured for each section.
A nonparametric analysis of variance (ANOVA) with a posteriori comparisons
was performed using commercially available GraphPad InStat v3.06 software
(GraphPad Software Inc., San Diego, CA). P values of 0.05 were considered
significant.
Immunohistochemistry. Snap-frozen colonic tissues, embedded in OCT
mounting medium (VWR BDH, Lutterworth, United Kingdom), were sectioned
using a cryostat to a thickness of 5 m. Sections were mounted on polysine slides
(VWR BDH) and air dried overnight before fixing in acetone at room temper-
ature for 20 min. After air drying for 1 h, sections were rehydrated in Tris-
buffered saline (TBS) for 5 min and then incubated with antibodies against CD3,
CD4, and CD8 (Serotec, Oxford, United Kingdom) at a dilution of 1:50 to 1:100
for 1 h. Sections were gently washed with TBS three times before addition of
biotinylated anti-rat immunoglobulin G (Serotec) at a dilution of 1:200 with 4%
(vol/vol) normal murine serum for blocking (Sera Laboratories International,
Horsted Keynes, United Kingdom) for 30 min. After washing, a 1:200 dilution of
0.1% avidin-peroxidase (Sigma-Aldrich, Dorset, United Kingdom) was added
and left for 30 min before further washing and treatment with diaminobenzadine
substrate (Sigma-Aldrich) for 5 min. The reaction was stopped with excess TBS,
and sections were counterstained with Mayer’s hematoxylin (Sigma-Aldrich) for
30 s, dipped in acid alcohol, and washed in tap water for 5 min. Sections were
dehydrated through an ethanol gradient of 70%, 90%, and 100% solutions (2 min
each), followed by clearing in Histoclear (VWR BDH) and mounting in DPX
(VWR BDH). A control slide using no primary antibody was also made to show
endogenous peroxidase-containing cells. Stained cell populations were counted
in five randomly selected fields per section, and data were expressed as the
number of T cells per 250 m2 of lamina propria.
TABLE 3. Primers
Primer no. Primer name Sequence (533)
1 NleH CRICC169 Fw ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTT
TAACTGTGTAGGCTGGAGCTGCTTCG
2 NleH CRICC169 Rv AATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCATGA
TAAGCATATGAATATCCTCCTTAG
3 NleH CRICC180 Fw ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTT
TAACGTATACTTATAGGAGGAATC
4 NleH CRICC180 Rv TTAAATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCAT
GATACACATCCGACCTCGACGAAGC
5 NleH1 EHEC Fw TGAAGGTTGAAATGTATGTTATCGCCATATTCTGTAAATTTGGGA
TGTTCTGTGTAGGCTGGAGCTGCTTCG
6 NleH1 EHEC Rv CACTACACTGGATAAAATTACTAAATTTTACTTAATACCACACTAA
TAAGCATATGAATATCCTCCTTAG
7 NleH2 EHEC Fw ATGTTATCGCCCTCTTCTATAAATTTGGGATGTTCATGGAATTCTT
TAACGTGTAGGCTGGAGCTGCTTC
8 NleH1 EHEC Rv TATCTTACTTAATACTACACTAATAAGATCCAGCTTTCCTCCGTGA
TAAGCATATGAATATCCTCCTTA
9 TNF--Fw ATGAGCACAGAAAGCATGATC
10 TNF--Rv TACAGGCTTGTCACTCGAATT
11 B-actin-Fw AGAGGGAAATCGTGCGTGAC
12 B-actin-Rv CAATAGTGATGACCTGGCCGT
13 IFN--Fw TGAACGCTACACACTGCATCTTGG
14 IFN--Rv CGACTCCTTTTCCGCCTTCCTGAG
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SEM. Intestinal segments were fixed in 2.5% glutaraldehyde and processed for
scanning electron microscopy (SEM) as previously described (14). SEM samples
were examined blindly at 25 kV using a JEOL JSM-5300 SEM [JEOL (UK) Ltd.,
Herts, United Kingdom].
IFA. An indirect immunofluorescence assay (IFA) was used for the detection
of C. rodentium (serotype O152) in formalin-fixed, paraffin-embedded sections as
previously described (14). Tetramethyl rhodamine isothiocyanate-conjugated
donkey anti-rabbit (Jackson ImmunoResearch Europe Ltd., Soham, Cam-
bridgeshire, United Kingdom) secondary antibody was used to visualize O152-
positive bacteria, while DNA of both bacteria and epithelial cells was counter-
stained with Hoechst 33342 (Sigma-Aldrich Co., United Kingdom). Sections
were examined with an Axio Imager M1 microscope (Carl Zeiss MicroImaging
GmbH, Germany). Images were acquired using an AxioCam MRm monochrome
camera and computer processed using AxioVision (Carl Zeiss MicroImaging
GmbH, Germany) and Adobe Photoshop 5.0 and Adobe Illustrator 8.0 software
(Adobe Systems Incorporated, CA).
RNA extraction and quantitative RT-PCR. Total RNA was isolated from
frozen colonic tissue using the RNeasy Plus minikit (Qiagen). All tissues used
were harvested from mice 14 days after oral gavage. Total RNA was measured
using a Nanodrop. TNF- or gamma interferon (IFN-) and -actin mRNAs
were measured by semiquantitative reverse transcription-PCR (RT-PCR) using
primers 9 to 14 listed in Table 3 and the one-step Reverse-iT hot-start kit
(Thermo). The PCR amplification cycle was 20 s at 94°C, 30 s at 60°C, and 60 s
at 72°C for 35 cycles. One microgram of RNA was used for measurement of
TNF- and IFN- transcript levels, and 100 ng of RNA was used for detection
of -actin mRNA. The PCR products were run on a 1% agarose gel alongside
the 100-bp ladder from NEB in Tris-borate-EDTA buffer. GeneTools (Syngene)
was used to conduct densitometric analysis. All TNF-/-actin and IFN-/-actin
ratios were compared between mice infected with wild-type and nleH mutant
bacteria. Statistical analyses were conducted with the one-way ANOVA Bonfer-
roni multiple-comparison test using the GraphPad InStat software (GraphPad
Software Inc., San Diego, CA), as all groups displayed normal distributions.
RESULTS
The NleH T3SS effector homologues. NleH belongs to a
family of T3SS effectors found in diverse enteric pathogens.
EPEC O127:H6 E2348/69 and EHEC O157:H7 EDL933 and
Sakai contain two NleH paralogues, which share 83 to 84%
protein identity. C. rodentium contains only one nleH gene,
which shares 83 and 81% amino acid sequence identity with
EHEC O157:H7 NleH1 and NleH2, respectively. NleH shares
49% amino acid sequence similarity with the serine/threonine
kinases OspG and YspK (Yersinia secreted protein kinase) of
Yersinia enterocolitica.
We employed BLASTp searches of the NCBI protein data-
base using EPEC E2348/69 NleH1 as the query sequence. The
Clustal W2 software (EMBL-EBI) was then used to create a
phylogram of the different homologues (Fig. 1). Two major
clusters were formed, one containing all the NleH effectors and
the other containing closer homologues of OspG, including an
OspG-like effector (90.8% identity to OspG of Shigella) from
FIG. 1. Distance tree of the NleH family. Homologues were iden-
tified using BLASTp searches of NCBI nr protein database with EPEC
2348/69 NleH1 as the query sequence. Protein sequences selected and
analyzed included E. coli O111:H NleH1 (GI:164457622), E. coli
O103:H2 NleH1 (GI:164457632), E. coli O157:H7 EDL933 NleH2
(GI:15801938), C. rodentium NleH (GI:44888794), phage cdtI gp23
(GI:148609405), Y. pseudotuberculosis IP 31758 (GI:153930640), Y.
frederiksenii ATCC 33641 YfreA (GI:77972806), Y. enterocolitica
subsp. enterocolitica 8081 (GI:123442682), Y. intermedia ATCC 29909
YintA (GI:77977119), Y. enterocolitica subsp enterocolitica 8081 YspK
(GI:13442682), S. flexneri OspG (GI:13449175), and E. coli O157:H7
str EC4045 OspG (GI:168711271), as well as EPEC 2348/69 NleH2
(unpublished). The BioEdit software was used to create a ClustalW
alignment. Clustal W2 (EMBL-EBI ebi.ac.uk) was used to create a
phylogram, and TreeView (Bioedit) was used for visualization.
FIG. 2. Course of fecal excretion of EHEC O157:H7 following oral
challenge of 12-day-old calves with wild-type strain 85-170 Nalr or the
85-170 Nalr nleH1 nleH2 mutant. Data represent the mean daily
fecal count (n 
 4 per strain)  standard error of the mean.
FIG. 3. (A) Course of fecal excretion of EHEC O157:H7 following
oral challenge of 6-week-old lambs with wild-type strain 85-170 Nalr or
the 85-170 Nalr nleH1 nleH2 mutant. Data represent the mean daily
fecal count (n 
 5 per strain)  standard error of the mean. (B) CI of
EHEC O157: H7 85-170 Nalr nleH1 nleH2 in lambs infected with an
inoculum containing a 1:1 ratio of wild-type EHEC and the nleH1
nleH2 double mutant. The null hypothesis that CI 
 1 was tested by
a two-sided t test and shows that the mean CI postchallenge is signif-
icantly less than 1 for all time points where it could be calculated
except day 1.
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EHEC O157:H7 strain EC4045. To determine the role of
NleH proteins in vivo, we generated EHEC O157:H7 (strain
85-170) nleH1 nleH2 and C. rodentium (ICC169 and biolu-
minescent strain ICC180) nleH mutants.
The EHEC O157:H7 nleH1 nleH2 double mutant is shed
in greater numbers than the parental strain from orally chal-
lenged calves. To assess the role of NleH in intestinal coloni-
zation of calves by EHEC O157:H7, wild-type and mutant
bacteria were separately inoculated into four 12-day-old Frie-
sian bull calves. Both wild-type and mutant strains colonized
the calves efficiently, and the mutant was excreted at lower
levels than the wild type during the first 4 days. From day 7 the
mutant was shed at higher levels than the wild-type strain, and
the difference became statistically significant (P 	 0.05) from
day 10 onwards (Fig. 2). The course of the fecal excretion of
the wild-type strain was consistent with previously observed
patterns (10, 33, 37).
Contribution of NleH1 and NleH2 to colonization of con-
ventional 6-week-old-lambs. A 6-week-old lamb model was
next used to compare the persistence of an E. coli O157:H7
nleH1 nleH2 double mutant and the isogenic wild-type
strain. The ability of the mutant to establish itself and persist in
lambs was investigated by monitoring the viable counts recov-
ered in fecal pellets collected per animal. When given as a
single inoculum, the wild-type E. coli O157:H7 isolate pro-
duced the classical shedding pattern in lambs, as described
previously (5, 42), persisting in relatively high numbers during
the early stages of infection and then declining by day 11
postinoculation (Fig. 3A). The nleH1 nleH2 mutant dem-
onstrated a similar shedding pattern, except that positive fecal
samples were noted only until day 12 postinoculation (Fig. 3A).
When both isolates were administered in the same inoculum,
the wild type persisted for 4 days longer than the nleH1
nleH2 mutant (data not shown). The mean CI was signifi-
FIG. 4. Anatomical localization of luminescent wild-type C. rodentium ICC180 and nleH strains during in vivo infection of mice. Images were
acquired using an IVIS50 system and displayed as pseudocolor images of bioluminescence. The variations in color represent light intensity at a
given location, with red being the most intense light emission and blue being the weakest signal. The colored scale to the right indicates relative
signal intensity in photons s1cm2 sr1. At each time point postgavage, mice were imaged with an integration time of 1 min.
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cantly less than 1 for all time points where it could be calcu-
lated except day 1 (Fig. 3B), demonstrating that the wild-type
strain outcompeted the nleH1 nleH2 mutant in the ovine
model.
Contribution of NleH to colonization in the C. rodentium
murine model. We followed the anatomical localization and
pathogenic burden using BLI and viable counts in stools of
mice infected with either wild-type or nleH C. rodentium.
Using BLI, we observed that both the wild-type and mutant
strains colonized the cecal patch and rectum by day 3 to 4
postinfection. After adaptation to the in vivo environment (day
6 to 7), the entire distal colon was then heavily infected. Clear-
ance began by day 10, at which point light intensity decreased.
By day 14 the gastrointestinal tract had mostly cleared the
infection (Fig. 4). Viable counts of bacteria in stool mirrored
the results obtained by BLI; no significant differences in viable
bacterial counts of the wild-type and nleH mutant strains
were seen (Fig. 5A). However, the nleH C. rodentium mutant
was significantly out competed by the wild-type strain in a
mixed infection (Fig. 5B).
NleH does not affect A/E lesion formation and T-cell infil-
tration in the C. rodentium murine model. The hallmarks of C.
rodentium infection include induction of extensive colonic hy-
perplasia and influx of T cells into the colonic lamina propria.
Histological examination and measurement of crypt length did
not reveal any differences between the parent and mutant
strains (data not shown). Immunohistochemistry, performed to
investigate the influx of CD3, CD4, and CD8 T cell subsets
into the colonic lamina propria at 14 days postinoculation,
revealed that although the nleH mutant-infected animals
showed slightly fewer CD3- and CD4-positive T cells in the
lamina propria, no significant differences were observed be-
tween animals infected with the mutant or wild-type C. roden-
tium strains (data not shown). Immunofluorescent staining
with anti-O152 and SEM analysis at day 9 or day 14 postin-
oculation did not reveal any differences between the wild-type
and nleH C. rodentium strains (Fig. 6).
NleH influences NF-B levels and expression of TNF- in
vivo. A recent study has shown that OspG inhibits degradation
of IB and hence activation of NF-B and that a Shigella ospG
mutant induces a stronger inflammatory response than the
wild-type strain after inoculation of rabbit ileal loops (20). In
order to determine if NleH influences activation of NF-B in
vivo, we infected NF-B-RE-luc reporter mice with C. roden-
tium wild-type strain ICC169 or ICC169 nleH; mice inocu-
lated with the commensal E. coli strain ICC299 (Table 1) or
PBS were used as controls. The number of nleH mutant bac-
teria shed from this mouse strain was similar to that of the wild
type (data not shown). No significant differences in whole-body
(including chest, neck, abdomen, and rectum) luminescence
counts were recorded by live imaging, at any time point, be-
tween PBS-gavaged animals and those gavaged with wild-type
C. rodentium, the nleH mutant, or the commensal E. coli. On
day 14 postchallenge, we recorded luminescence counts in
different organs. While no significant difference in the lumi-
nescence counts was seen in the mesenteric lymph nodes,
spleens, and ceca of the different mouse groups (Table 4),
there was a significant (P 
 0.0024) 2.5-fold increase in the
signal from the colon in mice infected with the wild-type C.
rodentium compared to those inoculated with C. rodentium
nleH, E. coli ICC299, or PBS (Fig. 7A and B). This difference
was similar to the three- to fourfold-increased luminescent
signal seen after mice were inoculated with TNF- as a positive
control (data not shown).
As NF-B induces the transcription of many proinflamma-
tory cytokines such as TNF- and IFN-, we compared the
levels of their transcripts in uninfected mice and mice infected
with either wild-type or nleH mutant C. rodentium. RNA
extracted from distal colons of mice was subjected to semi-
quantitative RT-PCR. Transcript levels were quantified as a
FIG. 5. (A) Course of fecal excretion following oral challenge of
groups of six 6- to 8-week-old C57BL/6 mice with either wild-type C.
rodentium ICC180 or the nleH mutant. (B) Mean CI of C. rodentium
nleH in mice infected with an inoculum containing a 1:2 ratio of
wild-type C. rodentium and the nleH mutant. The null hypothesis that
CI 
 1 was tested by a two-tailed nonparametric Wilcoxon test and
showed that the mean CI postchallenge is significantly less than 1 for
all time points where it could be calculated.
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ratio of TNF- or IFN- to -actin. This revealed that the
levels of TNF- mRNA were significantly higher in tissues
extracted from infected mice than in those from uninfected
control mice. Mice infected with the wild-type C. rodentium
had significantly higher TNF- transcript levels than those
infected with the nleH mutant (Fig. 8). The levels of IFN-
transcript were comparable in all mouse groups (data not
shown).
DISCUSSION
Many gram-negative bacterial pathogens use T3SS effectors
to modulate host cell signaling pathways. Effector proteins can
trigger local (e.g., alteration in the cytoskeleton) or systemic
(e.g., immune response) changes. Colonization of the mucosal
surface requires temporal modulation of the host immune sta-
tus. While downregulation of innate immunity might aid the
pathogen to launch an infection and to reach a critical mass,
activation of the immune system might assist the pathogen in
its competition with the resident gut microflora. It is therefore
not surprising that pathogenic bacteria are equipped with vir-
ulence factors which have antagonistic immune modulation
activities. Indeed, in a recent report Lupp et al. demonstrated
that C. rodentium population expansion in vivo is mediated by
an inflammatory response that disrupts the endogenous intes-
tinal microbiota (22). In contrast, using polarized culture mod-
els, Ruchaud-Sparagano et al. have shown that EPEC inacti-
vates innate immune responses in vitro (32).
In this study we investigated the role of NleH in coloniza-
tion, competitiveness, and activation of the NF-B pathway in
vivo. EPEC O127:H6 E2348/69 and EHEC O157:H7 EDL933
and Sakai contain two, almost identical, copies of nleH, while
C. rodentium harbors only a single nleH gene. The functional
consequences of this gene duplication are not known. Inter-
estingly, a recent shotgun sequencing of a number of EHEC
O157:H7 isolates has shown that they contain, in addition to
nleH, a gene whose product shares 90.8% sequence identity
with OspG (NCBI BLASTp).
Investigation of the contribution of NleH toward coloniza-
tion and competitiveness of EHEC O157:H7 in bovine and
ovine hosts, which are important animal reservoirs of the
pathogen, showed that the EHEC O157 nleH1 nleH2 dou-
ble mutant was shed in greater numbers than the parental
strain from orally challenged calves, significantly from day 10
postinoculation. The precise effect of deleting nleH on factors
or regulatory mechanisms involved in EHEC O157:H7 coloni-
zation in bovine intestines remains to be investigated. In single-
infection studies with lambs, there was no statistical difference
in shedding after oral inoculation with the same strains. How-
ever, CIs measured following oral inoculation of lambs with a
mixture of wild-type EHEC O157:H7 and the nleH1 nleH2
double mutant revealed that the mutant was significantly out-
competed. The reasons for the different phenotypes observed
in the bovine and ovine models are currently not known. How-
ever, these results show that effector proteins might have dis-
similar or even opposite functions in different hosts.
In order to determine the contribution of NleH to infection
with C. rodentium, we mutated nleH in the wild-type ICC169
and luminescent ICC180 strains. Deletion of nleH from C.
rodentium had no significant effect on in vivo tissue tropism,
bacterial burden, colonic hyperplasia, or infiltration of CD3,
CD4, and CD8 cells to the lamina propria. A subtle phe-
notype was recently reported for C. rodentium nleH in single
infection, as expansion of the mutant population in vivo lagged
behind that of the wild-type population during early stages (6
days postchallenge), although at later stages (10 days) the
mutant and wild type colonized at comparable levels (11). The
reasons for the different results might be due to the mouse
status (i.e., composition of the normal gut flora), preparation
of the inocula, or bacterial strains. Importantly, we found that
in a mixed infection the nleH mutant was significantly outcom-
peted by the wild-type strain, suggesting that expression of
NleH increases the bacterial fitness in vivo. This could explain
the need for conservation and multiplicity of the gene in
EHEC and EPEC strains.
As we did not observe any difference in colonization and
clearance dynamics, hyperplasia, and T-cell infiltration be-
tween the wild-type and nleH mutant strains, NleH appears
to have a local rather than systemic role, possibly in displacing
FIG. 6. Interaction of wild-type C. rodentium strain ICC180 and its nleH mutant with the colonic epithelium in vivo. (A) At day 9
postchallenge, typical foci of intimately adherent bacteria (arrows) were observed on H&E-stained sections, accompanied by a highly disorganized
epithelium. IFA staining revealed these bacteria to be of the O152 serotype (arrowheads), corresponding to C. rodentium serotype. These foci of
intimately adherent bacteria were confirmed to be A/E lesions by SEM. Neither O152-positive bacteria nor A/E lesions were observed on sections
or samples derived from uninfected mice. (B) No adherent bacteria were observed in the colons of mice infected with ICC180 and the ICC180
nleH mutant at day 14 postchallenge, although crypt hyperplasia was still present. For the IFA panel: Hoechst 33342 (blue, false color), DNA;
tetramethyl rhodamine isothiocyanate (intense blue, false color), O152-positive bacteria. Representative micrographs are shown. Bar, 20 m
(H&E and IFA) or 100 m (B).
TABLE 4. Specific bioluminescence from each organ at harvest
Inoculum
Specific bioluminescence (mean  SD) from:
Cecum Mesenteric lymph nodes Spleen Colon Intestines
ICC169 2.59  105  8.00  104 2.35  106  9.47  105 9.25  104  2.29  104 1.41  106  2.92  105 1.72  106  4.69  105
nleH mutant 1.80  105  9.89  104 2.75  106  1.26  106 2.12  105  2.38  105 5.69  105  2.53  105 2.08  106  1.04  106
PBS 3.61  105  8.78  104 3.02  106  8.61  105 8.33  104  1.71  104 6.34  105  2.37  105 1.53  106  6.35  105
Commensal
strain
2.69  105  4.42  104 2.58  106  8.11  105 1.39  105  2.81  104 5.02  105  1.03  105 2.38  106  4.27  105
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the normal gut flora. Considering that both NleH (C. Hemra-
jani, unpublished data) and OspG (20) are protein kinases and
share a high level of sequence identity, we investigated, using
reporter mice, if NleH plays a role in activation of the NF-B
pathway. Unexpectedly, we found lower activation of NF-B in
the colon in mice infected with the C. rodentium nleH mutant
than in those infected with the parental wild-type strain. Con-
sistent with these results, we found lower colonic levels of
TNF- at 14 days postchallenge in mice infected with the
nleH C. rodentium mutant than in those infected with the
wild-type strain, while no difference was recorded for IFN-.
These data suggest that NleH triggers local activation of NF-
B, which in turn leads to a differential increase in the levels of
proinflammatory cytokines.
Collectively these results demonstrate that the role of NleH
during infection is host specific. NleH, one of the core and
conserved T3SS effectors in A/E pathogens, is likely to work
with other effectors in optimizing the level of local gut inflam-
matory responses and the relationship with the endogenous gut
flora for the benefit of the pathogen.
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ABSTRACT 20 
The human pathogens enteropathogenic (EPEC) and enterohemorrhagic 21 
Escherichia coli and the related mouse pathogen Citrobacter rodentium subvert a 22 
variety of host cell signalling pathways via their plethora of type III secreted 23 
effectors, including triggering of an early apoptotic response. However, EPEC 24 
infected cells do not develop late apoptotic symptoms. In this study we 25 
demonstrate that the NleH family effectors, homologues of the Shigella effector 26 
kinase OspG, blocks apoptosis. During EPEC infection NleH effectors inhibit 27 
elevation of cytosolic Ca
2+
 concentrations, nuclear condensation, membrane 28 
blebbing and promote cell survival. NleH1 alone is sufficient to prevent pro-29 
caspase-3 cleavage induced by the pro-apoptotic compounds staurosporine, 30 
brefeldin A and tunicamycin. Using the C. rodentium we found that NleH inhibits 31 
pro-caspase-3 cleavage at the bacterial attachment sites in vivo. A yeast two-32 
hybrid screen identified the endoplasmic reticulum six transmembrane protein 33 
Bax inhibitor-1 (BI-1) as an NleH interacting partner. We have mapped the 34 
NleH-binding site to the N-terminal 40 amino acids of BI-1. Knockdown of BI-1 35 
resulted in the loss of NleH anti-apoptotic activity. These results show that NleH 36 
effectors are inhibitors of apoptosis that target BI-1 to carry out their 37 
cytoprotective function.  38 
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Introduction 39 
Enteropathogenic Escherichia coli (EPEC), enterohaemorrhagic E. coli (EHEC) and 40 
the mouse pathogen Citrobacter rodentium (reviewed in (1, 2)) are closely related 41 
diarrheagenic pathogens that intimately adhere to gut enterocytes and instigate 42 
localized effacement of brush border microvilli (3), collectively known as attaching 43 
and effacing (A/E) lesions. Injection of bacterial effector proteins via a type III 44 
secretion system is an integral part of the EPEC, EHEC and C. rodentium infection 45 
strategy (4, 5). These pathogens encode a plethora of effector proteins (6, 7) that 46 
target an intricate array of host cell signalling processes to facilitate colonization, 47 
multiplication, dissemination and infection (5). Importantly, 21 effectors are 48 
conserved between EPEC, EHEC and C. rodentium (referred to as core effectors) (6), 49 
while other effectors are strain-specific. 50 
NleH is one of the core effectors (8). EPEC and EHEC contain two nleH genes (nleh1 51 
and nleH2), while C. rodentium harbours a single copy of nleH. NleH effectors are 52 
homologous to the Shigella effector OspG, a protein kinase which prevents 53 
ubiquitination and subsequent degradation of phospho-IBα and downstream 54 
activation of the transcriptional factor NF-B (9). Using C. rodentium, we have 55 
shown that NleH increases NF-B activity and tumor necrosis factor alpha (TNF) 56 
expression in the mouse colonic mucosa and confers a competitive advantage in 57 
mixed infections (10).  58 
Among the other core effectors, EspF disrupts the mitochondria membrane potential 59 
(11), opens the tight junctions (12) and induces degradation of the anti-apoptotic 60 
protein AbcF2 (13). However, despite the potent pro-apoptotic effect of EspF, EPEC 61 
infected cells exhibit early features of apoptosis including expression of 62 
 4 
phosphatidylserine on the cell surface, and cleavage of cellular DNA and cytokeratin-63 
18 (14, 15) but do not undergo cell shrinkage, membrane blebbing or nuclear 64 
condensation and fragmentation, all key features of late stages apoptosis (14-16). 65 
Indeed, the proportion of apoptotic cells in monolayers infected with EPEC was 66 
shown to be significantly lower than that of cells infected with Salmonella (14). 67 
Apoptosis can occur via two major pathways: the intrinsic (mitochondria- and ER-68 
mediated pathways) and extrinsic (receptor mediated pathway) (17). Induction of 69 
apoptosis via the intrinsic pathway involves activation of the Bcl-2 homology–3-only 70 
proteins and oligomerization of the pro-apoptotic proteins Bak and Bax (18), leading 71 
to permeabilization of the mitochondrial outer member and release of cytochrome c 72 
(17). Cytosolic cytochrome c interacts with the apoptosis activating factor-1 and pro-73 
caspase-9 in the presence of dATP forming the apoptosome which cleaves and 74 
activates the executioner caspases pro-caspase-3, -6, -7 (19, 20) that in turn cleave a 75 
large number of protein substrates ensuing apoptosis (21). As apoptosis relies on a 76 
fine balance between pro- and anti-apoptotic factors, we hypothesized that A/E 77 
pathogens encode effector/s with anti-apoptotic activity, which neutralise the EspF 78 
effects and promote cell survival. In this study, we demonstrated that NleH plays a 79 
role in modulating apoptotic responses during EPEC and C. rodentium infections by 80 
inhibiting caspase activation. 81 
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Results 82 
Cells infected with EPEC nleH undergo apoptosis 83 
In order to investigate the role of NleH effectors, we generated a double nleH EPEC 84 
mutant, which was used to infect HeLa cells. Quantification of the number of adherent 85 
living cells after 5 h of infection showed that less than 50% of cells infected with the 86 
EPEC nleH1nleH2 mutant remained attached while no significant cell loss was 87 
observed in wild type EPEC-infected compared to uninfected cells. Complementation 88 
of the EPEC mutant with either nleH1 or nleH2 significantly restored cell survival 89 
(Fig. 1A). 90 
We next determined if the cells infected with the wild type, nleH1nleH2 and nleH1 91 
or nleH2 complemented nleH1nleH2 strains presented apoptotic phenotypes by 92 
assessing nuclear condensation (Hoechst staining) and membrane blebbing (phase 93 
contrast and scanning electron microscopy). The potent inducer of apoptosis, 94 
staurosporine (STS) (22), was used as a control. Quantification of the number of cells 95 
with condensed nuclei revealed that cells infected with the EPECnleH1nleH2 96 
mutant (15%) and STS-treated cells (38%) contained significantly more condensed 97 
nuclei (arrow) in comparison to uninfected cells or cell infected with wild type EPEC 98 
or the nleH1 or nleH2 complemented mutant (all ≤2%) (Fig. 1B and S1A). Similar 99 
results were observed for membrane blebbing (Fig 1C and S1B).  100 
Free cytoplasmic Ca
2+
 is an important second messenger of apoptosis (reviewed in 101 
(23)). We therefore measured cytosolic Ca
2+ 
levels after 3.5 h of infection with the 102 
different EPEC strains using
 
the Ca
2+ 
sensitive fluorescent indicator Fluo-4 Direct in a 103 
96 well fluorometer. Although elevation of cytosolic Ca
2+ 
concentration was observed 104 
during infection with wild type EPEC in comparison to uninfected cells, significantly 105 
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higher cytosolic Ca
2+ 
levels were observed during infection with the nleH1nleH2 106 
mutant (Fig. 1D). Taken together, these results suggest that NleH effectors have an 107 
anti-apoptotic activity. 108 
NleH inhibits cleavage of pro-caspase-3 independently of its kinase activity 109 
We used the global caspase inhibitor Z-VAD-fmk to determine if the observed cell 110 
loss in the absence of nleH1 and nleH2 was due to caspase-dependent apoptosis. 111 
Addition of Z-VAD-fmk restored survival of cells infected with the nleH1nleH2 112 
mutant as well as control cells treated with STS (Fig. 2A). These results suggest that 113 
NleH1 and NleH2 inhibit caspase-dependent apoptosis during EPEC infection. 114 
Active (cleaved) caspase-3 is one of the main apoptosis executioners. To investigate if 115 
NleH effectors can prevent apoptosis, HeLa cells infected with wild type EPEC or the 116 
nleH1nleH2 mutant were treated with STS. Analyzing the level of pro-caspase-3 117 
(inactive) by western bloting revealed that infection of cells with wild type EPEC 118 
inhibited caspase-3 cleavage induced by STS (Fig. 2B, lane 2) compared with 119 
uninfected cells or cells infected with the nleH1nleH2 mutant (Fig. 2B, lanes 1 and 120 
3). These data show that NleH inhibits STS-induced pro-caspase-3 cleavage. 121 
To further investigate if NleH1 alone can prevent apoptosis, cells were transfected 122 
with nleH1 and treated with STS or with inducers of ER stress related apoptosis, 123 
brefeldin A (BFA) or tunicamycin (TUN) (24). The number of transfected cells with 124 
cleaved caspase-3 was quantified by immunofluorescence. Mock-transfected cells or 125 
cells transfected with the gfp control displayed high level of cleaved caspase-3 (40-126 
50%) whereas no cleaved caspase-3 was observed in cells transfected with nleH1 or in 127 
untreated cells (Fig 2C). These results indicate that NleH1 can prevent caspase-3 128 
activation in cells treated with either of the pro-apoptotic compounds. 129 
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NleH1 contains the highly conserved kinase subdomains I, II and III (9) and has a 130 
conserved Lys (K159) in the subdomain II associated with the ATP binding site. 131 
Before investigating if the putative kinase activity plays a role in the anti-apoptotic 132 
function, we determined if NleH is indeed a protein kinase. To this end, purified His-133 
NleH1WT and His-NleH1K159A were incubated with γ-
33
P-ATP in the presence or 134 
absence of the general kinase substrate myelin basic protein (MBP); Abl kinase was 135 
used as a positive control. Autoradiography revealed auto-phosphorylation of 136 
NleH1WT and a strong MBP phosphorylation by Abl and NleH1WT. NleH1K159A 137 
phosphorylated neither itself nor MBP (Fig. S2A). These results show that NleH1 is 138 
an autophosphorylated protein kinase. We then investigated if the kinase activity of 139 
NleH1 plays a role in its anti-apoptotic activity by incubating NleH1K159A-transfected 140 
cells with the different pro-apoptotic compounds. As shown in Fig 2C, cells 141 
transfected with both nleH1K159A and wild type nleH1 inhibited equally caspase-3 142 
activation after treatment with STS, BFA or TUN. These results suggest that the 143 
kinase activity of NleH is not involved in its cyto-protection function. 144 
In order to determine if NleH can also exert its anti-apoptotic activity in the context of 145 
an in vivo infection, we infected C57BL/6 mice with wild type and nleH C. 146 
rodentium. Both strains colonized the colon at similar levels (data not shown). 147 
Immunofluorescence of thin colonic sections revealed increased cleaved caspase-3 148 
levels only in mice infected with the nleH mutant strain (Fig. 2D). These results 149 
demonstrate that NleH can also inhibit apoptosis in vivo. 150 
NleH effectors interact with BI-1 151 
In order to identify the signalling pathway/s by which the NleH effectors are able to 152 
inhibit apoptosis, a yeast two-hybrid (Y2H) screen was performed uisng NleH1 as bait 153 
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and a commercial HeLa cDNA library as a prey. A binding partner identified in the 154 
screen was Bax Inhibitor-1 (BI-1), which is an evolutionarily conserved apoptosis 155 
inhibitor (25, 26). BI-1 interaction with NleH1 and NleH2 was confirmed by a direct 156 
Y2H assay (Fig 3A.I and data not shown).  157 
Sequence alignment of NleH and its Shigella homologue OspG revealed that NleH 158 
effectors contain an N-terminal 100 amino acids fragment that is missing from OspG 159 
(Fig. S3A). In order to determine if this region is involved in BI-1 binding we deleted 160 
the first 300 bp of nleH1 and tested if the truncated NleH1 still binds BI-1 using a 161 
Y2H assay. The co-transformants grew on selective medium (data not shown), 162 
indicating that the N-terminus of NleH1 is not involved in binding BI-1. However, 163 
despite the fact that binding of NleH to BI-1 is mediated by a region homologous to 164 
OspG, OspG neither interacted with BI-1 in Y2H (data not shown) nor protected cells 165 
from STS-induced caspase-3 activation (Fig S3B). Taken together, these results show 166 
that NleH and OspG have distinct intracellular functions. 167 
BI-1 is a six trans-membrane ER protein containing a predicted cytoplasmic N-168 
terminal 40 amino acids domain (BI-11-40). In order to determine if NleH1 binds this 169 
domain we performed a Y2H assay. Yeast co-transformed with BI-11-40 and NleH1 170 
grew on selective medium (Fig. 3A.II), indicating that the N-terminal domain of BI-1 171 
comprises the NleH binding site. 172 
BI-1 co-localizes with NleH and is essential for cyto-protection during EPEC 173 
infection 174 
In order to investigate co-localization of NleH and BI-1 we co-transfected HeLa cells 175 
with vectors encoding myc-tagged BI-1 and HA-tagged NleH1. As shown in Fig 3B, 176 
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NleH1 and BI-1 were co-localized in reticular perinuclear structures, while NleH was 177 
also found at the plasma membrane. 178 
To determine if BI-1 is directly involved in the anti-apoptotic phenotype, HeLa cells 179 
were treated with BI-1 or control (scrambled) siRNA. Knockdown of BI-1 expression 180 
was confirmed by semi-quantitative RT-PCR using GADPH as a total mRNA control 181 
(Fig. 3C). The cells were then infected with wild type EPEC and the level of cytosolic 182 
Ca
2+ 
levels were measured 3.5 h later. As shown in Fig. 3D, the level of cytosolic Ca
2+ 
183 
was 20% higher in infected BI-1 knockdown cells compared with infected cells 184 
treated with control siRNA. No significant difference was observed between 185 
uninfected cells treated with BI-1 or control siRNA. These results suggest that BI-1 186 
modulates the cytosolic Ca
2+ 
levels during EPEC infection. 187 
Quantification of live adherent cells revealed that infection of BI-1-depleted cells with 188 
wild type EPEC for 5 h resulted in significant cell loss (50%) compared to control 189 
(scrambled) siRNA-treated cells, demonstrating that BI-1 plays an important role in 190 
cell survival during EPEC infection. In addition, no significant difference in the levels 191 
of remaining adherent cells was observed between controls or BI-1 siRNA-treated 192 
cells infected with the EPEC nleH1nleH2 mutant and BI-1-depleted cells infected 193 
with wild type EPEC (Fig. 3E). The absence of an additive effect between deletion of 194 
nleH and depletion of BI-1 suggests that BI-1 is directly involved in the anti-apoptotic 195 
NleH signalling pathway. 196 
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Discussion 197 
While induction of cell death is a defence strategy used by the host to remove infected 198 
cells, bacterial pathogens employ diverse strategies to inhibit apoptotic pathways. For 199 
example, Chlamydia trachomatis secrets the CPAF protease, which inhibits apoptosis 200 
by cleaving the pro-apoptotic BH3-only proteins (27); Neisseria gonorrhoea injects 201 
PorB (28), which blocks caspase activation by preventing mitochondrial 202 
depolarization and release of cytochrome c, (29); Salmonella enterica translocates the 203 
type III secretion system effector SopB  which inhibits apoptosis by activating Akt 204 
(30) and Legionella pneumophila inhibits apoptosis by translocating the type IV 205 
secretion system effector SdhA (31).  206 
Several reports have demonstrated that different EPEC proteins induce early stage 207 
apoptosis. For example, EspF has been reported to bind the anti-apoptotic protein 208 
AbcF2 leading to its degradation, therefore facilitating cell death (13). In addition, 209 
targeting of Map and EspF to the mitochondria (11, 32) may also trigger apoptotic 210 
signals. Moreover, several studies demonstrated that purified outer membrane EPEC 211 
proteins are able to induce expression of TNF- and activate caspase-3, leading to 212 
apoptosis (33, 34). It is notable, however, that despite the presence of pro-apoptotic 213 
factors and the stress signals induced by the EPEC effectors, the proportion of 214 
apoptotic cells in monolayers infected with wild type EPEC is lower than that of cells 215 
infected by Salmonella (14). The first indication that EPEC has an anti-apoptotic 216 
activity was provided by Roxas et al. who reported that EPEC induces 217 
phosphorylation of EGFR (35). Interestingly, similar activity was recently found in H. 218 
pylori, which activates the pro-survival phosphoinositide 3-kinase/Akt pathways via 219 
the EGFR, increasing the expression of the anti-apoptotic factor Bcl-2 and decreasing 220 
the expression of the pro-apoptotic factor Bax (36).  221 
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In this paper we have demonstrated that EPEC counteracts the pro-apoptotic signals 222 
by translocating the T3SS effectors NleH1 and NleH2, which block capsase-3 223 
activation, cytosolic Ca
2+
 accumulation, nuclear condensation and fragmentation, 224 
membrane blebbing and cell death and detachment, while OspG (9) does not have the 225 
same anti-apoptotic effect. Moreover, whereas inhibition of NF-B activation by 226 
OspG is dependent on its kinase activity, we have demonstrated that the kinase 227 
activity of NleH1 was not required for its anti-apoptotic function. The role of the 228 
NleH kinase activity during infection is currently not known.  229 
Our results show that NleH effectors inhibit apoptosis by a novel mechanism, 230 
involving BI-1. BI-1 is a six-transmembrane protein localised at the ER membrane 231 
from where it exerts its cytoprotective function (26, 37). We found that the cytosolic 232 
N-terminal 40 amino acids of BI-1, which face the cytosol, consists of the NleH-233 
binding site, while the first 100 amino acids of NleH, which are missing from OspG, 234 
were dispensable for NleH-BI-1 interaction; OspG did not bind BI-1. 235 
BI-1 was originally identified in a cDNA library screen for human proteins that inhibit 236 
cell death in yeast expressing Bax, a pro-apoptotic member of the Bcl-2 family (26, 237 
37). Over-expression of BI-1 in mammalian cells suppresses apoptosis induced by a 238 
variety of stimuli including Bax, etoposide, STS and growth factor deprivation, 239 
suggesting its ability to prevent more than one form of apoptosis (26). Indeed, over-240 
expression of BI-1 reduces Bax activation, pro-caspase cleavage, mitochondrial 241 
membrane depolarization and ultrastructural changes induced by pro-apoptotic ER 242 
stress agents such as TUN, BFA and Thapsigargin (25). These data correlate with our 243 
observation that ectopic expression of NleH1 inhibits cleavage of pro-caspase-3 in the 244 
presence of STS, TUN and BFA. The mechanism by which BI-1 inhibits apoptosis is 245 
not currently known but the identification of a bacterial binding partner may help to 246 
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decipher its physiological function. To our knowledge, this is the first time that a 247 
bacterial protein is reported to target an ER protein in order to block apoptosis. 248 
Our data show that NleH effectors are multi functional. They are protein kinases that, 249 
while triggering NF-B and production of TNF during C. rodentium infections (10), 250 
also have a cyto-protective function. Importantly and uniquely, we have shown that 251 
NleH exerts its anti-apoptotic activity in vivo, which provides a plausible explanation 252 
as for why the nleH mutant is out competed by the wild type strain during mixed 253 
infections (10). 254 
The gastrointestinal epithelium has a high turnover rate and renews every 3-5 days, in 255 
a process involving proliferation, differentiation and apoptosis (38). A high rate of 256 
apoptosis would result in detachment and shedding of enterocytes, along with any 257 
associated bacteria. A recent report has shown that Shigella employs the effector 258 
protein OspE, which modulates integrin-linked kinase to inhibit cell detachment and 259 
exfoliation of mucosal epithelial cells (39). Similarly, expression of NleH may 260 
facilitate pathogenesis by slowing down enterocyte loss and sustain colonization of 261 
the attached, extra-cellular, EPEC, EHEC and C. rodentium bacteria.  262 
263 
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Material and methods 264 
The bacterial strains (Table S1), plasmids (Table S2), primers (Table S3), growth 265 
conditions, molecular biology, protein purification, kinase assay, yeast two-hybrid 266 
assays, and experiments with cultured cells and mice are described in detail in the 267 
supplementary Materials and Methods. 268 
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Figure legend 386 
Fig. 1. Cells infected with EPEC nleH undergo apoptosis. 387 
Quantification of live adherent HeLa cells (A), nuclear condensation (B), membrane 388 
blebbing (C) and cytoplasmic Ca
2+
 (D) following infection of HeLa cells with wild 389 
type EPEC, nleH1nleH2 mutant and p(nleH1) or p(nleH2) complemented strains. 390 
The number of adherent cells was significantly reduced in cells infected with EPEC 391 
nleH1nleH2 (*) compared with uninfected cells or cells infected with wild type 392 
EPEC. Complementing the mutant with either p(nleH1) or p(nleH2) partially restored 393 
the wild type phenotype (A). Thenumber of cells displaying nuclear condensation or 394 
fragmentation (B) or membrane blebbing (C) was significantly higher in HeLa cells 395 
infected with nleH1nleH2, or after treatment with STS, as a control (*) compared 396 
with cells infected with EPEC wild type or the complemented mutant strains. 397 
Although significant Ca
2+
 release was observed in wild type EPEC-infected compared 398 
with uninfected cells (#), HeLa cells infected with the nleH1nleH2 had 399 
significantly elevated cytosolic Ca
2+
 levels in comparison with cells infected with 400 
wild type EPEC (*) or uninfected cells (**) (D). In A, B and C the non-parametric 401 
Mann-Whitney test was used to determine significance, as the data did not follow 402 
Gaussian distribution (* p value <0.05). In D significance was tested using the one 403 
way analysis of variance (ANOVA) Bonferroni multiple comparisons test (*,#, ** p 404 
value < 0.05). 405 
 406 
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Fig. 2. NleH inhibits caspase-3 activation. 407 
(A) Z-VAD-fmk inhibits EPEC-induced cell detachment. HeLa cells treated with 408 
the caspases inhibitor Z-VAD-fmk were infected with wild type EPEC, 409 
nleH1nleH2 mutant and p(nleH1) or p(nleH2) complemented strains and 410 
the number of live adherent cells was counted. Z-VAD-fmk inhibited loss of 411 
STS-treated control and EPEC nleH1nleH2-infected cells (* p value < 412 
0.05). The non-parametric Mann-Whitney test was used to determine 413 
significance, as the data did not follow Gaussian distribution (* p value 414 
<0.05). 415 
(B) Analysis of pro-caspase-3 cleavage. HeLa cell lysates, infected for 1 h with 416 
wild type EPEC or nleH1nleH2 mutant and then treated for 3 h with STS, 417 
were analyzed by Western blot with pro-caspase-3 (inactive) and tubulin-418 
control antibodies. Untreated uninfected lysates were used as control (lane 4). 419 
STS treatment induced capase-3 activation (lane 1). Infection with wild type 420 
EPEC inhibited STS-induced pro-caspase-3 cleavage (lane 2), while infection 421 
with nleH1nleH2 mutant did not (lane 3).  422 
(C) Cleaved caspase-3 (active) was quantified in cells transfected with nleH1, 423 
nleHK159A or pEGFP and treated with either STS, BFA or TUN. Anti-HA 424 
(green) and anti-cleaved caspase-3 (red) were used to detect HA-NleH1 and 425 
NleH1K159A or active caspase-3 by immunofluorescence. Ectopic expression 426 
of NleH1 or NleH1K159A prevented cleavage of pro-caspase-3 by treatment 427 
with STS (B), BFA (C) and TUN (D) compared to mock transfected cells or 428 
cells transfected with pEGFP. The non-parmentric Mann-Whitney Test was 429 
used to determine significance. (* p value <0.05). 430 
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(D) NleH inhibits caspase-3 activation in vivo. Colonic sections extracted from 431 
mice infected for 9 days with wild type or nleH C. rodentium were 432 
immunostained with anti-cleaved caspase-3 antibody, anti-intimin antibody 433 
(to label bacteria) and Hoechst. Specific caspase-3 activation at bacterial 434 
attachment sites was observed in mice infected with nleH mutant but not 435 
with wild type C. rodentium. 436 
 437 
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Fig. 3.  NleH1 and NleH2 target the BI-1 pathway. 
(A) NleH-BI-1 protein interaction. Yeast cells co-transformed with pGBT9-
NleH1/pGAD-BI-1 [I] and pGBT9-NleH1/pGAD-BI-11-40 [II] grew on 
selective medium, whereas yeast co-transformed with pGBT9/pGAD-BI-1 
[III], pGBT9-NleH1/pGAD [IV] and pGBT9/pGAD-BI-11-40 [V] did not, 
demonstrating specific interaction of NleH1 with BI-1 and BI-11-40. 
(B) NleH1 and BI-1 are co-localized. HeLa cells co-transfected with HA-NleH1 
and Myc-BI-1 immunostained with anti-HA (red) and anti-Myc (green) 
antibodies. NleH1 co-localizes with BI-1 at a reticular perinuclear region 
(white arrows) and also localizes to the plasma membrane (red arrows). 
(C) BI-1 knockdown was verified by semi-quantitative RT-PCR. GADPH RT-
PCR was used as a total mRNA concentration control. 
(D) Quantification of cytoplasmic Ca2+ level in HeLa cells depleted of BI-1 or 
treated with control siRNA. While no significant Ca
2+ 
release was observed in 
uninfected cells transfected with BI-1 or control siRNA, a significant increase 
of Ca
2+ 
release was observed in BI-1 depleted cells infected with wild type 
EPEC in comparison to infected cells transfected with control siRNA. 
Significance was tested using the one-way analysis of variance (ANOVA) 
Bonferroni multiple comparisons test (* p value < 0.05). 
(E) Quantification after infection of live adherent HeLa cells depleted of BI-1 or 
treated with control siRNA. The number of adherent cells treated with BI-1 
siRNA and infected with wild type EPEC was similar to that of 
nleH1nleH2-infected cells but was significantly lower than cells treated 
with control siRNA and infected with wild type EPEC. Significance was 
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tested using the one way analysis of variance (ANOVA) Bonferroni Multiple 
comparisons Test (* p value < 0.05).  
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SUPPLEMENTARY DATA 
SUPPLEMENTARY MATERIALS AND METHODS 
Bacterial Strains and Growth Conditions 
The strains and primers used in this study are listed in Table S1 and S2. The lambda 
red system (1) was used to delete nleH1 and nleH2 from wild type EPEC strain 
E2348/69 (2), generating strain ICC303. nleH1-sepcific primer pair 1 & 2 was used to 
amplify the kanamycin cassette from pSB315 (3). nleH2-sepcific primer pair 3 & 4 
was used to amplify the chloramphenicol cassette from pKD3 (1). Deletion of nleH1 
and nleH2 was confirmed using primer pairs 19 & 20 (nleH external); 21 & 22 
(kanamycin cassette-specific), 23 & 24 (nleH2 external) and 25 & 26 
(chloramphenicol cassette-specific). The C. rodentium ICC180 nleH mutant 
(ICC285) was made previously as described in (4).  
Bacteria were cultured in LB broth at 37°C for 18 h with appropriate antibiotics (100 
µg ml
–1 
of ampicillin, 25
 
µg ml
–1 
of chloramphenicol or 50 µg ml
–1 
of kanamycin). 
Overnight LB cultures were primed for infection by 1:100 dilution in DMEM 
(Dubelcco’s minimal Eagle medium) containing 1000 mg/L glucose without phenol 
red and a further incubation for 3 h at 37°C without agitation; 1 mM isopropyl--D-
thiogalactopyranoside was added for the final 30 min when needed (for expression 
from pSA10-derived plasmids). HeLa cells were infected with primed bacteria 
normalized to a multiplicity of infection (MOI) of 1:50 or 1:100 for the specified time 
points. 
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Plasmids and nleH Gene Cloning 
The plasmids used in this study are listed in Table S3. For purification of His-tagged 
NleH, nleH1 was amplified using primers 29 & 30, and cloned into pET28a 
(generating pICC451). pICC451 and pICC449 was used as a template for site directed 
mutagenesis (K159A) using QuikChange® Site-Directed Mutagenesis Kit 
(Stratagene) and the primer pair 31 & 32 (generating pICC452 and pICC450 
respectively). For cloning into the bacterial expression vector pSA10 (5) neH1 and 
nleH2 were amplified using primer pairs 5 & 6 and 7 & 8, respectively (generating 
pICC443 and pICC444 respectively). For yeast two hybrid screen, neH1, nleH2 and 
ospG were cloned into pGBT9 (Clontech) (to generate pICC447,pICC448 and 
pICC456 respectively) using primers 9 & 10, 11 & 12 and  35 & 36 respectively. 
Deletion of the 100 first amino acids of NleH was done by inverse PCR on 
pGBT9(nleh1) using the primer 33 & 34 generating pGBT9(nleh1Δ100) (pICC455). 
For transfection experiments, nleH1 and nleH1K159A were cloned into the transfection 
vector pHM6 (Roche) using primers 13 & 14 and E2348/69 DNA or pICC452 as 
templates respectively, generating pHM6(nleH1) (pICC449) and pHM6(nleH1K159A) 
(pICC450). The pEGFP-N1 (Clonetech) vector was used as a control in all 
transfection experiments. For transfection experiments, bi-1 was cloned into the 
transfection vector pRK5-Myc using primers 37 & 38 and pICC458 as a template. 
Protein Purification and Dialysis 
NleH1-His and NleH1(K159A)-His were purified using a Ni
2+ 
agarose His-Bind 
Resin Column (Novagen). Purified NleH1-His and NleH1(K159A)-His were dialysed 
against EB50 buffer (50 mM Tris pH 8, 2mM DTT, 2mM EDTA, 10% glycerol, 50 
mM NaCl). Dialysed proteins were then concentrated using 10KDa Millpore’s 
Amicon Centricons and frozen in 50 μl aliquots at -80°C. NaCl concentration was 
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adjusted and 0.1% TritonX 100 was added equally to all samples to prevent 
precipitation during storage. 
Kinase Assay 
NleH1-His and NleH1(K159A)-His were added to the kinase assay reagent mix (50 mM 
Tris-HCl pH 7.5, 10 mM MgCl2, 100 mM NaCl, 1 mM Dithiothreitol, 50 μM ATP) with 
5 μCi [γ-33P]ATP (MP Radiochemicals, 370 MBq/ml, 3000 Ci/mmol) with or without 
10 μg of the general substrate myelin basic protein (MBP; Sigma). 100 units of Abl 
tyrosine Kinase (NEB) was used as a positive control as per the manufacturer’s 
instructions. The mixture was incubated for 30 min at 37°C and subjected to SDS-PAGE 
followed by Coomassie blue staining and autoradiography.  
Tissue Culture, Transfection and Pharmacology 
HeLa cells were grown and infected as described (6). Cells were transfected with the 
different expression vectors using lipofectamine 2000 (Invitrogen) or with 20 μM BI-
1 or control siRNA using
 
hyperfect (Qiagen) according
 to the manufacturers’ 
recommendations.
 
After 72 h, knockdown of BI-1 expression was tested by RNA 
isolation using the QIAGEN RNAeasy kit according to the manufacturer’s 
recommendation and semi-quantitative RT-PCR using BI-1 (h)-PR (Santa cruz, sc-
37298-PR) or GADPH (primers 15 & 16) primers. 
Apoptosis was induced by the addition of 1 μM of staurosporine (STS, Calbiochem) 
for 4 h during EPEC infection and for 6 h during transfection. ER stress was induced 
by the addition of 10 μg/ml of brefeldin A (BFA, Sigma) or 5 μg/ml of tunicamycin 
(TUN, Sigma) followed by 18 h incubation. The global caspases inhibitor z-VAD-
fmk (Calbiochem) was used at a final concentration 66 μM (added together with 
bacteria or with STS).  
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Epifluorescence microscopy and scanning electron microscopy 
For analysis of nuclear condensation and membrane blebbing, HeLa cells were 
infected with a MOI of 1:50 for 1h as described previously. Following 5 washes with 
HBSS, 250 g/ml gentamicin (Invitrogen) was added to kill the bacteria (to avoid 
cytotoxic effect of bacterial multiplication) for a further 2 h before processing for 
DNA staining with Hoescht 33342 (Molecular
 
Probes) or scanning electron 
microscopy (SEM). 
Membrane blebbing was analyzed by phase contrast and was distinguished from 
attached bacteria stained with Hoescht 33342. Membrane blebbing was confirmed by 
SEM. For SEM, cells were fixed with formaldehyde, washed in phosphate buffer (0.1 
M, pH 7.3), fixed overnight in 3% glutaraldehyde and post-fixed in 1% osmium 
tetroxide for 30 min. Samples were processed using standard dehydration and critical 
point drying methods, sputter coated using a gold sputter (gold-palladium target). 
Samples were examined using a Jeol JSM-6390 SEM. 
For cleaved caspase-3 stainings, transfected cells were fixed in pre-chilled methanol 
for 10 min at -20°C, permeabilized, washed and quenched for 30 min with 50 mM 
NH4Cl and stained as described (6). Cleaved caspase-3 (active) was detected with 
rabbit anti-cleaved caspase-3 (Cell Signalling Technology), incubated overnight at 
4°C, and HA-NleH1 was stained with mouse anti-HA (Covance), diluted at 1/1000 
and 1/500 respectively in 5% BSA. Donkey anti-rabbit IgG conjugated to rhodamine 
(RRX) and donkey anti-mouse IgG conjugated to Cy2 (Jackson laboratories) were 
used at concentrations recommended by the manufacturer. For Myc-BI-1/HA-NleH1 
co-localization, transfected cells were fixed with paraformaldehyde, permeabilized 
with Triton X-100, washed with PBS, quenched for 30 min with 50 mM NH4Cl. HA-
NleH1 was detected with mouse anti-HA (Covance) diluted at 1/500 and then with 
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donkey anti-mouse IgG conjugated to RRX. Myc-BI-1 was next detected with mouse 
anti-myc conjugated to FITC (Sigma) diluted at 1/240 in 5% BSA. 
Before epifluorescence observation, the coverslips were mounted on slides using 
ProLong Gold antifade reagent (Invitrogen) and visualized by Zeiss Axioimager 
immunofluorescence microscope. All images were analysed using Axiovision Rel 4.5 
software. 
Cell Viability Assay 
HeLa cells grown in 24 well plates were infected for 1 h with an MOI of 1:100 and 
then treated with 250 g/ml gentamicin for 4 h. Cells were washed 3 times with PBS, 
trypsinized and trypsin was inactivated with culture media. 0.05% Trypan blue in PBS 
was mixed with HeLa cells at a 1:1 ratio just prior to counting on a Nebauer 
haemocytometer. All counts were compared to the level of uninfected untreated cells 
and plotted as percentage of adherent cells. 
Detection of pro-caspase-3 by Western blotting 
HeLa cells, grown in 6-well plates, were infected for 1 h with an MOI of 1:100. After 
washing in HBSS 5 times, 250 g/ml gentamicin and STS were added and the cells 
were incubated at 37°C for 3 h and washed. Then, cells were lyzed in 1% Triton X-
100 containing a protease inhibitor cocktail (Sigma). Cells were scraped on ice and 
the lysates were sonicated. Whole-cell lysates were concentrated using biomax 
protein concentrating columns (Millipore), run on 12% SDS-PAGE gels and 
transferred to PVDF membrane. Membranes were stained overnight at 4°C with anti-
pro-caspase-3 (Cell Signalling Technology) followed by incubation with anti-rabbit 
IgG-HRP conjugate (Dako), diluted 1/3000, for 45 min at room temperature. 
Membranes were incubated with ECL reagents (GE healthcare) and luminescence was 
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detected using LAS 3000 Fuji imager. The same membrane was then washed and 
incubated with the primary mouse anti-tubulin antibody (DSHB) and secondary anti-
mouse IgG-HRP conjugate (Dako). 
Measurement of cytosolic Ca
2+
 levels 
Cytosolic Ca
2+
 levels were measured using the commercially available fluorescent 
indicator Fluo-4 Direct (Invitrogen) according to the manufacturer’s instructions. 
HeLa cells were grown in a 96 well microplate, incubated with Fluo-4 Direct for 1 h 
at 37°C and then infected for 3.5 hrs using primed bacteria (MOI 1:100). Fluorescent 
intensities were determined using a fluorometer set for excitation at 494 nm and 
emission at 516 nm.  
Yeast-two hybrid system 
A pre-transformed MATCHMAKER HeLa cell cDNA library (Clontech) was 
screened against the NleH1 bait according to the manufacturer’s protocol. Plasmid 
from positive colonies were purified using the yeast plasmid purification protocol 
described in Clonetech Yeast Protocols Handbook (PT3024-1), transformed into 
HB101, selected on M9 minimal media supplemented with proline, thiamine, 
streptomycin (100 μg/ml) and ampicillin (100μg/ml) and sequenced. Protein 
interactions were confirmed by co-transforming the yeast AH109 with 
pGBT9(nleH1), pGBT9(nleH1100), pGBT9(nleH2) or pGBT9(ospG) and pGAD(bi-
1) or pGAD(bi-11-40), and plating on selective media (-Ade, His, Trp, Leu). 
Murine models 
All animal experiments were performed in accordance with the Animals Act 1986 and 
were approved by the local Ethical Review Committee. Specific-pathogen-free female 
wild-type inbred C57BL/6 6- to 8-week-old mice were used
 
in this study. All animals 
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were housed in individually HEPA-filtered
 
cages with sterile bedding. Independent 
experiments were performed using at least four mice per group. 
Oral inoculation and harvesting  
Mice were orally inoculated using a gavage needle with 200 µl
 
of overnight LB grown 
bacterial suspension of C. rodentium in PBS ( 5 x 109 CFU). The number of viable 
bacteria used as the inoculum was determined
 
by retrospective plating onto LB agar 
containing antibiotics.
 
Stool samples were recovered aseptically at various time points
 
after inoculation and the number of viable bacteria per gram
 
of stool determined after 
homogenization at 0.1g ml
–1 
in PBS and plating onto LB agar containing the 
appropriate antibiotics and showed no significant differences in colonisation between 
groups (data not shown).
  
Tissue collection and IFA staining
 
Segments of the cecum and the terminal colon of each mouse were
 
collected at 9 days 
post-inoculation, rinsed of their
 
content, and fixed in 10% buffered formalin for 
microscopic
 
examination. Formalin-fixed tissues were then processed, paraffin
 
embedded, sectioned at 5 µm. Sections were unwaxed in Histoclear by washing twice 
for 10 min and rehydrated in 100%, 95% and 80% Ethanol respectively before 
immersion in PBS 0.1% Tween 20 0.1% saponin (PBS-TS). Sections were placed in 
10 mM sodium citrate and heated to 100°C for 10 minutes for heat induced antigen 
unmasking. Blocking was conducted in PBS-TS with 10% normal donkey serum 
before labelling. For caspase-3 cleavage, an indirect immunofluorescence assay (IFA) 
was used using chicken anti-intimin antibody to label bacteria and rabbit anti-cleaved 
caspase-3 (Cell Signalling) overnight at 4°C and Hoechst at room temperature for 1 h 
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in a humidified chamber for DNA labelling. Multiple separate sections of each mouse 
were observed and at least 4 sites of adherent bacteria were analysed per mouse.  
Sections
 
were examined with an Axio Imager M1 microscope (Carl Zeiss
 
MicroImaging GmbH, Germany). Images were acquired using an AxioCam
 
MRm 
monochrome camera and computer processed using AxioVision
 
(Carl Zeiss 
MicroImaging GmbH, Germany), Adobe Photoshop
 
5.0 and Adobe Illustrator 8.0 
software (Adobe Systems Incorporated,
 
CA).
 
 
Statistics 
All statistical tests were performed using commercially available GraphPad InStat 
v3.06 software (GraphPad Software Inc., San Diego California USA) on experiments 
tested in triplicate and repeated a minimum of three times. 
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Table S1: List of strains 1 
Strains Characteristics Reference 
E2348/69 Wild-type EPEC O127:H6 (2) 
ICC303 EPEC E2348/69 ΔnleH1ΔnleH2, nleH1::Kan, nleH2::Cm (Kanr Cmr) This study 
AH109 S. cerevisiae MATa mating type with HIS3, ADE2, lacZ, and MEL1 
reporters for interaction, and TRP1 and  LEU2 transformation 
markers 
Clontech 
Y187 S. cerevisiae MATα mating type with lacZ, and MEL1 reporters for 
interaction, and TRP1 and  LEU2 transformation markers 
Clontech 
ICC180 Bioluminescent C. rodentium harboring the Photorhabdus luxCDABE 
operon (Kan
r
) 
(7) 
ICC285 ICC180 ΔnleH (Kanr Cmr) (4) 
*Kan
r
 (Kanamycin), Cm
r
  (Chloramphenicol)  
2 
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Table S2: List of plasmid 3 
Plasmids Characteristics Reference 
pSA10 pKK177-3 expression vector containing lacI gene  (5) 
pICC443 p(nleH1), Derivative of pSA10, expressing NleH1 This study 
pICC444 p(nleH2), Derivative of pSA10, expressing NleH2 This study 
pGBT9 Y2H expression vector with GAL4 DNA binding domain (GAL4-
BD) 
Clonetech 
pGAD-T7 Rec Y2H vector containing library inserts fused to GAL4 DNA 
activation domain (GAL4-AD) 
Clonetech 
pGAD424 Y2H expression vector with GAL4 DNA activation domain 
(GAL4-AD) 
Clonetech 
pICC447 pGBT9(nleH1), Derivative of pGBT9, expressing NleH1 fused to 
GAL4-BD  
This study 
pICC448 pGBT9(nleH2), Derivative of pGBT9, expressing NleH2 fused to 
GAL4-BD  
This study 
pICC455 pGBT9(nleH1D100), Derivative of pGBT9 expressing NleH1 
deleted from its first 100 amino acids fused to GAL4-BD 
This study 
pICC456 pGBT9 (OspG), Derivative of pGBT9 expressing OspG fused to 
GAL4-BD 
This study 
pICC457 pGAD(BI-1), Derivative of pGAD424 expressing BI-1 fused to 
GAL4-AD 
Clonetech 
pHM6 Mammalian expression vector with N-term HA tag  Roche 
pICC449 pHM6(nleH1), Derivative of pHM6, expressing HA-NleH1 This study 
pICC450 pHM6(nleH1K159A), Derivative of pHM6, expressing HA-
NleH1K159A 
This study 
pET28a Vector for expression of His-tagged proteins Novagen 
pICC451 pET28a expressing NleH1 His tagged This study 
pICC452 pET28a expressing NleH1K159A His tagged This study 
pSB315 Source of aphT cassette (1) 
pKD4 oriRg, blaM, KanR cassette flanked by FRT sites  (1) 
pKD46 ori101, repA 101 (ts), araBp-gam-bet-exo, blaM (1) 
pRK5-myc Mammalian expression vector with N-term Myc tag (8) 
pICC458 pRK5-myc transfection vector expressing BI-1 This study 
pRK5-myc-OspG pRK5-myc transfection vector expressing OspG (9) 
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Table S2: List of primers 4 
 Sequence 5' - 3' 
1 ATGCTATCACCATCTTCTGTAAATTTGGGGTGTTCATGGAATTCTTTAACCACGTTGTGTCTCAAAATCTC 
2 AATTTTACTTAATACCACACTAATAAGATCTTGCTTTCCTCCATGATAAGGAATTCCCCGGATCCGTCGAC 
3 ATGTTATCGCCCTCTTCTATAAATTTGGGATGTTCATGGAATTCTTTAACGTGTAGGCTGGAGCTGCTTC 
4 TATCTTACTTAATACTACACTAATAAGATCCAGCTTTCCTCCGTGATAAGCATAGAATATCCTCCTTA 
5 CCGCGGGTCGACATGCTATCACCATCTTCTG 
6 AAAACTGCAGTCATCAAATTTTACTTAATACCACACTAAT 
7 CCGCGGGTCGACATGTTATCGCCCTCTTCTA 
8 AAAACTGCAGTCATCATATCTTACTTAATACTACACTAAT 
9 CGGGATCCTGCTATCACCATCTTCTG 
10 CCAATGCATTGGTTCTGCAGCTAAATTTTACTTAATACC 
11 CGGGATCCTGTTATCGCCCTCTTCTA 
12 CCAATGCATTGGTTCTGCAGTTATATCTTACTTAATACT 
13 CCCGGAAGCTTGATGCTATCACCATCTTCT 
14 ATAGTTAGCGGCCGAATTTTACTTAATACCACACTAAT 
15 AAGGTCGGAGTCAACGGATTTGGT 
16 AGTGATGGCATGGACTGTGGTCAT 
17 CTATTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAG 
18 TTAGCATCTATGACTTTTTGGGGCGTTCAAGTG  
19 GTCATGGTGATGTTTGTTAAG 
20 TACCAACTCCATCCATGCAAC 
21 CAGGATCTTGCCATCCTATGGA 
22 GCTTGATGGTCGGAAGAGCATA 
23 GCAAATCCTGCGTGCTGACGG 
24 CGGATCCTCATCCACATTGTAAAGATCC 
25 TTATACGCAAGGCGACAAGG 
26 GATCTTCCGTCACAGGTAGG 
27 AAAACTGCAGTCATCATACCACACTAATAAGATCTTGCTT 
28 AAAACTGCAGTCATCATACTACACTAATAAGATCCAGCTT 
29 GGAATTCCATATGCTATCACCATCTTCTG 
30 GGATCCAGAACCCTAAATTTTACTTAATACC 
31 GAT GCA ACA AAA GTC CTG GCG ATG TTT ACT ACA TCT CAA AGC 
32 GCT TTG AGA TGT AGT AAA CAT CGC CAG GAC TTT TGT TGC ATC 
33 GCTGTTCATTCGAATAGACCTG 
34 CAGGATCCCCGGGAATTCCG 
35 GCGAATTCAAAATTACCAGCACCATTATTCA 
36 CGGGATCCTCACAGATATTTGCGGTTCAGCA 
37 CCGGAATTCCAACATATTTGATCGAAA 
38 CCCAAGCTTTCATTTCTTCTCTTTCTTCTTA 
  
 5 
 40 
SUPPLEMENTARY FIGURE LEGENDS 6 
 7 
Fig. S1. HeLa cells infected with EPEC nleH undergo apoptosis. Cells infected 8 
for 3 h with wild type EPEC, nleH1nleH2 and complemented strains p(nleH1) or 9 
p(nleH2) were either stained with Hoechst for evaluation of nuclear condensation and 10 
fragmentation (A, arrows) or processed for SEM to visualize membrane blebbing (B, 11 
arrows). Uninfected and STS-treated cells were used as controls. 12 
Fig. S2. Autoradiograph (A) and Commasie staining (B) of NleH1 kinase assay using 13 
[γ-33P] ATP. Kinase assays were conducted using purified proteins in the presence or 14 
absence of the general substrate myelin basic protein (MBP). NleH1 phosphorylated 15 
MBP (Lane 1) and autophosphorylated itself (Lane 2). A K159A substitution resulted 16 
in loss of kinase activity (Lanes 3 and 4). Abl kinase was used as a positive control 17 
(Lanes 5 and 6). The MBP substrate used in the kinase assays is shown in lane 7. 18 
Fig. S3. 19 
(A) Sequence alignment of NleH1, NleH2 of EPEC strain E2348/69, and OspG of 20 
Shigella flexneri 2A strain 320. ! and $ correspond to hydrophobic residues (I 21 
or V and L or M), % corresponds to aromatic residues (F or Y), # corresponds 22 
to charged residues (N, Q, D, E). 23 
(B) Ectopic expression of OspG did not prevent cleavage of pro-caspase-3 24 
following treatment with STS, similarly to mock or GFP transfected cells. 25 
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